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ABSTRACT 
 Stroke is the most common cause of disability worldwide, and it is expected that 
the global number of stroke survivors will increase significantly over the coming 
decades. Many survivors of stroke have both short and long-term deficits in function, 
the most common of which are motor deficits. However, an often forgotten aspect of 
stroke is its negative and often long-lasting effects on cognitive function. At the 
moment, there are some effective intervention strategies for treating motor dysfunction 
post-stroke, but we currently have very limited strategies for treating cognitive 
dysfunction. Furthermore, there are very few stroke models specifically focusing on 
higher-order cognitive dysfunctions, also known as executive functions, which have 
been shown to be affected in a substantial portion of stroke survivors. This makes it 
difficult to effectively study the effects of potential therapies to alleviate post-stroke 
cognitive dysfunction. It is also known that the seat of higher-order cognitive function is 
the prefrontal cortex (PFC), and that damage to this region or by damaging connections 
to the area can result in executive dysfunction. Therefore, the goal of this thesis is to 
develop new animal models of post-stroke cognitive dysfunction, targeting specific 
regions of the rodent PFC. The overarching hypothesis of the project was that injections 
of the vasoconstrictor, endothelin-1, into particular regions of the prefrontal cortex will 
cause ischemic lesions in this area, as well as measureable cognitive deficits in higher-
order cognitive functions. The overall objectives of the thesis were: 
 
1. To refine and evaluate the effects of endothelin-1 injections into the prefrontal 
cortex on brain lesion size, and initial behavioural effects in the rat. 
2. To measure the effects of refined, focal ischemic lesions within the medial 
prefrontal cortex on aspects of set-shifting and temporal order memory, both of 
which are higher-order cognitive functions, in the rat. 
3. To further evaluate the model using endothelin-1 to create focal lesions in the 
orbital prefrontal cortex versus lesions in the medial prefrontal cortex to assess 
its effects on decision making in the rat. 
 
 The initial modelling of post-stroke cognitive dysfunction was attempted using 
the compound endothelin-1 (ET-1), an endogenous polypeptide capable of constricting 
blood vessels in the brain. Two separate medial prefrontal cortical (mPFC) ET-1 
injection protocols (four injections versus two injections into the mPFC) in the rat were 
examined in an attempt to understand the size and location of the resulting brain lesion. 
It was found that the two injection protocol, as compared to the four injection protocol, 
resulted in a more targeted lesion in the mPFC and resulted in fewer animal mortalities. 
As well, it appeared that mPFC lesions caused anxiogenic behaviours in these animals 
as assessed through the elevated plus maze, indicating that these lesions were having 
some effects on post-stroke cognitive behaviour. Further experiments with the two-
injection endothelin-1 model previously established assessed for deficits in specific 
higher-order cognitive domains, specifically set-shifting and temporal order memory. 
This was done using a modified set-shifting maze and a temporal object recognition 
task. It was found that lesions to the medial prefrontal cortex caused specific context-
dependent set-shifting dysfunctions in stroke animals. However, attempts to determine 
the lesion‟s effects on temporal order memory did not function as expected, indicating 
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that the methods used to assess this behaviour need to be modified in the future. Finally, 
two separate models of prefrontal stroke targeting the medial and orbital prefrontal 
cortices were both examined for their effects on decision making and inhibitory control 
as assessed through a delay discounting maze, wherein animals would have the choice 
between an immediately available, but small, food reward or a larger food reward, to 
which access was delayed. As well, during this testing the animals‟ ultrasonic 
vocalizations, which can indicate affective or aversive emotional states, were also 
recorded while the animals were anticipating a food reward. What was found was that 
lesions to the orbital, but not the medial, prefrontal cortex caused rats to choose the 
lower food reward as compared to control animals. Interestingly, only the medial 
prefrontal lesioned animals changed the relative frequency and duration of their 
ultrasonic vocalization calls post-stroke, indicating that changes in animal vocalizations 
are not necessarily correlated to changes in behaviour.  
 
 Overall, the work presented in this thesis suggests that specific higher-order 
cognitive dysfunctions can be accomplished using endothelin-1, thereby providing a 
potentially new model for the study of post-stroke cognitive dysfunction. 
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CHAPTER 1 
GENERAL INTRODUCTION 
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OVERVIEW 
 Stroke is a very common acute neurological injury that affects over 50,000 
Canadians per year, having devastating effects on both the lives of those afflicted and 
their families and friends. When people think of the effects of stroke in a general sense, 
it is thought of in terms of deficits and weaknesses in movement, which are indeed the 
most common post-stroke deficits (Lawrence et al. 2001). However, some of the 
overlooked deficiencies following stroke are the cognitive changes that occur when 
certain areas of the brain are damaged as a consequence of improper blood flow. These 
deficits can be long-lasting and have detrimental effects on the quality of an individual's 
life, which can have important clinical outcomes which can include increased recovery 
time post-stroke and increased incidence of depressive episodes (King 1996; Nys et al. 
2006). These deficits in cognitive function, an understandably broad category, can 
include deficits in learning and memory, language difficulties, emotional incontinence, 
problems with goal-oriented behaviour, disinhibitory behaviour, and other higher order 
cognitive deficits. These cognitive deficits, although less common than motor deficits, 
do occur frequently post-stroke. 
 One of the unfortunate aspects about acute stroke treatment and why so many are 
left debilitated is the lack of pharmacological and behavioural interventions that can be 
administered during or shortly after the stroke. One of the only therapeutic interventions 
available to clinicians in North America, recombinant tissue plasminogen activators (r-
tPAs), has an effective time window of 3-6 hours post-stroke, depending on various 
circumstances. Clot-busters can only be used during an ischemic rather than 
hemorrhagic insult and severely restricts its use as tPA can only be used after the patient 
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arrives to a medical facility and undergoes a CT scan (or MRI) and clinically-verified as 
ischemic. As such, valuable time from onset to intervention is lost as inadvertent use of 
tPA on a hemorrhagic stroke will cause more bleeding and worsen clinical outcomes. 
 In a broad sense motor dysfunctions post-stroke, although debilitating, have the 
capacity to be treated or minimized through a number of therapeutic options. Some of 
the most common forms of motor therapies, physical and occupational therapy, have 
been used with a notable degree of success (Steultjens et al. 2003). As well, a relatively 
new and notable therapy is known as constraint induced movement therapy, which has 
been demonstrated to work in both animal models of stroke as well as to help restore 
limb function in patients (McIntyre et al. 2012; Schmidt et al. 2014). In contrast, there 
has been very limited success for the treatment of cognitive dysfunction that has 
occurred due to stroke, and this treatment has been specific to only select subsets of 
cognitive functions (Cicerone et al. 2005; Chung et al. 2013). Another issue that is faced 
with regards to stroke and cognitive function relating to treatment therapies, is the lack 
of ischemic models that demonstrate replicable higher-order cognitive deficits (Jiwa et 
al. 2010). If we are to treat post-stroke cognitive dysfunctions, we need to be able to 
model them effectively.  
 Therefore, the overall aim of the work contained in this thesis is to contribute to 
the development of a new animal model of stroke damage that will successfully mimic 
some of the higher-order cognitive deficits that are seen post-stroke. Specifically, this 
work describes the preliminary modelling of post-stroke ischemic cognitive dysfunction 
in the rat, which has the potential to be further refined and used for the development of 
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behavioural or pharmacological therapies for the treatment of post-stroke cognitive 
dysfunction. 
 The purpose of this first chapter is to provide background regarding the disease 
of stroke, how it causes damage, what sorts of deficits result, and the current state of 
research regarding cognitive dysfunction post-stroke.  
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1.1 STROKE 
 
 The disease of stroke is a non-communicable ailment resulting from the poor 
flow of blood to the brain, ultimately culminating in damaged brain tissue and cell 
death. Although the relative rate of death from this disease, and cardiovascular disease 
in general, has been decreasing in many parts of the Western world since the second half 
of the 20th century, the effects of this disease can still be widely felt (Sarti et al. 2000). 
The overall death rate from stroke varies, but roughly one quarter to one third of 
individuals who suffer a stroke die within a short amount of time post-insult (Anderson 
et al. 1994; Weimar et al. 2002; Hollander et al. 2003). Despite improvements in death 
rates, much of the insidiousness of stroke comes from the number of individuals that are 
left temporarily or permanently disabled post-insult. It has been demonstrated that 
approximately one third of stroke survivors continue to have deficits in function five 
years post-stroke, and one seventh of these survivors are permanently institutionalized 
(Hankey et al. 2002). In another study examining the effects of even minor ischemic 
events, described as patients with minor functional deficits as assessed by the National 
Institutes of Health Stroke Scale (NIHSS) score, almost one third of patients continued 
to have substantial deficits in function (Khatri et al. 2012). In Canada, it has been 
estimated that approximately 400,000 individuals experience the ongoing effects of 
stroke, which equates to little over 1% of the total population of the country (Krueger et 
al. 2015). In other higher-income countries, this trend is similar (Feigin et al. 2014; 
Mozaffarian et al. 2014).  
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 However, not only is this disease having a profound effect in developed 
countries, but currently developing countries with less robust health-care systems are 
also burdened by stroke, and the rates of stroke are increasing in these areas (Feigin et 
al. 2009). The economic and social burden of this disease is also deeply felt. In Canada 
alone, stroke has been estimated to cost 2.9 billion dollars annually in direct medical 
costs and other indirect costs (Mittmann et al. 2012).   
 The risk factors associated with ischemia are numerous, and include 
hypertension, current smoking status, waist-to-hip ratio, diet, exercise, alcohol intake, 
stress, and genetic factors (O‟Donnell et al. 2010; Traylor et al. 2012). Although the 
relative number of people smoking in Canada and many other countries is decreasing 
(Ng et al. 2014), Canadians on the whole are gaining weight (Luo et al. 2007), 
exercising less than they should be (Colley et al. 2011), and getting older (Statistics 
Canada 2014), which has the potential to affect the rates of stroke in Canada in the 
coming decades. 
 Strokes can be subdivided into two major categories, ischemic strokes and 
hemorrhagic strokes. Ischemic strokes involve a reduction of blood flow in vessels in 
the brain, and hemorrhagic strokes are the result of a ruptured blood vessel in the brain. 
The work contained within the following chapters of this thesis focuses on the effects of 
ischemic stroke rather than hemorrhagic stroke, therefore a brief discussion as to what 
ischemia is, and its cellular and molecular effects on the brain, will be given. 
 
 
   
7 
 
1.2 ISCHEMIA 
 
 As mentioned previously, the most common form of stroke is the result of an 
ischemic event, which can be caused by an embolus lodged within the vessel, a 
thrombus having developed within the artery, or a lack of blood flow to the brain caused 
by some other event external to the brain. These events result in a reduction of blood 
flow, and this reduction can become acutely damaging at flow rates below 35 mls per 
100 g of tissue per minute (Bandera et al. 2006) . Because of this, a lack of glucose and 
oxygen from the blood to brain cells ultimately leads to a cascade of damage within the 
brain.  
 When comparing the relative rates of ischemia to other forms of stroke, notably 
hemorrhagic stroke, ischemia occurs much more commonly. It has been estimated that 
ischemic strokes form the majority of all strokes in the United States, occurring in 
approximately 87% of all stroke cases (Mozaffarian et al. 2014), and values reported 
previously in Canada appear to be similar (Mayo et al. 1996). As ischemia is the most 
prevalent form of stroke, and the animal models discussed in subsequent chapters of this 
thesis model damage caused through ischemic mechanisms, how ischemia causes 
damage will now be discussed further, with a basic summary presented in Figure 1.1.  
 
 1.2.1 Mechanisms of Ischemic Damage 
 
 To understand how ischemia causes damage in the brain, the first issue that must 
be discussed is the different regions of damage that occur due to ischemia. Ischemic 
8 
 
 
 
Figure 1.1 Basic overview of mechanisms of ischemic damage 
Adapted and simplified from Durukan and Tatlisumak (2007)  
Resulting in apoptosis / necrosis of brain tissue 
Failure of ionic pumps can cause 
Production of free radicals causing 
inflammation 
Increased levels of intracellular 
Ca2+ 
Excess extracelluar K+  
Pathological release of glutamate 
from neurons and astrocytes 
Reduction of ATP production 
Reduction of blood flow reduces presence of  
Glucose  Oxygen 
Ischemic Event (occlusion) 
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damage can be subdivided into two major areas: the core of the infarct and the 
penumbra (Astrup et al. 1981). These two regions can be differentiated by how much 
blood these areas receive during an ischemic event, how quickly these two regions 
succumb to reduced blood flow, and by what mechanisms the cells die (Kaufmann et al. 
1999; Broughton et al. 2009; Yuan 2009). 
 In brief, the core of the infarct is the area that receives little to no blood flow as a 
result of the ischemic event. Unlike many tissues in the body, which can survive 
ischemic conditions for a comparably longer period of time (Jaeschke and Lemasters 
2003; Basile et al. 2011), ischemic conditions in the brain quickly result in damage. As a 
result of this lack of blood flow, the cells in the brain can die relatively quickly, and can 
perish within minutes during acute injury (Lee et al. 2000).  
 The core of the infarct is different from the ischemic penumbra, which is an area 
that receives more blood flow than the core, but may still be susceptible to short or long-
term damage depending on a few different circumstances which can include the amount 
of blood flow, the type of neuronal cells involved, the occurrence of spreading 
depression following insult, and its susceptibility to reperfusion injury (Jenkins et al. 
1981; Dijkhuizen et al. 1998; Lee et al. 2000; Hinzman et al. 2015). 
 
 1.2.2 The Ischemic Cascade 
 
 The ischemic cascade is the series of interlinked events that ultimately culminate 
with the death of neuronal tissue in the central nervous system. Ultimately, the primary 
issue at play with the ischemic cascade is the lack of adenosine triphosphate (ATP) 
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within the brain tissue, which is the result of insufficient production of this molecule 
caused by a lack of nutrients reaching these cells (Xing et al. 2012). The lack of ATP 
production leads to a loss of ionic homeostasis, as the cellular mechanisms responsible 
for the addition and/or removal of Na
+
, K
+
, Cl
-
, and Ca
2+
 no longer function. This leads 
to pathological influxes and effluxes of these ions into and out of the cytoplasm 
(Rothman and Olney 1986). These events further precipitate downstream effects, which 
can have detrimental effects both for these cells undergoing this ionic imbalance as well 
as other nearby cells.    
 The beginning of the ischemic cascade can be understood by knowing that cells 
within the brain function almost exclusively through the production of ATP, produced 
by the breakdown of glucose to gain the energy found within its chemical bonds. Most 
other mechanisms of energy production (including lactic acid production), as well as 
energy storage in the form of glycogen, are not nearly as prevalent in the brain 
compared to other areas of the body (Brown and Ransom 2007). Because of this, the 
brain needs a consistent supply of glucose, as well as oxygen, to survive.  
  Once the brain has used up its minimal stores of glucose and oxygen during an 
ischemic event, the ionic balances that neurons need in order to survive begin to break 
down. To give a sense of the importance of proper ionic balance in the brain, one of the 
primary molecules that contributes to this in neurons, the sodium-potassium pump, has 
been estimated to use over 40% of the available oxygen in the rat brain under normal 
conditions (Clausen et al. 1991). As these molecules are no longer available to perform 
their functions under ischemic conditions, potassium begins to leak from the cell and 
sodium, along with chloride, begin to enter (Jiang et al. 1992). 
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This loss of ionic balance, which leads to the depolarization of neurons, can cause the 
release of the excitatory neurotransmitter, glutamate. Glutamate's release from the 
presynaptic neuron is dependent on calcium influx into the cytoplasm. From there, 
glutamate binds to ionotropic glutamate receptors on the post-synaptic neurons and 
depolarizes these cells (Sharma and Vijayaraghavan 2003). Too much depolarization 
within the infarct area over a short period of time can lead to pathologic excitatory 
conditions in the brain, which can ultimately cause cell death (Hinzman et al. 2015). 
 Inflammatory processes are also activated during and after the ischemic event, 
and can also damage parts of the brain (Zheng and Yenari 2004). Much of this 
inflammatory damage can be done through calcium, which activates the inflammatory 
system. Calcium again acts as a second messenger and upregulates a number of 
cytokines present through the action of NfκB, a known transcription factor (Clemens et 
al. 1997; Zheng and Yenari 2004). This further production of cytokines can directly lead 
to cell death in some cases, but can also be involved in the recruitment of phagocytic 
cells which also play a role in neuronal death (Neher et al. 2013). 
 Other events in stroke that lead to cell death in the peri-infarct zone include 
apoptosis, a form of programmed cell death, which is mainly triggered by the influx of 
calcium caused both by the glutamate release from neurons as well as the damage 
induced by the anoxic conditions surrounding the cell (Nicholson et al. 1977). All of this 
accumulated cellular damage caused by ischemic conditions in the brain, whether it was 
within the core or the penumbra of the insult, may ultimately lead to deficits in function, 
as detailed in the following section. 
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1.3 DEFICITS IN FUNCTION POST-STROKE 
 
 Because of the aforementioned cellular damage that is incurred due to ischemia, 
people can suffer functional deficits in a multitude of modalities that affect everyday 
life. The length of time that these deficits last can be short term, lasting a timeframe of 
days to weeks. This is because many smaller stroke injuries can be repaired through a 
variety of different cellular and molecular mechanisms that occur post-stroke, including 
the formation of new synapses (Jones and Schallert 1992), an increase in the number of 
dendritic spines (Kolb and Gibb 1993), increased expression of growth factors (Talwar 
and Srivastava 2014), and the growth of new neurons in particular parts of the brain (Liu 
et al. 1998). The difficulty is that very often there is not a full spontaneous recovery of 
function, even after the brain's repair and growth mechanisms have been activated. The 
rates of full spontaneous recovery of function in the brain appear to depend on both the 
initial amounts of damage that have occurred in the brain as well as the location of these 
lesions (Desmond et al. 1996; Vogt et al. 2012). 
 If these deficits disappear without intervention, they are said to have 
spontaneously recovered. Depending on the nature of the deficit, some spontaneous 
recovery without intervention can generally be seen with motor deficits for the first one 
to three months post-stroke, after which time recovery without intervention is limited 
(Bonita and Beaglehole 1988; Duncan et al. 1994). Some similar timeframes are seen 
for cognitive deficits, although the window of spontaneous recovery has been shown to 
be slightly longer than that in motor deficits (Wade et al. 1988; Chemerinski et al. 
2001).  Unfortunately, spontaneous recovery of deficits in function does not occur 
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equally for everyone, with those with mild deficits often regaining full capacity of 
function, and those with more severe deficits being unable to live independent lives 
(Cramer 2008). Factors that can affect rates of spontaneous recovery in stroke can 
include age (Zhang et al. 2005), size and location of infarct (Rogers et al. 1997; 
Plowman et al. 2012), and the experimental method by which the damaged was caused 
(Voorhies and Jones 2002), among others. As well, not only does spontaneous recovery 
not always happen, but some individuals with stroke may actually see some declines in 
function over time (Tatemichi et al. 1993).  
 Because the disease of stroke affects many different aspects of behaviour and 
overall function, its effects will be broken down into three separate categories: motor 
dysfunction, sensory dysfunction, and cognitive dysfunction.  
 
 1.3.1 Motor Dysfunction 
 
 Motor dysfunction incorporates many separate disabilities in movement, and can 
include weakness in one side of the body (hemiparesis), complete loss of use of 
movement (paralysis), and spastic or uncoordinated movements of voluntary muscles  
(Bonita and Beaglehole 1988; Ward 2012) . Hemiparesis is the most common form of 
motor disability post-stroke, and can occur in approximately 80% of stroke patients 
(Granger et al. 1988). Overall, the number of people who survive the initial insult and 
have ongoing motor deficits is approximately 25% (Bonita and Beaglehole 1988). 
 Despite the number of challenges faced by people with ongoing motor 
disabilities post-insult, there have been significant improvements in the development of 
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successful recovery treatments to alleviate motor dysfunction. One of the best known of 
these treatments, constraint induced movement therapy (CIMT) has proven to be very 
effective in hemiparetic patients (Wolf et al. 2006), although  . Other forms of motor 
therapy that are commonly employed include task-specific training as well as providing 
environmental enrichment for patients in recovery (Takeuchi and Izumi 2013). These 
forms of treatment for motor dysfunction post-stroke, although the disease is still 
debilitating for many patients, can offer the promise of full functional recovery. 
   
 1.3.2 Sensory Dysfunction 
  
 The loss of sensory function that occurs post-stroke is thought to be quite 
common, estimated to occur in approximately half of the individuals and affects many 
different types and aspects of sensory function. However, one study indicated that over 
80% of patients, one week post-stroke, had sensory dysfunction in at least one sensory 
modality (Kim and Choi-Kwon 1996). Overall, tactile sensation appears to be the 
modality of sensory function that is most affected by stroke, although proprioception 
can also be affected (Tyson et al. 2008). Although there is still much work to be done in 
the domain of sensory dysfunction and restoring function, much progress has been made 
regarding experimental treatments for this aspect of the disease. The evidence regarding 
its treatment has been well summarized by a review by Sullivan and Hedman (2008), 
and includes a large variety of treatments including  sensory discrimination tasks, 
electrical stimulation, and intermittent pneumatic pressure.  
 
15 
 
 1.3.3 Cognitive Dysfunction  
 
 Although not as prominent or as common as motor dysfunction, cognitive 
dysfunction post-stroke is still a major concern. Post-stroke cognitive dysfunction has 
been estimated to occur in approximately one third of stroke survivors (Zhou et al. 
2005), however, estimated measurements of cognitive dysfunction are dependent on the 
types of tests used, as well as determining the degree of impairment needed to qualify as 
a deficit in cognitive function (Sun et al. 2014). Therefore, depending on the type of test 
used, estimates as to the number of patients exhibiting cognitive dysfunctions post-
stroke can be even higher. For example, it has been shown that in some cases, post-
stroke depression can occur in over half of patients recovering from stroke (Kauhanen et 
al. 1999).  
 One of the more difficult aspects of cognitive dysfunction is the lack of recovery 
of function in many individuals affected. In one two-year study by Hochstenbach et al. 
(2003), it was demonstrated that in a few patients some long-term cognitive 
improvements were made, but for most patients cognitive dysfunction either did not 
improve and/or actually worsened over the course of the study. This finding is repeated 
in a number of other studies demonstrating poor long-term cognitive improvement post-
stroke (Desmond et al. 1996; Rasquin et al. 2004). So, although cognitive recovery is 
possible in a small subset of patients long-term, many do not fully recover cognitive 
function and others can suffer further cognitive decline. 
 Emotional dysfunction and disturbances are also common post-stroke of which 
the most common symptom is depression, reported to occur as either mild or major 
16 
 
depression in roughly one fifth of patients (Brodaty et al. 2007). Emotional dysfunction 
can also include mania, anxiety, and disinhibitory control, which all occur somewhat 
less frequently post-stroke.  
 For the most part, cognitive and emotional deficits are typically assessed post-
stroke by a number of neurological tests, including the Montreal Cognitive Assessment 
(MoCA), the Mini Mental State Exam (MMSE) (Cumming et al. 2013), which are some 
of the more common cognitive tests used.  
 Now that the rates of cognitive dysfunction and general categories of these 
deficits have been explained, specific types of deficits with a concentration on higher-
order cognitive deficits will now be discussed. 
 
1.4 TYPES OF COGNITIVE DYSFUNCTION POST-STROKE 
 
 As discussed in the previous section, cognitive dysfunction can be a common 
occurrence in stroke patients. As well, one of the other major issues regarding cognitive 
dysfunction post-stroke is that it can also affect motor function as well as delay recovery 
time post-stroke (Tatemichi et al. 1994). 
 There are a multitude of different types of common cognitive dysfunctions that 
occur post-stroke, and some of these broad categories will be reviewed below. 
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 1.4.1 Memory Deficits 
 
 Depending on the nature of the stroke, individuals often have complications with 
learning new information as well as retaining and recalling information. Overall, 
approximately 30% of patients surviving a stroke have some form of memory deficit 
(Cullen et al. 2007), and the recovery from these memory deficits is not assured. These 
memory deficits include deficits in both prospective and retrospective memory (Kim et 
al. 2009), wherein “prospective deficits” refers to failing to be able to remember and 
plan out and execute new actions, and “retrospective deficits” refer to the recollection of 
previously acquired memories. Overall, deficits in memory function post-stroke do not 
appear to be correlated with having more severe strokes, but they are associated with 
decreased functional capabilities with everyday tasks and can interfere with overall 
stroke recovery (Wade et al. 1986). 
  
 1.4.2 Mood Disorders and Emotional Incontinence  
 
 Although perhaps not as common as other types of cognitive deficits, emotional 
incontinence and mood disorders do occur post-stroke (Robinson 1997). The sorts of 
deficits included in this category include increased levels of anxiety, which can occur in 
over one fourth of patients (Barker-Collo 2007), as well as post-stroke mania and 
chronic fatigue. 
 Interestingly, although mood disorders may be common post-stroke, many 
psychiatric issues appear to dissipate within the first year following insult, suggesting 
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that these symptoms will alleviate themselves over time (House et al. 1991). Despite 
this, these deficits in function has been reported in a number of patients post-stroke,  and 
affect not only the stroke survivor but also their family, friends, and caregivers, causing 
them undue burden (Williams 1994). 
 
 1.4.3 Post-Stroke Depression 
 
 One crucial aspect of cognitive dysfunction that has garnered a lot of attention is 
depression following stroke. Post-stroke major depression has been reported to occur in 
as many as one third of all stroke survivors (Gonzalez-Torrecillas et al. 1995), and can 
occur for a variety of reasons. The first of these reasons is the location of the lesion, 
with lesions located near the anterior portion of the left hemisphere resulting in more 
cases of depression (Robinson et al. 1984), although further meta-analysis of the 
literature of post-stroke depression gives a conflicting view of this hypothesis (Bhogal et 
al. 2004). Lesion size has also been linked to the severity of post-stroke depression, with 
larger lesions being associated with increased depressive symptoms (Nys, van 
Zandvoort, van der Worp, et al. 2005).    
 The time course of the disease has been reported to run for approximately 1-2 
years post-insult (Parikh et al. 1987), and somewhat paradoxically the earlier the 
depressive symptoms appear following the stroke, the shorter these depressive 
symptoms can last (Aström et al. 1993).  
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 1.4.4 Post-Stroke Dementia 
 
 Dementia, although it is an amalgamation of many forms of cognitive 
dysfunction, specifically refers to an acquired persistent deficit in overall mental 
function, with deficits in at least three different spheres of mental function which can 
include memory, abstract thought, or personality (Cummings 1984). Although 
Alzheimer's disease is reportedly the most common form of dementia, dementia 
incurred through one or multiple ischemic events is also prevalent, and it has been 
estimated that approximately one fifth of people under 65 with dementia acquired it 
through some sort of vascular event (Harvey 2003). In another study of those 85 years of 
age, just under half of those with dementia acquired it through some sort of disruption of 
the vasculature of the brain (Skoog et al. 1993).   The risk factors associated with 
developing this form of impairment post-stroke are similar to the factors associated with 
having the initial ischemic or hemorrhagic insult (Barba et al. 2000)  
  
 1.4.5 Higher-order Cognitive Dysfunctions  
 
 Higher-order cognitive functions, also known as executive functions, are a series 
of top-down cognitive functions related to the overall behavioural flexibility of an 
organism (Diamond 2013). The types of behaviours associated with these functions 
include attention and attentional processing, decision making, and goal-oriented 
behaviour. 
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 Those who have had a stroke often have difficulties paying proper attention to 
stimuli or features of their environment (McDowd et al. 2003). Other attentional 
difficulties encountered post-stroke include both the slowing of attentional processing 
(Hochstenbach et al. 1998), as well as properly being able to switch attentional focus 
(Vataja et al. 2003). These sorts of deficits can be caused through, or correlated to, 
damage to certain specific areas of the brain which include the prefrontal cortex as well 
as frontal-subcortical connections to this region. 
 Another form of cognitive deficit related to higher-order cognitive dysfunction 
includes pathological gambling (Cognat et al. 2010), which can be related to improper 
decision making as well as poor impulse control. From individual case studies, it 
appears that this effect can be due to bilateral lesions to the basal ganglia, but other 
stroke lesions are known to cause deficits in proper decision making and poor impulse 
control (Bechara 2000).  Not only are there differences in the types of higher-order 
cognitive deficits post-stroke, but there are even differences in the types of deficits 
between the sexes as well, with women becoming more impulsive and displaying more 
planning deficits as compared to men, controlling for other demographic factors 
(Scheffer et al. 2011), further complicating rehabilitation post-insult. 
 Finally, what is especially difficult with deficits in higher-order cognitive 
functions post-stroke is that they can interfere with the recovery of basic life tasks. For 
example, deficits in maintaining attention have been shown to be correlated with 
decreased functional recovery post-stroke, which is probably attributable to the fact that 
learning motor skills can be dependent on functional attentional processing (McDowd et 
al. 2003). As well, deficits in cognitive function that result from deep lacunar infarcts 
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have also been associated with a slower functional recovery, which provides 
justification for the idea that aiding the recovery of cognitive deficits post-stroke could 
improve other forms of functional recovery (Mok 2004).  
  
1.5 TREATMENT OPTIONS FOR COGNITIVE DEFICITS 
 
 Unfortunately, the current treatment climate for cognitive deficits post-stroke is 
lacking. This is due to the considerable shortage of effective treatments and therapies to 
prevent cognitive dysfunction from occurring, or for treating those with long-term 
cognitive dysfunction post-stroke, although there are a host of new and novel therapies 
currently in development. 
 In the past there have been a number of pharmacological agents tested with the 
express purpose of rescuing brain tissue before it undergoes permanent damage. 
Unfortunately, virtually all of these pharmacological products failed during some phase 
of the clinical trials. It has been suspected that many of these drugs have failed because 
of certain parameters behind the models tested, one of which is that some of the current 
animal models do not accurately reflect what is seen in human patients (Cheng et al. 
2004; Minnerup et al. 2012).  
 As well, there has been a considerable lack of specifically focused and effective 
cognitive therapeutics. Although there have been some pharmacological products 
developed for the treatment of other neurological diseases characterized by cognitive 
deficits, these drugs are either not effective in the treatment of cognitive deficits post-
stroke or have not been extensively tested in order to be approved for treatment. In the 
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following sections a brief review of the current and experimental treatments used to treat 
or alleviate some of the cognitive deficits found post-stroke is presented and 
summarized in Table 1.1. 
 
 1.5.1. Current Pharmacological and Behavioural Treatments 
 
 The main pharmacological therapies that are used to alleviate and prevent the 
worst effects of an acute ischemic stroke are recombinant tissue plasminogen activators, 
or r-tPAs. This family of compounds is quite effective in preventing the worst of  
damage that occurs from stroke by dissolving the thrombus or embolus that has been 
lodged inside of the blood vessel (Zangerle et al. 2007). Unfortunately, the use of r-tPAs 
is not a panacea for stroke treatment for a number of reasons. First, the drug cannot be 
used for the treatment of hemorrhagic stroke, as the dissolution of blood clots would 
cause further damage. Secondly, r-tPAs can increase the risk of intracerebral 
haemorrhage, even in cases of ischemic stroke (Hacke et al. 1998). Third, another aspect 
of r-tPAs is their relatively small time window for use, which means that only a small 
minority of patients that could receive this drug end up receiving it at the hospital 
(Katzan et al. 2004). However, despite these drawbacks, when r-tPAs are used they can 
be very effective at preventing damage post-stroke.  
 Another drug that is used in clinics worldwide is MCI-106 (also known as 
Edaravone under the trade name Radicut ®), which is a free radical scavenger licensed 
for use in Japan (Lapchak 2010). The drug works through the quenching of HO· radicals 
formed during the inflammatory response during ischemia, which limits the amount of  
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Table 1.1 Summary of treatment options for stroke and post-stroke cognitive 
deficits from section 1.5. 
 
Current Therapies r-TPAs ↓  infarct size1  
 Edaravone ↓ amount of free radicals 
↓ infarct size 
 Behavioural ↓ aphasia, attentional 
deficits 
Experimental Therapies Cholinesterase inhibitors ↑ cognitive functions, 
including executive 
function
2 
 Antidepressants ↓ depressive symptoms3 
↓ emotional disturbances 
↑ spatial memory 
 Behavioural Improvements in some 
specific cognitive 
dysfunctions (working 
memory, post-stroke 
depression) 
 
  
                                                          
1
 Zangerle et al. 2007  
2 
Auchus et al. 2007 
3
 Li et al. 2009 
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damage done through inflammation. One of the advantages of Edaravone is that it has a 
therapeutic window of 24 hours post stroke onset, giving ample opportunity to mediate 
damage. Although the drug is so far unused in North America to treat ischemic stroke, 
current safety and efficacy trials are ongoing in an attempt to bring it to market (Kaste et 
al. 2013).  
 Many of the behavioural therapies that are implemented for treating cognitive 
deficits specifically target certain daily activities or functions that a person would 
employ in everyday life. Unfortunately, the targeted treatments for specific losses in 
function often cannot transfer to a patient's other daily life activities (Sturm and Willmes 
1991; Doornhein and De Haan 1998), which potentially makes the relearned skill 
applicable only to that cognitive domain and difficult to generalize to others. 
 One of the major targets of current behavioural treatment is aphasia; a language 
disorder with symptoms ranging from loss of communicative ability to understanding 
different forms of communication themselves, and there is much evidence to 
demonstrate that targeted therapies for the treatment of aphasia have positive effects for 
patients, the most prominent of which is speech language therapy (Bhogal et al. 2003; 
Zumbansen and Thiel 2014). Other current cognitive behavioural therapies for stroke 
include treatment for attentional deficits  (Loetscher and Lincoln 2013). Again, one of 
the issues with cognitive treatments is the transferability of benefits from one area of life 
to another. This is to say, improving in one cognitive domain does not necessarily imply 
that one can improve at another simultaneously, which can limit the use of broad-based 
behavioural treatments.  
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 1.5.2 Experimental Pharmacological and Behavioural Treatments 
  
 Because of the lack of current therapies for recovery of cognitive function post-
stroke, new methods are being developed to alleviate these incurred deficits in function.  
Despite many failed clinical trials of pharmacological therapies aimed to treat stroke 
through a variety of mechanisms (Kidwell et al. 2001), there are new therapies that have 
shown considerable promise at alleviating the post-stroke cognitive impairments that are 
commonly found in this disease. At this point, many of these are still in various stages 
of clinical trials, although a number of drugs previously developed and marketed for the 
treatment of other neuropsychiatric disorders, have shown some promise in the 
treatment of post-stroke cognitive dysfunction. 
 The first family of drugs with some demonstrated effectiveness for post-stroke 
cognitive dysfunction are cholinesterase inhibitors, which are currently used clinically 
as treatments for Alzheimer's disease. Two of these, donepezil and galantamine, have 
demonstrated particular promise. Donepezil has been shown to improve cognitive 
function in cases of vascular dementia as well as to improve cognitive function in cases 
of acute ischemic stroke (Black et al. 2003; Barrett et al. 2011). As well, galantamine 
has demonstrated potential for the improvement of executive functions post-stroke 
(Auchus et al. 2007) as well as being effective for the treatment of post-stroke aphasia 
(Hong et al. 2012).  
 Some current anti-depressant drugs have also shown promise. Experiments using 
Fluoxetine, a selective serotonin reuptake inhibitor (SSRI) have demonstrated efficacy 
in the treatment of some cognitive dysfunction, alleviating some of the spatial memory 
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deficits (Li et al. 2009) as well as emotional disturbances that occur post-stroke (Choi-
Kwon et al. 2006). As well, it also appears to function well for preventing the depressive 
symptoms that occur following stroke, which is to be expected for an SSRI (Yi et al. 
2010). 
 Experimental forms of behavioural therapy that attempt to target overall 
cognitive function are in the midst of being developed. Unfortunately, at this stage the 
results have been mixed (Chung et al. 2013; Prokopenko et al. 2013), and it appears that 
individually targeted therapies for particular cognitive deficits may function best. For 
example, individual tasks with the aims of strengthening working memory appear to 
function quite well (Westerberg et al. 2007), as well as new experimental tasks 
specifically targeting aphasia (Palmer et al. 2012), as mentioned in the previous section. 
 Other forms of behavioural therapy, including cognitive behavioural therapy 
(CBT) for depression post-stroke have demonstrated some promise (Broomfield et al. 
2011) , but recent studies have indicated that they may not be as effective as previously 
thought (van Eeden et al. 2015). 
 As can be seen, many of our current therapies for cognitive dysfunction post-
stroke are lacking, and although there are some experimental therapies "in the works", 
further research is required. One manner by which research into post-stroke cognitive 
dysfunction could be facilitated would be to increase the diversity of our current 
repertoire of animal models of post-stroke cognitive dysfunction, thereby giving us 
innovative means to test novel therapies. 
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1.6 CURRENT RODENT MODELS OF STROKE DISPLAYING COGNITIVE 
DYSFUNCTION 
 
 There is a long history of modelling brain ischemia, dating back to the early 20
th 
century with global ischemic animals models induced through a variety of mechanisms 
(Hossmann 1998). This is in contrast to many of the newer models of stroke, which 
attempt to model the disease through more focal means, done most often by targeting 
the middle cerebral artery (MCA). However, part of the issue with the current animal 
models of ischemic stroke is that there is no specific emphasis on modelling the 
cognitive changes that occur post-stroke, as many of them concentrate on replicating the 
pathological motor symptoms  seen in human patients (Kumar et al. 2016). The issue 
here, as highlighted in previous sections, is that patients often present with cognitive 
deficits post-stroke. If research into new treatments is to continue in this domain, new 
stroke models with a focus on cognitive deficits need to be developed. 
 In the following section a brief review of the current animal models displaying 
cognitive deficits, as found in the literature, is presented. Although there are models 
which focus on neo-natal ischemic stroke, some of which have shown cognitive deficits 
(Almli et al. 2000; Gonzalez et al. 2009), the focus in the following sections will be 
cognitive deficits induced in adult animals, with a specific focus on rodent models.  
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 1.6.1 Middle Cerebral Artery Occlusion (MCAo) 
 
 The most common form of stroke in human patients is an occlusion affecting 
brain territory supplied by the middle cerebral artery, which has been estimated to 
account for approximately two thirds of all ischemic strokes in human patients 
(Bogousslavsky et al. 1988).  The MCA is the largest of the branches of the internal 
carotid artery, and feeds a significant portion of the brain (Grotta et al. 2015). The vessel 
is ultimately responsible for sections of all four lobes of the human brain as well as 
significant anatomical structures within, including the caudate nucleus, the globus 
pallidus, and large swaths of the cerebral cortex (Tatu et al. 2012). 
 The technique of specifically occluding the MCA was first developed in the rat 
by Robinson et al (1975), which was accomplished by permanently ligating the right 
middle cerebral artery, producing changes in both behaviour and neurotransmitter 
abundances in select regions. Further refinement of this model was done through the 
work accomplished by Bederson et al. (1986) as well as Longa et al. (1989) in order to 
more reliably produce select focal lesions and to accurately describe the regions 
damaged by this method.     
 Depending on the exact methods by which the MCAo was induced, as well as 
the amount of time the MCA is occluded, this surgical procedure in the rat can cause 
damage to many different structures in the brain. These structures can include portions 
of the amygdala, hypothalamus, and hippocampus, as well as causing extensive damage 
to much of the neocortex and striatum (Rubino and Young 1988; Butler et al. 2002; 
Popp et al. 2009).  
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 The MCAo model offers many advantages to the study of cerebral ischemia in 
the rat; it can closely mimic human ischemic stroke through the production of motor and 
sensory deficits (Yonemori et al. 1998; Zhang et al. 2000), it produces a fairly 
reproducible lesion, and has a relatively low mortality rate (Macrae 2011). As well, the 
model has demonstrated a significant correlation between infarct volume and motor 
deficits (Rogers et al. 1997), replicating another facet of strokes found in human patients 
(Alexander et al. 2010). Though not as commonly observed, animals that have 
undergone an MCAo can experience some cognitive deficits, including deficits in spatial 
learning and memory (Wang et al. 2006; Hu et al. 2013).   
 Although the MCAo model is one of the most prominent models in the literature 
for studying the pathophysiology of stroke, it is not without its drawbacks. Some of 
these drawbacks can be due to the methods by which we induce the stroke, and others 
are simply because of the nature of the model. For example, the use of the intraluminal 
filament in the temporary MCAo model can run the risk of producing an intracerebral 
haemorrhage (Schmid-Elsaesser et al. 1998). The intraluminal thread model also runs 
the risk of producing damage outside of the area of interest, as the thread may block 
other vessels feeding from the internal carotid artery (Macrae 2011). Microsphere 
injections into the blood stream intended to occlude the MCA can also cause problems, 
in that the blockage intended for the MCA can become multifocal and can be found 
throughout the brain, as well as producing a heterogeneous lesion within the area fed by 
the MCA (Mayzel-Oreg et al. 2004).  Methods for inducing a temporary MCAo that 
require a craniotomy and the use of vascular clips can produce lesions, but are 
technically complex and may produce a lesion of variable size (Macrae 2011)    
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 Other drawbacks with the MCAo model include the differences in relative 
recovery times between rats and human patients. Although the temporary occlusion of 
the MCA in rodents causes demonstrable deficits in function, many of these deficits are 
temporary in nature, with some motor functions returning to almost full capacity within 
one to three weeks (Sun et al. 2008; Liu et al. 2009).  In humans, even with therapy, a 
full recovery from a stroke caused by an MCAo takes considerably longer, if it happens 
at all (Kwakkel et al. 1999; Miyai et al. 1999)   
 However, specifically concerning this thesis, one of the biggest disadvantages of 
this model is the lack of documented higher-order cognitive deficits associated with a rat 
MCAo (Jiwa et al. 2010), despite the fact that many human patients who have had a 
stroke can experience higher-order cognitive changes post-stroke (Leśniak et al. 2008; 
Paradiso et al. 2011). So, although the MCAo model represents an effective method of 
modelling cerebral ischemia, the drawbacks of the model are well documented and 
further stroke modelling, especially of cognitive deficits post-stroke, is required. 
 
 1.6.2 Bilateral carotid artery occlusion (BCAo)  
  
 Bilateral carotid artery occlusion, a method of mimicking stroke cardiac arrest 
originally developed by Eklöf and Siesjö (1972) involves the occlusion of two of the 
main arteries that feed the forebrain.   
 Specifically for studying cognitive deficits post-stroke, one of the main 
advantages of this model is that certain modifications of the model can induce a variety 
of cognitive deficits. For example, learning and memory performance in the radial arm 
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maze has been shown to be affected in this model, most likely due to the damage 
induced to certain select regions of the hippocampus (Ni et al. 1994; Peng et al. 2007). 
Furthermore, this model has demonstrated some deficits in higher-order cognitive 
functions, including deficits in executive functions as measured through reversal 
learning and attentional set-shifting tasks (Soria et al. 2013). 
 One of the disadvantages of this model is that it does not represent a focal 
ischemic event within the brain, but rather it best represents a prolonged state of chronic 
hypoperfusion culminating in vascular dementia (Farkas et al. 2007). As well, much of 
the damage precipitated by the ischemic event occurs within the CA1 region of the 
hippocampus and other deeper brain regions, and can leave much of the rest of the 
cortex unaffected (Iwasaki et al. 1989). Because of this, the model may be unsuitable to 
effectively study focal ischemic injury, which is generally the more common form of 
brain injury due to stroke.    
 
 1.6.3 Hypertensive Stroke-Prone Animals 
 
 The Stroke Prone Spontaneously Hypertensive Rat (SPSHR) was originally 
developed by Okamoto and Aoki (1963). This strain of rat has demonstrated some 
deficits in cognitive function as measured through the radial arm maze (Peng et al. 
2005). As well, the model has also demonstrated deficits in spatial and working memory 
within the Morris Water Maze (Grünblatt et al. 2015). 
 Although this method of modelling hypertension, and through further 
experimentation has demonstrated some deficits in executive function in some non-
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human primates, (Moore et al. 2002), so far none have demonstrated clear evidence of 
executive dysfunction for rats or other rodent models. Therefore, it is unclear at this time 
whether this model simply does not display these behavioural deficits or whether 
deficits in these behaviours have simply not been adequately explored. 
 Another disadvantage of the model is that the animals may display these 
cognitive deficits, not as a result of an ischemic insult but as the result of continuous 
hypertension, which in other modalities has demonstrated decreased cognitive capacity 
or dementia without the involvement of a coincident stroke (Kilander et al. 1998; Inaba 
et al. 2009).  
   
 1.6.4 Photothrombosis 
 
 Photothrombosis, proposed initially by Rosenblum and El-Sabban (1977) in 
mice and further refined by Watson et al. (1985), is a method by which infarcts can be 
induced by photochemically causing platelet aggregation in surface vessels of the brain. 
The process works through the injection of a photo-active dye (typically a compound 
called Rose-Bengal) into the blood stream of a live animal. Once the dye has been 
injected, a cold light beam is shined on the area of the brain that the experimenter wants 
damaged. This light causes the photo-active particles to produce reactive oxygen species 
which damage the endothelial cells of blood vessels, leading to the formation of thrombi 
within the vessels themselves (Labat-gest and Tomasi 2013). 
 This method has been used very successfully to produce motor deficits in 
animals, depending on the area that has been targeted (Wood et al. 1996; Lee et al. 
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2007). In terms of modelling cognitive deficits, this form of stroke has been able to 
produce some deficits in rodent, and can even mimic progressive cognitive decline post-
stroke. For example, a mouse model of progressive cognitive decline induced through 
photothrombosis directed bilaterally at the sensorimotor cortex induced object 
recognition deficits as well as persistent deficits in spatial learning and memory assessed 
through the Morris Water Maze (Schmidt et al. 2015). Along with these findings, rats 
undergoing this procedure in the sensorimotor cortex also experience difficulties with 
memory recall and spatial memory (Diederich et al. 2014). In addition, photothrombosis 
has been used within the prefrontal cortex, leading to changes in behaviour in a 
conditioned passive avoidance reaction task (Romanova et al. 2002). Interestingly, this 
model was not tested for changes in other prefrontal cortex-associated behaviours. 
   This method, like any other, is not without its drawbacks. Because the dye is 
found equally within all arterial vessels, the light that is shined upon the vessels will 
affect each vessel relatively equally. Because of this, the properties of the infarct are 
unlike what is found in human patients, with a smaller infarct core and a large 
penumbra. Photothrombosis does not produce a typical penumbra, as all vessels within 
the light beam will become occluded relatively equally (Labat-gest and Tomasi 2013). 
As for the cognitive deficits that are induced, the model is less able to target some of the 
deeper structures, although there are some papers describing deep brain tissues that can 
be affected, provided that the light has some means by which it can reach the target (e.g. 
fibre optics) (Kuroiwa et al. 2009). So far, however, there are no known 
photothrombotic models that target deep brain tissues that have a significant effect on 
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higher-order cognitive functions. 
 
 1.6.5 Endothelin-1 
  
 Endothelin-1, an endogenous 21 amino acid peptide that constricts blood vessels, 
has been used in many studies to help elicit ischemic conditions in animal models.  This 
molecule is part of a family of endothelin molecules that work to constrict blood vessels 
by attaching to specific endothelin receptors found on smooth muscle cells which line 
the vessels (Yanagisawa et al. 1988). The most common of these, endothelin-1, can 
attach to G protein-coupled endothelin A and endothelin B receptors, and works to 
promote vessel constriction through the use of Ca
2+
 as a secondary messenger within 
muscle cells (Marsden et al. 1989). However, most of the action of endothelin-1 in the 
brain is done through endothelin A (ETA) receptors, as these are the dominant receptors 
expressed in vascular smooth muscle (Yu et al. 1995). 
 ET-1 can be directly injected onto large blood vessels, restricting the flow for a 
certain amount of time, mimicking an ischemic event (Ansari et al. 2013). As well, ET-1 
can be injected directly into the parenchyma of the brain in order to cause ischemic 
damage through the vasoconstriction of smaller penetrating vessels (Hughes et al. 2003).  
 The vessels that have been primarily targeted with ET-1 include the MCA and 
the anterior cerebral artery (ACA), and each of these have demonstrated a varying 
degree of cognitive dysfunction (Sharkey et al. 1994; Ward et al. 1998; Lowrance et al. 
2015).  As well, Cordova et al. (2014) have demonstrated preliminary results that 
injections of ET-1 in the prefrontal cortex can have effects on executive function as 
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measured through an attentional set-shifting paradigm. As well, previous research in the 
Tasker laboratory has been able to use this model to produce deficits in motor function 
through the selected targeting of lesions in the motor strip (Livingston-Thomas et al. 
2013; Livingston-Thomas et al. 2014). 
 Although the model does allow for targeted lesions in the rodent brain, there are 
some drawbacks to consider. The first of which is the induction of astrocytosis, the 
growth of new astrocytes, as well as the facilitation of axonal sprouting. However, these 
effects have only been noted within the spinal cord, and not from parenchymal 
injections directly into the cerebrum or cerebellum (Uesugi et al. 1996). As well, the 
endothelin model of stroke induction appears to be less effective in mice versus rats as 
the compound did not produce an ischemic lesion in four separate laboratory mouse 
strains that have been tested (Horie et al. 2008). The model has also been known to 
induce seizures, depending on the area of injection and age of the animal (Mátéffyová et 
al. 2006). Finally, the use of ET-1 to induce MCAo can produce a lesion of variable size 
depending on proximity of injection(Windle et al. 2006).   Although there are some 
drawbacks to using endothelin-1 as previously mentioned, it provides a reliable and 
replicable method of inducing targeted focal ischemic lesions in the rodent brain. This is 
why it was selected as the method by which ischemic lesions would be induced within 
the work in this thesis. 
 
1.7 TESTS OF HIGHER-ORDER COGNITIVE DYSFUNCTION IN 
EXPERIMENTAL RODENTS 
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 When examining the cognitive capabilities of patients affected by stroke, there is 
often a verbal component within the exams, as well as tests requiring detailed verbal 
instructions for the patient to complete. For example, in the Montreal Cognitive 
Assessment (MoCA), a test that can be used to assess a patient's cognitive abilities 
(Nasreddine et al. 2005), the patient is asked to draw a clock in a particular fashion, to 
complete a two-item verbal  abstraction task, and to complete a verbal fluency task. 
Unfortunately, directly assessing the cognitive capabilities of an animal by simply 
asking the animal to complete a particular task, or assessing the animal's verbal 
abstraction capabilities, is not possible. Therefore, our cognitive tasks need to be 
designed in such a way that the animal can complete a behavioural task requiring some 
level of cognitive capability without the use of verbal cues, designed to be analogous to 
existing behavioural tests used with humans. Reviewed here are a number of cognitive 
tasks used to assess particular aspects of rodent behaviour used in a variety of cognitive 
studies.   
 
 1.7.1 The Morris Water Maze (MWM) and Radial Arm Maze   
 (RAM) 
  
 The MWM and RAM are some of the most widely utilized mazes for examining 
particular aspects of cognitive function; specifically they can be attuned to look for 
deficits in spatial memory and working memory, respectively (Davis et al. 1986; Hamm 
et al. 1996; Anderson et al. 2000). The MWM functions by the experimenter placing an 
animal in a large pool of opaque water with a hidden escape platform, which the rat 
37 
 
attempts to find in order to cease swimming. Over time, rats learn where the platform is 
located and the amount of time spent locating the platform decreases.  
 The RAM is also able to test for aspects of working memory by baiting certain 
arms of the maze with food rewards and measuring the amount of time it takes for the 
animals to locate the pellets. Counting the number of errors the animal makes indicates 
how proficient they are at the task (Olton and Samuelson 1976). 
 Both of these mazes have been separately used to assess aspects of cognitive 
decline in some models of stroke. For example, it has been shown that animals that have 
undergone an MCAo have increased times to find the platform, suggesting damage that 
has affected spatial memory (Dahlqvist et al. 2004). The RAM task has been used to 
assess cognitive function, specifically working memory, as a result of stroke. Animals 
that have undergone a four vessel occlusion fare worse in this task compared to control 
animals (Volpe et al. 1984). 
 The main purpose of these tests, particularly for the RAM, is for examining 
higher order cognitive function, specifically working memory. However, working 
memory is only one aspect of higher-order cognitive function, and these tests do not 
fully take into account aspects of inhibitory control, proper decision making, and 
attentional processing.  For other higher-order cognitive functions to be adequately 
tested, we require a different set of mazes and tasks, some of which that are pertinent to 
this thesis will be described further. 
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 1.7.2 Set Shifting Tasks 
 
 Although it is currently widely accepted that non-primates have functional 
equivalents to the human dorsolateral prefrontal cortex, at times it was believed that 
there were no homologous brain structures to this region (Preuss 1995). However, a 
seminal study done by Birrell and Brown (2000) demonstrated that damage to specific 
areas of the medial prefrontal cortex affected an animal's ability to switch from one 
now-irrelevant stimulus in its environment to a now-relevant stimulus, known as set-
shifting. 
 Animal set shift tasks, which are used to assess how quickly an animal can shift 
its attention, are quite useful to test the higher-order cognitive functions of both non-
human primates and rodents. Set shifting tasks function by training an animal to 
associate one feature of their environment with the receipt of a reward, to consider this 
choice as "correct", and then to switch the feature to a previously irrelevant 
environmental feature. This task is functionally analogous to what is performed in 
human subjects with the Wisconsin Card Sorting Test (WCST) (Birrell and Brown 
2000). Other forms of set-shifting tasks have also been developed, relying on choice 
behaviour within modified t-mazes rather than different burrowing media or smells as 
found within Birrell's study (Stefani et al. 2003; Floresco, Ghods-Sharifi, et al. 2006). 
Each of these tests have demonstrated that affecting those regions of the brain most 
associated with higher-order cognitive functions, particularly the medial prefrontal 
cortex, affect set-shifting behaviour. 
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 1.7.3 Temporal Object Recognition Tasks 
 
 One of the higher-order cognitive functions that can be affected by stroke is the 
understanding of events in the proper linear sequence in time, known as temporal order 
memory. This form of memory has broad implications for cognition and consciousness 
as a whole, as it is highly connected to episodic memory: memories about personal 
autobiographical events (St Jacques et al. 2008). Interestingly, it has been demonstrated 
that in humans temporal order memory can be affected without affecting object 
recognition within the tasks themselves (Kesner et al. 1994), providing evidence that 
this form of memory is truly about the linear nature of events. For testing a person's 
individual temporal order memory, we can employ a variety of tasks, including the 
examination of the serial position effect by placing a series of cards with words and 
pictures in the correct order (Shimamura et al. 1990; Schoo et al. 2014) or by getting 
participants to complete a series of tasks and to recall which events were performed in 
which sequence (Schmitter-Edgecombe and Seelye 2012).  
 Testing an animal's ability to place events in the correct sequence often relies on 
specific manipulations of object recognition tasks, and takes advantage of a rat's natural 
tendency to explore objects that are more novel to them (Ennaceur and Delacour 1988). 
For example, one version of a temporal object recognition task functions by placing an 
animal in an arena with two identical objects and allowing them to explore these objects 
for a certain amount of time, giving them a short break, and then allowing them to 
explore a completely different pair of identical objects. Finally, one of each of the two 
previously explored objects is placed within the arena, wherein the animal should spend 
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more time exploring the object seen during the first phase of the trial as compared to the 
second object, due to its greater degree of novelty (Hannesson et al. 2004; Warburton 
and Brown 2015).  
  
 1.7.4 Decision Making and Inhibitory Control Tasks 
  
 In human stroke patients, proper decision making and inhibitory control can be 
altered, which can have negative effects for these individuals (Bechara 2000; M. 
Hoffmann et al. 2010), and it has been noted that damage to the prefrontal cortex can 
cause both improper decision making and disinhibition (Manes et al. 2002).  
 Decision making refers to making the optimal choice amongst a different set of 
options, which can be tested in human patients through the use of gambling-like tasks 
including the Iowa Gambling Task (Brevers et al. 2013). This task requires individuals 
to pick cards from a series of decks, each of which will result in receiving "money" from 
the testers. Picking cards from certain decks will result in higher immediate rewards 
than other decks, however, picking cards from these decks will incur a delayed penalty 
for the participants, overall resulting in a net loss of money (Bechara et al. 1994). 
Picking cards from other decks presented will result in smaller gains of money, but will 
also result in considerably smaller penalties, leading to overall net gains. Although it is 
more advantageous to pick the decks with the lower reward, individuals with damage to 
parts of the prefrontal cortex pick the disadvantageous decks as compared to those with 
intact prefrontal cortices.  
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 As with humans, rodents can also be tested in gambling-like tasks (Paine et al. 
2013), which measure an animal's ability to make the optimal choice to obtain the 
highest amount of reward over a given span of time. Animals can also be tested in other 
cost-benefit decision making tasks, which typically offer the choice between two sets of 
options: a higher-valued reward and a lower-valued reward. All things being equal, the 
higher-valued reward would be hypothesized to be chosen more frequently. However, 
there is a cost to choosing the higher-valued reward, typically being the amount of time 
required to wait for the higher-reward. In this task, animals with an intact prefrontal 
cortex will more often choose to wait for the larger reward as compared to lesioned 
animals (Rudebeck et al. 2006). 
 Effort based decision making is similar in nature to cost-benefit decision making, 
the cost in this case being the amount of effort required to obtain the reward. This 
behaviour has been tested by, again, employing a t-maze configuration, with one arm 
providing easy access to a low food reward, and the other arm having a physical 
obstacle to overcome to obtain a higher food reward (Walton et al. 2002). Interestingly, 
the areas of the brain primarily responsible for this particular task are thought to be 
slightly different as compared to other decision making or inhibitory control tasks 
(Walton et al. 2003), again suggesting that the rodent prefrontal cortex can be further 
subdivided into regions controlling particular actions, which will now be explored 
further. 
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1.8 EXECUTIVE FUNCTION AND THE PREFRONTAL CORTEX 
  
 The exact definition of what are, or are not, executive functions has been 
discussed thoroughly in the literature for a number of years. Essentially, the term refers 
to a set of top-down controls of mental processes determining the decision making of a 
particular organism (Diamond 2013). Many of the previously discussed higher-order 
cognitive functions fit into this realm of executive functions, including attentional 
processing, working memory, planning, decision making, and the temporal integration 
of information (Fuster 2005). 
 The brain region thought to be most in control of executive functions in 
mammals is the prefrontal cortex (PFC) (Fuster 2005), and, as a result, this region has 
been extensively studied through various lesion studies in attempt to determine which 
particular behaviours are controlled by which regions of the PFC. 
 
 1.8.1 Review of lesion studies with the prefrontal cortex and its  
 effects on cognition 
 
 The prefrontal cortex is seen as the seat of executive function, which directs and 
oversees the behaviour of the organism (Miller and Cohen 2001). In previous years there 
has been dispute as to whether rats and other rodent species have a true prefrontal 
cortex, with regions similar to what are found in non-human primates and humans 
(Preuss 1995). Although the range of behaviours exhibited by rats as compared to 
humans is limited, behavioural and cytoarchitectural experiments provide reasonable 
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evidence to conclude that rats do have a prefrontal cortex comparable to our own, 
controlling similar functions (Uylings et al. 2003). 
 Detailed below, are examples of studies examining the effects of lesions within 
this brain region and its effects on cognition in rodent models, non-human primates, and 
human patients. 
 
  1.8.1.1 Human Studies 
 
 Although studies examining brain injury of the prefrontal cortex in humans are 
typically case studies and therefore retrospective in nature, there is still much to be 
learned from them. Perhaps the best known historical case study regarding prefrontal 
cortical damage was the case of Phineas Gage, who suffered an industrial accident 
leading to a railroad spike penetrating and damaging parts of Mr. Gage's prefrontal 
cortex (Harlow 1999)(Reprint). Although Mr. Gage physically recovered from his 
injuries and survived a number of years post-trauma, his personality had drastically 
changed becoming unreliable at work, fitful, impatient, and he was described as "[a] 
child in his intellectual abilities" (Harlow 1868). 
 Over the past number of years there have been well-documented cases and 
studies regarding damage to specific areas of the prefrontal cortex correlating well with 
deficits in particular cognitive functions and certain irregular behaviours. These 
behaviours can include some of those described by Dr. Harlow with regards to Phineas 
Gage, as well as others that have been well documented. For example, patients 
experiencing damage to the PFC have difficulties understanding the consequences of 
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their future actions as assessed through decision-making tasks mimicking real life 
choices (Bechara et al. 1994).   
 The human prefrontal cortex, much like the prefrontal cortex of other animals, 
can be further subdivided anatomically (Siddiqui et al. 2008). Further sub-categorization 
of these areas has determined that the dorsolateral prefrontal cortex is activated during 
attentional set-shifting, and that damage to the dorsolateral prefrontal cortex (dlPFC) is 
associated with deficits in function in the attentional set shifting task (Milner 1963; 
Konishi et al. 1998). Other processes that appear to be affected by damage to this region 
include proper decision making, as assessed through the Iowa Gambling Task (Fellows 
and Farah 2005), as described previously. 
 Another further subdivision of the prefrontal cortex includes the ventromedial 
portion (vmPFC), which controls areas related to reversal learning and attentional 
processing, similar to that seen in non-human primates (Fellows and Farah 2003). 
Ventromedial lesions also appear to affect moral judgements (Ciaramelli et al. 2007), 
causing patients to make more "utilitarian" moral decisions.  
 From many of these studies, it is clear that the prefrontal cortex plays a critical 
role in executive functions and higher order cognition. Although other areas can play a 
role in some behaviours associated with executive function, in both humans and other 
animals (Stuss and Alexander 2000; Jahanshahi et al. 2002; Balleine et al. 2007), none 
have as profound or as well documented a role as the PFC.  
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  1.8.1.2 Non-Human Primate Models 
 
 The effects of prefrontal cortical lesions has also been extensively studied in 
non-human primates, as these animals are most closely related to humans and have 
similar anatomical features within their prefrontal cortex (Petrides and Pandya 1999; 
Semendeferi et al. 2002; Ongür et al. 2003).  
  Related to their similar anatomical features, there is considerable evidence that 
particular regions of the non-human primate prefrontal cortex relate to particular 
behaviours controlled by the human prefrontal cortex. For example, the study of 
prefrontal cortical lesions in macaque monkeys has indicated that attentional processing 
can be damaged by lesions to the lateral prefrontal cortex (Rossi et al. 2007), similar to 
what is reported in human findings examining functional locations (Asplund et al. 
2010). As well, rhesus macaques have also had reported difficulty with attentional set 
shifting tasks analogous to impairments in the WCST following damage to the 
prefrontal cortex in humans (Moore et al. 2009). 
 
  1.8.1.3 Rodent Modelling 
 
 Some of the first studies examining the effects of frontal lesions on the 
behaviour of the rat were done by Bourke et al (1954), in which they examined the 
effects of lesions in white rats, finding that these lesions caused changes to habit 
behaviour in these animals. Other earlier studies regarding parts of the frontal cortex 
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used object recognition, which can be affected by frontal damage (Becker and Olton 
1980) 
 Further testing with more complicated tasks revealed that not only could these 
animals perform these more complicated tasks, but that lesions within the prefrontal 
cortex caused deficits in these tasks as compared to control animals. For example, 
reversal learning, thought to be dependent on certain subsections of the prefrontal 
cortex, was impaired by lesions to the medial prefrontal cortex (de Bruin et al. 1994). 
Further studies indicated that rats required a particular portion of the prefrontal cortex to 
perform set-shifting, as explored by Birrell and Brown (2000). Since then, other 
methodologies for testing and comparing the cognitive capabilities of the rodent's 
prefrontal cortex to the human's have been established, including other tests of attention, 
choice behaviour, and decision making.    
 
1.9 REVIEW 
 
 The previous sections of this review have given a detailed background into the 
disease of stroke, the current deficits those that suffer from a stroke may face, and the 
current state of the literature regarding the modelling of stroke. This disease is 
debilitating and to date few regulated and implemented treatment options for those who 
suffer from profound cognitive deficits exist. Despite this, a very small subset of 
research concentrates on the alleviation of cognitive deficits post-stroke, and there are 
few models that concentrate specifically on "higher-order" or executive function 
deficits.  
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 The purpose of this body of work conducted and reported in this thesis is to 
develop, test, and examine a new animal model of stroke that is intended to cause 
significant higher-order cognitive deficits in rats. This body of research and 
development was done with the goal that this new model can be utilized to test 
behavioural or pharmacological therapies to treat the cognitive symptoms associated 
with stroke.  
 
 1.9.1 Hypothesis 
 
 The hypothesis for this thesis is that injections of the vasoconstrictor, endothelin-
1, into particular regions of the prefrontal cortex, will cause ischemic lesions in this 
area, as well as measureable cognitive deficits in higher-order cognitive functions. 
These will be measured through the use of particular histological experiments and 
behavioural assessments. 
 
 1.9.2 Objectives of the Thesis  
 
 The use of endothelin-1 to induce ischemic lesions in the prefrontal cortex, as a 
model of stroke, will be evaluated through the following three objectives:  
  
1. To refine and evaluate the effects of endothelin-1 injections into the prefrontal 
cortex on brain lesion size, and changes in behaviour in the rat. 
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2. To measure the effects of refined, focal ischemic lesions within the medial 
prefrontal cortex on aspects of set-shifting and temporal order memory, both of 
which are higher-order cognitive functions, in the rat. 
3. To further evaluate the model using endothelin-1 to create focal lesions in the 
orbital prefrontal cortex versus lesions in the medial prefrontal cortex for the 
purposes of assessing regional effects.  
 
 Chapter 2 of this thesis will explore the first objective, which was to establish the 
stroke model through testing two separate ET-1 injection protocols. Once an ET-1 
injection protocol was selected due to its targeted focal ischemic lesion to the rodent 
mPFC, preliminary experiments were conducted to understand the behavioural effects of 
this stroke lesion. In Chapter 3 the second objective, which is to test higher-order 
cognitive functions in the rat, was explored using the animal model established from 
Chapter 2. Tests of higher-order cognitive function, specifically set-shifting and 
temporal object recognition, were employed to understand how stroke lesions in the 
mPFC would affect attention and temporal memory. Chapter 4 will examine the final 
objective, which was to examine two separate ET-1 models affecting the mPFC and 
oPFC and to determine whether these models had effects on inhibitory control and 
ultrasonic vocalizations. Finally, Chapter 5 will provide a general overview of the thesis 
and outline future experiments to further the knowledge obtained by the experiments 
performed in chapters two through four. 
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CHAPTER 2 
PREPARATORY EVALUATION AND VALIDATION OF MODELS OF POST-
ISCHEMIC COGNITIVE DYSFUNCTION  
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SUMMARY 
 
 Modelling ischemic strokes that cause damage specific to cognitive functions is 
an area of research which has been overshadowed by other animal models concentrating 
on the recapitulation of the motor dysfunctions of this disease. The majority of research 
examining dysfunction following stroke makes use of the middle cerebral artery 
occlusion model (MCAo), which has little documented evidence of higher order 
cognitive deficits. Therefore, to properly model higher-order cognitive dysfunction post-
stroke, new models are required. The experiments described in this chapter had two 
aims: (1) to evaluate the cellular damage caused by the injection of endothelin-1 (ET-1), 
a potent vasoconstrictor, into the medial prefrontal cortex, and (2) to evaluate a model of 
ET-1 damage for evidence of cognitive dysfunction using two separate behavioural 
tasks. The first experiments demonstrated that the vasoconstrictor ET-1 can cause 
damage to the prefrontal cortex, and that a model consisting of a pair of bilateral 
injections was suitable for the purposes of subsequent experimental procedures. The 
second set of experiments used this two-injection model, and two different behavioural 
tests–the elevated plus maze (EPM) and the temporal object recognition task (TOR) –to 
test the outcomes of this surgical procedure. The animals displayed increased levels of 
anxiety as a result of this surgical procedure relative to the control group, as measured 
through the EPM. The TOR task, employed to test an animal's temporal order memory, 
failed to properly measure this outcome in either the sham or stroke group, which would 
indicate that this task requires further testing modifications before future use. 
  
51 
 
2.1 INTRODUCTION 
 Stroke is one of the main forms of death and disability worldwide, with an 
estimated 5.7 million deaths worldwide and 16 million new strokes that occur per year 
(Strong et al. 2007). The only major pharmaceutical product given to help prevent 
damage post-stroke, recombinant tissue plasminogen activator (r-TPA), is administered 
to ischemic stroke patients within 3 - 6 hours of stroke onset and has been shown to 
cause considerable improvements in functional outcome (Lubeck et al. 2016). Although 
this drug is effective at preventing tissue damage post-stroke, it can only be 
administered to patients under specific circumstances, and it has been estimated that 
only 7% of ischemic stroke patients receive r-TPA post-injury (Schwamm et al. 2013).  
 Current preclinical stroke research has been very successful at replicating many 
of the signs of upper limb motor dysfunction following stroke in animals, which has led 
to a better understanding of the cellular and molecular mechanisms underlying 
neuroplasticity post-stroke (Kleim et al. 2007). Unfortunately, there is a lack of animal 
models of stroke that cause complex cognitive deficits, despite the fact that 
approximately one third of stroke survivors suffer from cognitive-dysfunction post-
injury (Tatemichi et al. 1994; Patel et al. 2003). To help remedy this situation, new 
models of cognitive dysfunction post-stroke are needed. 
 Endothelin is a potent vasoconstrictor initially discovered in 1988 in cell culture 
(Yanagisawa et al. 1988). Further investigation revealed that endothelin-1 (ET-1), the 
most biologically prominent of the four discovered isoforms of endothelin, could be 
used directly to occlude blood vessels in vivo (Sharkey and Butcher 1995; Luscher and 
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Barton 2000). Since its discovery and subsequent characterisation, this compound has 
been used in a host of vascular impairment models in order to study the effects of stroke 
on behaviour in vivo (Thiyagarajan and Sharma 2004; Faraji et al. 2009; Livingston-
Thomas et al. 2014). Until recently, however, use of this drug to cause potential 
cognitive dysfunction through targeted injections into the brain had not been described.  
 The purposes of the experiments described in this chapter were two-fold. First, 
initial experiments were performed to assess the relative size and dimensions of damage 
caused by endothelin-1 injections to the prefrontal cortex in two sets of injection 
protocols. The second purpose of the experiments was to assess the behavioural effects 
of one of the injection protocols. The two tests employed in the experiment were the 
elevated plus maze to assess for changes to anxiety-related behaviour, and a temporal 
object recognition test used to assess an animal's ability to differentiate different time 
intervals, as previous experiments have demonstrated a relationship between frontal lobe 
damage and dysfunctions in temporal order memory.  
 The hypothesis of these initial experiments was that injections of ET-1 would 
cause measurable ischemic lesions in the prefrontal cortex, and that these lesions would 
have measureable (statistically significant) effects on behaviour and cognitive function. 
 
 
 
 
53 
 
2.2 METHODS 
 2.2.1 Experiment 1: Development of an Injection Protocol 
 Two separate protocols were assessed: one for two sets of bilateral injections of 
ET-1 to the PFC (n = 6) and one for one set of bilateral injections of ET-1 to the PFC (n 
= 5). With the exception of the number of injections performed, the surgical protocols 
were identical. 
 The surgical protocols for the injections were performed as follows. Adult 
Sprague Dawley rats (weights 400 - 600 g) were used, and each rat was anaesthetised by 
being placed into an induction box prefilled with 3.5% isoflurane (PPC, Richmond Hill, 
Canada) in oxygen, and was left in the box for 8 minutes. The anaesthesia was 
maintained throughout the surgery with a 2-3% isoflurane mixture. After 8 minutes, 
animals were mounted on a stereotaxic frame (Kopf Instruments, Tujunga, USA), and 
the heads were shaved. Once shaved, topical Xylocaine (AstraZeneca, Mississauga, 
Canada) was applied to the shaved area and left for 5 minutes, following which a 2 cm 
midline incision was made down the top of the cranium. This incision was held open by 
4 clamps.  
 Depending on which surgical injection procedure was performed, the coordinates 
differed for each rat.  Two to four small burr holes were drilled into the cranium above 
the coordinates for drug injection. A 26-gauge 10 µl syringe (Hamilton, Reno, USA) 
was lowered into each of the injection sites using coordinates as listed in the following 
tables. The exact coordinates for each of these injection protocols are given in Tables 
2.1 and 2.2. 
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Table 2.1 Surgical injection coordinates for a 4 injection protocol.  A/P = 
anterior/posterior, M/L = medial/lateral, D/V = dorsal/ventral, with distances in mm 
relative to bregma. n = 6.  
 A/P (mm) M/L (mm) D/V (mm) Volume (µl) 
Injection 1 +3.5 -0.7 -4.5 1  
Injection 2 +3.5 +0.7 -4.5 1 
Injection 3 +2.5 -0.7 -4.5 1 
Injection 4 +2.5 +0.7 -4.5 1 
 
Table 2.2 Surgical injection coordinates for a 2 injection protocol.  A/P = 
anterior/posterior, M/L = medial/lateral, D/V = dorsal/ventral, with distances in mm 
relative to bregma. n = 5.  
 A/P (mm) M/L (mm) D/V (mm) Volume (µl) 
Injection 1 +3.0 -0.7 -4.5 1  
Injection 2 +3.0 +0.7 -4.5 1 
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In each case the injection needle was left in place for 1 minute prior to ET-1 injection. 
After one minute, 1 µl of ET-1 (400 pmol) dissolved in artificial cerebral spinal fluid 
(aCSF, see appendix A for composition) was injected at each injection point into the 
cortex at a rate of 0.5 µl/minute for a total of two minutes.  
 Once injected, the needle was left in place for 4 minutes to allow for drug 
dispersal at the injection site, and then the needle was slowly retracted from the brain. 
The same procedure was repeated for each injection point. After the ET-1 injections, the 
incision site was sutured and topical Xylocaine was reapplied. At the conclusion of the 
surgery each animal was given a 2.0 mg/kg subcutaneous injection of butorphanol 
tartrate. Over the course of the recoveries, four of the animals either died or had to be 
euthanized post-surgery, of which one was from the two injection group and three were 
from the four-injection group. Therefore, the final group numbers analyzed for each 
group were n = 3 for the four-injection group and n = 4 for the two injection group. 
 
  2.2.1.1 Histology 
 
 On post-surgery day 4 (PSD4), the surviving rats were anaesthetized with 
isoflurane and euthanized by decapitation. Brains were removed and immersion fixed in 
10% formalin. Brain tissue was sectioned into 100µm coronal segments throughout the 
anterior section of the brain using a vibratome (Ted Pella, Redding, USA), mounted on 
Surgipath X-tra glass slides (Leica Biosystems, Richmond, USA) and subsequently 
stained with cresyl violet (0.1 % w/v). Images were prepared using a Nikon D3100 
digital camera and a light box. Infarct quantification was performed by taking each 
56 
 
digital image and tracing the area of tissue displaying a lack of, or abnormal, cresyl 
violet staining or altered cytological architecture. Tracing was performed using ImageJ 
software, version 1.45s (ImageJ, National Institutes of Health, USA). Once each area 
had been traced, the volume of infarct damage was quantified by summing each 
individually calculated area and multiplying the area by the distance between each 
section (100 µm). 
 
  2.2.1.2 Statistical Analysis 
 
 Statistical analyses were performed using Graph Pad Prism, Version 5.00 (Graph 
Pad, La Jolla, USA). In this first experiment, the two sets of injection protocol lesion 
sizes were assessed by a two-way ANOVA.  In the analysis, statistical significance was 
considered at p ≤ 0.05. 
  
 2.2.2 EXPERIMENT 2: BEHAVIOURAL TESTING 
   
  2.2.2.1 Experimental Animals 
 
 All procedures were conducted in accordance with the guidelines of the 
Canadian Council for Animal Care and were approved in advance by the University of 
Prince Edward Island Animal Care Committee, protocol number 12-035. Adult male 
Sprague-Dawley rats (N = 21, 126-150g on arrival) were purchased from Charles River 
Laboratories (Montreal, Canada) and singly housed on a 12 h light/dark cycle (lights on 
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at 06:00 and off at 18:00) with food (Purina rat chow) and water available ad libitum 
until training and testing. Upon arrival, the animals were handled by the experimenter 
for 5 minutes each day for three days during an acclimation period. All surgeries, 
behavioural training, and behavioural testing occurred during the light phase of the light 
cycle.  
 
  2.2.2.2 Surgical Procedures 
 
 The two-injection model, as described in section 2.2.1, was performed on the 21 
male Sprague-Dawley rats, with 11 rats in the ET-1 injected group, and 10 rats in the 
sham injection group receiving vehicle control (1 µl of aCSF per injection point). Post-
surgery, three animals were euthanized for humane reasons; two from the ET-1 group, 
and one from the sham group. Therefore, the final group numbers were n = 9 for each 
group. For exact details regarding the methodology of the surgery, refer to section 2.2.1. 
  
  2.2.2.3 Behavioural Testing Protocols 
 
 Testing for the elevated plus maze (EPM) was completed during the light phase 
of the light/dark cycle. Testing consisted of placing the animal in an elevated plus maze 
platform (elevated 83 cm from the floor of the room), constructed of welded metal with 
the floor of the maze covered with adhesive liner. Each of the four arms of the maze had 
dimensions of 112 (length) × 10 (width) cm. Two of the arms had no walls and were 
exposed (open arms), and the other two arms had metal walls which were 28 cm high 
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(closed arms). Once the animals were placed in the centre platform of the maze, the 
timer was started and animals had 5 minutes to explore the maze. Behaviour was video-
recorded using a Logitech webcam (Logitech, Romanel-sur-Morges, Switzerland) 
suspended over the centre of the maze, connected to a laptop, using ANY-Maze 
Software version 4.76 (Stoelting Co., USA). The variables tested during the experiment 
were the amount of time spent in the closed arms, the amount of time spent immobile, 
the amount of distance moved throughout the trial, and the number of rearing motions 
made during testing. Animals were tested three times over the course of the experiment; 
pre-surgery, on PSD8, and on PSD29. 
 The testing procedure for the temporal object recognition task was modified 
from Hannesson et al. (2004). The testing area consisted of a round, empty, fibreglass 
container (148.6 cm in diameter; walls 63.5 cm in height). To aid in colour contrast for 
video recording, the floor of the maze was covered in brown adhesive shelf liner. On 
PSD5 and PSD6 each animal was acclimated separately to the maze for 10 minutes. 
Testing began on PSD7 and consisted of placing the animal in the maze with a pair of 
identical objects positioned equidistant from the centre of the maze and the maze walls. 
The rat was allowed to explore for 4 minutes before being returned to its home cage. 
After a delay of 60 minutes, the animal was placed back in the maze with a new pair of 
identical objects for a further 4 minutes. After an additional delay of 180 minutes, the 
animal was returned to the maze with one object from each of the two previous trials for 
3 minutes. The time spent exploring each of the objects was recorded. Exploration of an 
object was defined as the animal's head being within at least two centimetres of the  
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Figure 2.1 Objects used for TOR testing. Each set of objects was used once during the 
four testing periods. 
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object's surface, and scoring was done using AnyMaze software (Stoelting, Wood Dale, 
USA). TOR testing took place on PSD7, PSD14, PSD21, and PSD28. Two sets of 
objects were used during this experiment, with a different set of plastic Lego objects 
tested each week. Examples of the objects used are given in Figure 2.1. 
 
   2.2.2.4 Histology and Infarct Quantification 
 
 On PSD29, the experimental animals were anaesthetized with isoflurane and 
euthanized by decapitation. Brains were removed and immersion fixed in 10% formalin. 
Brain tissues were sectioned, mounted, stained and infarcts quantified as described 
previously in Section 2.2.2.1 
 
   2.2.2.5 Statistical Analysis 
 
 Statistical analyses were performed using Graph Pad Prism, Version 5.00 (Graph 
Pad, La Jolla, USA). The outcomes of the behavioural tests employed were assessed via 
two-way repeated measures ANOVAs comparing the day of testing with the surgery 
group. Post-hoc comparisons were made using Bonferroni post-test, one way ANOVAs, 
or t-tests where appropriate. In all analyses, statistical significance was considered at p ≤ 
0.05. 
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2.3 RESULTS 
 
 2.3.1. Experiment 1 - Histology  
 
 Histological analysis of the infarct produced in the two different surgical 
protocols revealed that both injection protocols damaged the area of the mPFC as 
anticipated (Figures 2.2 A and B).  Comparison of the two and four injection protocols 
using  a two-way ANOVA of protocol versus infarct area at each 300 µm section, 
revealed a statistically significant difference between the two-injection and four-
injection models (F1,19 = 22.0, p < 0.01). Figure 2.3 displays each of the estimated areas 
of damage at 300 µm intervals. Although there was no statistical difference in the 
number of mortailities between each of the surgical injection grouns, becauseof the 
more focused damage to the mPFC and overall fewer animal mortailities, the two 
injection model was used for future injection protocols. 
 
 2.3.2. Experiment 2 
 
  2.3.2.1 Histology 
 
 Figures 2.4 A and B demonstrate the extent of damage produced following 
bilateral endothelin-1 injections into the mPFC as examined 29 days post stroke surgery. 
Figure 2.4 A gives an overview of the damage, with four coronal sections through the 
infarcted area. Figure 2.4 B demonstrates an overview of the estimated volume of. 
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A. 
B.  
 
Figure 2.2. Cresyl violet- stained brain tissue following the two- and four-injection 
ET-1 models. Damaged tissue is represented by lower stain uptake, as well as altered 
cytoarchitecture. (A) Representative sections following the 4 injection mPFC protocol 
and (B) representative sections following the 2 injection mPFC protocol. 
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Figure 2.3. Line graphs representing the approximate amount of damaged tissue as 
a result of each ET-1 surgical injection protocol. The approximate amount of area 
damaged was calculated every 300 µm from the anterior of the brain to approximately 
bregma. For the four-injection group, n = 3, and for the two-injection group, n = 4. 
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A. 
 
 
 
 
 
 
 
 
 
 
Figure 2.4A A representative example of the ischemic insult found within the 
prefrontal cortex within the experiments described in section 2.2.2., displayed through 
successive coronal sections of the area of interest.  
B. 
 
 
 
 
 
 
 
 
Figure 2.4 B Line graph representing the relative volume of damage at different 
stereotaxic levels in the ET-1 group (n = 9) within the experiments described in section 
2.2.2.   
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damage every 200 µm, demonstrating the largest amount of damage occurred between 
+3.3 mm and +2.7 mm anterior to bregma, coinciding with the bilateral injections 
placed at +3.0 mm anterior to bregma. Total size of the infarct was 27.98 ± 3.917 (Mean 
± SEM). 
  2.3.2.2 Elevated Plus Maze  
 
 Animals were tested on the EPM pre-surgery, on PSD8, and again on PSD29. 
Analyses of the EPM data suggest there were differences between the sham and stroke 
groups, as well as differences within the stroke group depending on when the animals 
were tested. Figure 2.5 gives an initial overview of the differences in time spent in the 
closed arms of the EPM. A two-way ANOVA revealed an interactive effect between the 
day tested and the surgery group (F(2,16) = 3.78, p < 0.05), so subsequent analyses looked 
at each of these factors separately. As assessed by a one-way ANOVA between testing 
days there were no statistically significant differences within surgery groups (sham: 
F(2,8) = 3.56, p > 0.05; stroke: F(2,8) = 1.25, p > 0.05). However, as assessed by an 
unpaired t-test there was a significant difference between surgical groups on PSD29, 
with animals in the stroke group spending more time in the closed arms of the maze than 
the open arms (t(16) = 2.340, p < 0.05). There was no significant difference between 
sham or stroke groups pre-surgery or on PSD8. 
 In terms of the amount of distance moved in the maze during the testing period, a 
two-way repeated measures ANOVA comparing the effects of the surgical procedure 
and the day of testing revealed statistically significant differences between testing days 
(F(2,16) = 6.08, p < 0.01) (Figure 2.6A). Bonferroni post-hoc analysis revealed that for  
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Figure 2.5 Percent time spent in the closed arms of the EPM pre- and post-surgery. 
Two-way repeated measures ANOVA revealed an interactive effect between the day 
tested (pre-surgery, PSD8, and PSD29) and the surgical group (sham or stroke, n = 9 for 
each group). Further post-hoc testing revealed there was a difference between sham and 
stroke animals on PSD29, indicating that stroke animals spent more time in the closed 
arms relative to their sham counterparts. Bars indicate mean ± SEM of time spent in 
closed arms.  
  
67 
 
 
Figure 2.6A. Distance moved in the EPM pre- and post-surgery. A two-way 
repeated measures ANOVA indicated a time effect, wherein stroke animals performed 
differently as compared to their pre-surgery and post-surgery day 29 values. There was 
no significant effect between surgical groups (n = 9 for both groups). 
 
 
Figure 2.6B Time spent immobile in the EPM pre- and post-surgery. Similar to 
distance moved, a two-way repeated measures ANOVA indicated a time effect, wherein 
stroke animals performed differently as compared to their pre-surgery and post-surgery 
day 29 values. No significant difference was detected between sham and stroke animals 
(n = 9 for both groups). 
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stroke animals, the amount of distance moved on PSD8 was lower than pre-
surgery and PSD29 (Pre-surgery vs PSD8 t(8) = 2.72, p < 0.05) (PSD29 vs PSD8 t(8) = 
2.49 p < 0.05). No statistical differences were found between test days for the sham-
treated group. A similar result was found for the amount of time the animals spent 
immobile in the maze.A two-way repeated measures ANOVA comparing the effects of 
the surgical procedure and the day of testing found a significant effect due to the testing 
day (F(2,16) = 7.86, p < 0.01). As well, upon post-hoc analysis this effect was only seen in 
stroke animals comparing between pre-surgery and PSD8 (t(8) = 3.56, p < 0.05), as well 
as between PSD29 and PSD8 (t(8) = 2.96, p < 0.05). No statistically-significant effects 
were seen in post-hoc analyses between days in the sham group. With regard to rearing 
behaviour while in the maze, a two-way repeated measures analysis revealed statistically 
significant differences between sham and stroke group behaviour (F(1,16) = 7.55, p < 
0.05) (Figure 2.7), no differences between days were found (F(2,16) = .779, p > 0.05). 
Further Bonferroni post-hoc analysis revealed that these differences were only 
significant between groups on PSD8 (t(8) = 3.02, p < 0.05). 
  2.3.2.3 Temporal Object Recognition 
 Table 2.3 gives an overview of the results of the temporal object recognition 
experiments. For each day tested (PSD7, PSD14, PSD21, and PSD28), a two-way 
ANOVA was performed examining the time spent with each object within and between 
the surgical groups. On PSD7, there was no statistical difference between time spent 
with either the first or second object (F(1,16) = .010, p > 0.05), or between the sham and 
stroke groups (F(1,16) = 3.02, p > 0.05). On PSD14, there was a significant interactive 
effect between the surgical groups and object preference (F(1,16)= 5.25, p < 0.05). Further  
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Figure 2.7 Number of rearing actions performed in the EPM. A two-way repeated 
measures ANOVA revealed a significant difference between sham (n = 9) and stroke 
animals (n = 9), and further post-hoc analysis revealed a significant difference between 
sham and stroke animals on PSD8, with animals in the stroke group performing less 
rearing motions than sham animals. 
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Table 2.3 Average time interacting with objects in TOR maze. For each day tested, a 
two-way ANOVA was performed examining the effects of surgery on the time spent 
interacting with each of the two objects. There was no statistically-significant difference 
between either time spent with the objects or between surgery groups on PSD7. On 
PSD14, an interactive effect was found between time spent with the objects and surgical 
group (n = 9 for both groups). Further testing revealed a statistically-significant 
difference between the examination time between the sham and stroke group regarding 
the amount of time spent with the object presented second (P < 0.05). For both PSD21 
and PSD28, no statistical difference between either the time spent with objects nor the 
surgery group was found. Data are presented as Mean ± SEM. 
 
  
 Sham Stroke 
Testing Day First Object Second Object First Object Second Object 
PSD 7 16.5 ± 2.52 14.6 ± 2.99 8.41 ± 2.97  11.3 ± 4.34 
PSD 14 20.3 ± 3.38 18.8 ± 2.98* 38.79 ± 12.4 7.57 ± 3.67* 
PSD 21 11.4 ± 1.76 11.6 ± 1.30 11.9 ± 4.21 21.4 ± 5.59 
PSD 28 16.6 ± 3.28 11.4 ± 3.63 13.8 ± 4.43 9.59 ± 2.48 
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investigation revealed a significant difference in the amount of time spent exploring the 
second object (t(8) = 2.42, p < 0.05). No other statistically significant differences were 
found on PSD14.  As well, two-way ANOVA analyses revealed no statistically 
significant differences between sham and stroke groups, or between the amount of time 
spent exploring each set of objects for neither PSD21 nor PSD29. 
 Table 2.4 gives an overview of the distance moved in the maze. Through a two-
way repeated measures ANOVA it was revealed that there was a statistically significant 
difference between sham and stroke groups (F(3,16) = 11.0, p < 0.01) with stroke group 
rats appearing to move less in the maze. Further post-hoc testing revealed that this effect 
was statistically-significant only for PSD14 (t(8) = 3.72, p < 0.01) 
 
2.4 DISCUSSION 
 
 
 To date, much of the current research into cognitive dysfunction post-stroke has  
examined deficits in working memory, spatial memory, and learning ability (Jiwa et al. 
2010). This may be because one of the most prominent areas of the brain that is 
damaged following global hypoperfusion and MCA occlusion is the hippocampus, an 
area intricately involved with spatial and working memory (Butler et al. 2002; Hartman 
et al. 2005). Although the hippocampus does play a role in some executive functions, it 
is the prefrontal cortex that is most involved with higher-order cognitive functions 
including goal directed behaviour and proper decision making (Miller and Cohen 2001). 
It is for this reason that the experiments in this chapter aimed to establish reliable lesions 
to certain sections of the prefrontal cortex and to assess behaviours associated primarily  
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Table 2.4 Average distance moved in TOR maze. A two-way repeated measures 
ANOVA revealed a significant effect (P < 0.05) of surgery on the distance moved in the 
TOR maze. Post-hoc Bonferroni testing between groups on each day indicated that on 
PSD 14 sham animals (n = 9) moved greater distances over the three minutes in the 
testing apparatus as compared to stroke animals (n = 9). Data are presented as Mean ± 
SEM 
 
 
 
 
 
 
 
  
   Distance moved (m) 
Testing Day Sham Stroke 
PSD 7 11.2 ± 1.13  6.49 ± 1.92 
PSD 14 13.4 ± 1.58 5.28 ± 1.40 * 
PSD 21 11.1 ± 1.26 6.02 ± 1.15  
PSD 28 12.7 ± 1.82 8.45 ± 1.77  
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with this region. 
 The first set of experiments was performed in order to understand the effects of a 
four injection model of ET-1 versus a two injection model. What was found was that a 
two-injection was preferable to the four-injection model for two main reasons: it 
resulted in (i) a smaller lesion more localized to the mPFC, and (ii) less animal 
mortality. The two-injection model also has the advantage of a shorter surgical time, 
decreasing the amount of time that an animal is under anaesthesia, which may be part of 
the reason for the lower mortality rate with this group. The four-injection model was 
performed due to previous literature examining the effects of ibotenic acid, a neurotoxin 
used to lesion different parts of the brain in experimental animals, which has previously 
been used in a four-injection model to damage the mPFC (Birrell and Brown 2000; 
Risterucci et al. 2003; Shah and Treit 2003). However, the way ibotenic acid works is 
somewhat different than ET-1, in that the acid directly stimulates NDMA receptors, 
directly causing excitotoxic damage (Inglis and Semba 1997). ET-1 indirectly causes 
excitotoxic damage via vasoconstriction at the injection site, resulting in eventual 
ischemic conditions around the site of injection and throughout tissue fed by the 
constricted blood vessels. That may explain why the damage incurred through its 
injection is more extensive and diffuse than an injection of a similar volume of ibotenic 
acid.  
 Many areas of the brain have long been associated with the regulation of certain 
emotional states. The prefrontal cortex is thought to regulate many higher-order 
cognitive functions, as well as to regulate behaviours associated with changes in 
emotions (Uylings et al. 2003; Salzman and Fusi 2010). For example, damage to the 
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prefrontal cortex has resulted in changes in aggressive behaviours in rats as well as 
humans (Kolb and Nonneman 1974; de Bruin et al. 1983; Giancola 1995). As 
demonstrated in the results of this chapter, there appear to be changes in how animals 
with lesions to the mPFC respond to anxiogenic situations, in that animals with mPFC 
lesions were more likely to spend time in the closed arms of the maze as well as exhibit 
freezing behaviours. Other differences in behaviour that were exhibited by the mPFC 
lesioned animals included a lower number of rearing actions as well as less distance 
moved throughout the EPM trials.  
 The literature regarding prefrontal cortical manipulations on anxiety responses is 
mixed. One study demonstrated that animals with depleted levels of dopamine in the 
prefrontal cortex displayed anxiogenic-like behaviours, spending more time in the 
closed arms of the elevated plus maze (Espejo 1997). As in the current study, these 
animals also displayed decreased locomotor activity. However, further lesion 
experiments have not corroborated that evidence, and have given evidence counter to 
what was found in our study (Shah and Treit 2003; Blanco et al. 2009). These lesions, 
however, did not recapitulate the transient locomotor decreases that we observed in our 
model. Although many experiments demonstrate an anxiolytic response to lesions of the 
prefrontal cortex, experiments performed by others have demonstrated a lack of 
anxiolytic behaviour post-lesion of both the anterior cingulate and infralimbic cortices 
(Lacroix et al. 1998; Bissiere et al. 2006). Further research with our model may be 
required to better delineate the role of ischemic lesions to the mPFC and its effects in 
anxiety behaviours. 
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 Although not specifically tested in this model, the behavioural changes seen in 
the elevated plus maze could be the result of damage to the prefrontal cortex, and areas 
outside of this region, affecting motor and/or sensory function. This could explain the 
transient reductions in movement in the stroke group between PSD8 and pre-surgery as 
well as PSD29, as well as the propensity for the increased amounts of time spent 
immobile. However, animals with chemically-induced lesions to the prefrontal cortex 
have exhibited increased levels of spontaneous movement or have produced no changes 
in movement overall (Carter and Pycock 1980; Swerdlow and Koob 1987). As well, 
previously cited research has demonstrated that  rats with ibotenic lesions in the mPFC 
do not have changes in locomotor activity (Shah and Treit 2003). Further, post-hoc 
analyses of the data presented in this chapter via linear regression were performed 
examining the relative size of the lesion versus the amount of distance moved in the 
maze on PSD8, hypothesizing that a larger infarct may result in decreased locomotor 
activity. However, no correlation between the two values was found (F(1,7) = 0.4318, p > 
0.05, R
2
 = 0.058). However, this analysis did not take into consideration the 
approximate locations of the damage, only the relative size of the area affected. Sensory 
deficits could also change behaviours within the elevated plus maze, but unfortunately 
sensory function was not assessed in these animals. Future experiments with this model 
of stroke induction should take motor and sensory function into account and a further 
battery of these tests should be employed post-surgery. 
Temporal object recognition tests are used as a measure of temporal processing 
in animals, as a means of determining whether animals can sequentially list the order of 
certain items presented. This effect has been successfully demonstrated in human 
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subjects as well as many other vertebrate species (Shimp 1976; Kesner et al. 1984; 
Butters et al. 1994). For temporal order recognition, the prefrontal cortex has been 
demonstrated to be a necessary component of recalling the proper sequence of particular 
events (Chiba et al. 1997). In our task, the animals in both the sham and the stroke group 
failed to demonstrate measureable temporal order memory as seen in other experiments 
(Hannesson et al. 2004; Barker et al. 2007), indicating a potential flaw in the 
experimental process. This unexpected result demonstrated that particular aspects of the 
experimental process should be modified in order to demonstrate temporal order 
memory as found in other experiments. One of the possible reasons as to why the 
temporal order memory effect was not observed could be that the objects were not 
dissimilar enough for the animals to be able to differentiate. Although the Lego objects 
differed in overall size, shape, and colour pattern, each of the objects are similar in that 
they have identical textures (i.e. all objects were uniformly plastic). Previous 
experiments performed in other laboratories have used similarly constructed objects 
from Duplo blocks, and were able to demonstrate temporal order memory in control 
animals (Barker and Warburton 2011). However, with no diagrams or pictures from 
these tests on which to base our comparisons, it is unknown whether the constructed 
objects in our experiments differed significantly from the objects used in other 
experiments. As a result, subsequent experiments and experimental procedures were 
altered, and the results of these methodological changes are discussed in follow up 
studies that are presented in Chapter 3. 
 In conclusion, the experiments described in this chapter provide data that ET-1 
lesions can be surgically induced in areas of the PFC with relative accuracy. Further, the 
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data presented in this chapter provides evidence that these induced lesions can affect 
cognitive function, although the reasons as to why certain behaviours were exhibited are 
unknown. Further experiments in chapters 3 and 4 explore the nature of other higher-
order cognitive functions that these lesions may affect. 
  
78 
 
CHAPTER 3 
HISTOLOGICAL AND BEHAVIOURAL EFFECTS OF ISCHEMIC LESIONS 
LOCALIZED TO THE MEDIAL PREFRONTAL CORTEX OF THE RAT 
 
A modified version of this chapter is published as: Deziel, R.A., Ryan, C., Tasker, 
R.A., (2015) Ischemic lesions localized to the medial prefrontal cortex produce 
selective deficits in measures of executive function in rats. Behavioural Brain 
Research. 293:54-61. 
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SUMMARY 
 Ischemic stroke is one the leading causes of neurological disability worldwide, 
and it has been estimated that about one quarter of stroke survivors experience some 
measurable long-term impairments of cognition. Many higher order cognitive deficits 
occur because of damage to the prefrontal cortex (PFC), which is one of the main areas 
of the brain responsible for executive functioning in mammals. Currently, there are few 
animal models that attempt to replicate the effects of stroke on executive function. In 
this study we used bilateral micro-injections (1 µl) of the vasoconstricting peptide 
endothelin-1 (ET-1) into the medial PFC in male Sprague Dawley rats (or vehicle 
control, n = 17-18 per group) in order to model ischemic lesions in the  medial PFC. The 
effects of these lesions on executive function were assessed using tests of set-shifting 
and temporal order recognition.  ET-1 injections in the medial PFC (mPFC) resulted in 
replicable and specific lesions within the PFC with an average infarct volume of 16.63 ± 
2.71mm
3
. The ischemic lesions resulted in specific contextual set-shifting deficits within 
the maze, including an increased number of trials to criterion and a significant difference 
in learning curves. However, no deficits in temporal order memory processing were 
noted between sham and stroke animals. It was concluded that ischemic lesions 
localized to the mPFC result in selective but not generalized deficits in executive 
function in rats.  
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3.1. INTRODUCTION 
 
 Stroke is one of the leading causes of death and disability, with an estimated 
795,000 new or recurring cases each year in the United States alone (Go et al. 2014). 
Although a majority of patients survive the initial cerebrovascular insult, many affected 
individuals have ongoing deficits in function that may persist for months or years post-
stroke (Kelly-Hayes et al. 2003). The most common groups of deficits induced by stroke 
damage can be broadly classified into two general categories: motor deficits and 
cognitive deficits (Lawrence et al. 2001; Nys, van Zandvoort, de Kort, et al. 2005; 
Langhorne et al. 2009). Although new methods have been, and continue to be developed 
to treat post-stroke motor deficits, there are few demonstrably effective strategies to 
treat the many forms of cognitive dysfunction that may occur post-stroke (T. Hoffmann 
et al. 2010; Loetscher and Lincoln 2013). Further, patients suffering from cognitive 
deficits are often less receptive to therapies used to treat motor dysfunction, 
exacerbating the effects of stroke and hindering recovery (Winstein 1999; Jehkonen et 
al. 2006). Many types of post-stroke cognitive deficits have been described, including 
encoding-based deficits (Madureira et al. 2001), aphasia (Pedersen et al. 1995), and 
executive dysfunction (Zinn et al. 2007a). Deficits in executive function, which are 
considered higher order cognitive functions controlled by the prefrontal cortex, include 
working memory, goal-based decision making, and the learning and proper application 
of rules (Miller and Wallis 2009; Diamond 2013). In patients who have survived an 
initial stroke, it has been estimated that approximately one half have some measureable 
long-term deficit in executive function (Zinn et al. 2007b).  
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 Although the mechanisms by which interrupted blood flow causes damage to the 
brain are relatively well understood, the potential deficits in behaviour resulting from 
this damage, as well as effective treatment strategies, are poorly understood and elusive.  
Furthering the current understanding in this regard relies heavily on the use of 
appropriate animal models (Minnerup et al. 2012; Hope et al. 2013).  One of the most 
commonly used stroke models, the rat middle cerebral artery occlusion (MCAo) model, 
produces a replicable and reliable lesion both in the cortex and striatum, and results in 
both motor and some cognitive deficits (Belayev et al. 1996; Bouët et al. 2007). 
Unfortunately due to the size and location of the lesion, which is typically centred 
within the occipital lobe, the study of complex cognitive deficits in rats is confounded 
by overlapping sensory and motor deficits that probably contribute to the lack of 
documented reports on executive function deficits using MCAo (Carmichael 2005; Jiwa 
et al. 2010).  Other commonly used stroke models, such as 2- and 4-vessel occlusion and 
hypoxia-ischemia, are similarly compromised in that the ischemic damage affects 
certain neuronal populations more than others, notably the CA1 region of the 
hippocampus, and photothrombotic models are largely restricted to surface vasculature 
(Kirino 1982; Traystman 2003; Schmidt et al. 2012). Recently, our laboratory and others 
have described how small well-localized ischemic lesions produced by surgical 
microinjection of endothelin-1 (ET-1) have been used successfully to produce discreet 
functional deficits in rats (Livingston-Thomas et al. 2013; Livingston-Thomas et al. 
2014). Endothelin-1 is a potent vasoconstrictor capable of temporarily occluding blood 
vessels via an action on endothelin receptors (Sumner et al. 1992). This feature of 
temporary occlusion allows ET-1 injections to mimic the effects of a temporary 
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ischemic stroke. The compound can be injected directly onto blood vessels in the brain 
in order to mimic already established surgical protocols, or it can be injected within the 
brain parenchyma itself, resulting in small vessel occlusion and a consequent ischemic 
lesion directly at the site of application or injection (Fuxe et al. 1997; Windle et al. 
2006). The ET-1 model is used throughout the studies described in this thesis. 
 Non-ischemic lesions occurring within the prefrontal cortex of rats can cause a 
variety of different behavioural effects, including temporal order memory dysfunction, 
working memory dysfunction, an attenuated fear response, alterations in social 
interaction, and deficits in attentional processing (Granon et al. 1994; Birrell and Brown 
2000; Shah and Treit 2003; Hannesson et al. 2004). In humans, ischemic lesions in the 
dorso-lateral PFC, which is functionally equivalent to the medial PFC region in rats, 
cause a variety of functional deficits including an increased incidence in depressive 
symptoms and attentional set-shifting difficulties (Stuss et al. 2000; Thomas et al. 2003).  
 The objectives of this study were two-fold:  first, to localize a stroke-induced 
lesion to the medial prefrontal cortex in rats via the injection of the vasoconstrictor ET-
1, and second, to evaluate any resulting deficits in executive function using a temporal 
order memory task and a set-shifting task. 
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3.2 METHODS 
 
 3.2.1 Experimental Animals 
 
 All procedures were conducted in accordance with the guidelines of the 
Canadian Council on Animal Care and were approved in advance by the University of 
Prince Edward Island Animal Care Committee, protocol number 12-035. Adult male 
Sprague-Dawley rats (n = 37, 250-275g on arrival) were purchased from Charles River 
Laboratories (Montreal, Canada) and singly housed on a reverse 12 h light/dark cycle 
(lights on at 18:00 and off at 06:00) with food (Purina rat chow) and water available ad 
libitum until training/testing (see below). Upon arrival, animals were acclimated to the 
facility for one week and were handled by the experimenter for 5 minutes each day for 
three days subsequent to the acclimation period. Subsequent to daily handling all 
animals were given 10 sucrose pellets (Bio-Serv, Frenchtown, USA) in their home cage 
in order to acclimate the animals to the reward. All behavioural training and testing 
occurred during the dark phase of the light cycle. All animals were weighed once daily. 
  
 3.2.2 Surgical Procedures 
 
 The surgical protocols for producing an ET-1 stroke lesion were as reported 
previously,
 
with the exception of injection coordinates and volumes (Livingston-Thomas 
et al. 2013; Livingston-Thomas et al. 2014).  Rats (ET-1 n = 19, sham n = 18) were 
anaesthetised by being placed into an induction box prefilled with 3.5% isoflurane (PPC, 
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Richmond Hill, Canada) in oxygen for 8 minutes, and anaesthesia was maintained 
throughout the surgery with a 2-3% isoflurane mixture. Animals were mounted on a 
stereotaxic frame (Kopf Instruments, Tujunga, USA), and the fur on the top of skull was 
shaved. Once shaved, topical Xylocaine (AstraZeneca, Mississauga, Canada) was 
applied to the shaved area and left for 5 minutes before a subsequent 2 cm midline 
incision was made down the top of the cranium. This incision was held open by 4 
clamps. Two small burr holes were then drilled into the cranium above the coordinates 
required for drug injection.  A 26 gauge 10 µl syringe (Hamilton, Reno, USA) was 
lowered into each of the injection sites (anterior/posterior +3.0, medial/lateral ±0.7, 
dorsal/ventral -4.5, all coordinates relative to bregma) and was left for 1 minute prior to 
ET-1 injection. After one minute, 1 µl of ET-1 (400 pmol) dissolved in artificial cerebral 
spinal fluid (aCSF) was injected into the cortex at a rate of 0.5 µl/minute. Once the ET-
1injection was complete, the needle was left undisturbed for 4 minutes to allow for drug 
dispersal at the injection site, and then the needle was slowly retracted from the brain. 
After both ET-1 injections, the incision site was sutured and Xylocaine was reapplied. 
At the conclusion of the surgery each animal was given a 2.0 mg/kg subcutaneous 
injection of butorphanol tartrate (Wyeth, Guelph, Ontario) for post-operative analgesia. 
During surgical procedures, one animal could not be properly anesthetised and one 
animal died, therefore final group numbers for sham and ET-1 injections were n = 18 
and n = 17, respectively. Sham treated animals received the same surgical treatment as 
stroke animals but received an equal volume injection of aCSF alone.  
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 3.2.3 Set-Shifting Task  
 
 All animals were habituated and trained in the set-shift maze over a two week 
period prior to surgery (Section 3.2.2).  The maze and testing protocol were modified 
from Stefani et al. (2003). The apparatus was a plus-maze constructed of Plexiglas walls 
(20 cm high) with metal arms (40 x 10.5 cm length and width).  Each arm was lined 
with a Plexiglas insert which varied along two different stimulus dimensions: brightness 
or texture. The inserts were painted either black or white, with one arm of each colour 
painted with the inclusion of bird gravel (Hagen, Montreal, Canada) to create a rough 
texture. Each of the inserts spanned the full length of the arm, and the centre rectangle of 
the maze consisted of an 11.5 × 10.5 cm Plexiglas insert, painted grey (see Figure 3.1).  
The day prior to any training or testing, the animal was placed on a restricted feeding 
schedule, which consisted of 4 hours of ad libitum feeding followed by 20 hours of food 
deprivation. Once 20 hours had passed, the training or testing commenced and the 
animal was placed back on ad libitum feeding once the training or testing was complete. 
Of the animals in the experiment, five were excluded from the set-shifting task due to 
failing out of the training process. 
 
  3.2.3.1 SST training protocol 
 
 The training regimen prior to surgery was divided into two separate sections and 
was conducted over two weeks. The first week of training consisted of placing the 
animal in the maze with sucrose pellets in all of the arms and in each of the food cups  
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Figure 3.1. A diagram of the attentional set-shifting maze. During testing phases the 
animal is placed pseudo-randomly into one of the four arms, and the opposite arm is 
blocked creating a T-maze. The animal then has the choice to turn right or left to receive 
a food reward, depending on which stimulus (light, dark, rough, or smooth) is being 
rewarded. 
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located at the ends of the arms. The animals remained in the maze for 5 minutes or until 
each of the food pellets was consumed. Over the course of the first week the number of 
food pellets in the maze was reduced until the last day when there was only 1 pellet in 
each of the food cups. 
 The second week of training consisted of placing the animal pseudo-randomly 
into one of the four arms of the maze, and blocking access to the arm directly opposite 
the start arm, thereby creating a T-maze. The food cups of the right and left maze arms 
were each baited with 1 sucrose pellet, and the animal was allowed to choose 1 arm.  A 
“choice” was defined as having all four limbs in contact with the Plexiglas insert within 
a choice arm. This procedure was performed 8 times in one training day, with the animal 
starting from each arm twice in one day. Between trials, the rat was placed into an inter-
trial interval box (a standard animal holding cage with the exterior lined with black 
Bristol board) for approximately 15 seconds. Two days after completion of SST training 
the animals underwent the surgery as described in Section 3.2.2.   
  
  3.2.3.2 SST testing protocol 
 
 On post-surgery day 8 (PSD-8), the animals began SST testing by being trained 
to associate one feature of the Plexiglas inserts (brightness or texture) with the receipt of 
a food reward. Each rat was placed into one of the four arms with the opposite arm 
blocked, and allowed to choose right or left.  Rats were randomly assigned to a 
brightness (light or dark) or texture (smooth or rough) group.  Criterion was defined as 
choosing the correct arm, defined as the pellet-baited arm, on 8 successive trials up to a 
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maximum of 80 trials in one session. If 80 trials were completed without having reached 
criterion, they were removed and retrained to the same feature for an additional 80 trials, 
or until criterion was reached, the following day. The animal was pseudo-randomly 
placed twice into each of the arms over an 8 trial block, and the maze apparatus was 
rotated once every four trials. Four animals were unable to reach criterion in the task and 
were removed from this portion of the study. 
 For rats that achieved criterion, the stimulus associated with reward was reversed 
on the following day (i.e. rats that had learned to associate brightness with a food reward 
were now re-trained to associate a texture with the receipt of a food reward, and vice 
versa). Animals were tested for a minimum of 80 trials with success criterion, as defined 
previously (see above). Again, the animal was pseudo-randomly placed twice into each 
of the arms over an 8 trial block, and the maze apparatus was rotated once every four 
trials. 
 
 3.2.4 Temporal Object Recognition Task 
 
 Temporal object recognition (TOR) measures an animal's ability to distinguish 
between objects seen more recently versus objects seen less recently and has previously 
been reported to be dependent on an intact medial PFC (Barker et al. 2007). The maze 
apparatus consisted of a round, empty, fibreglass container (148.6 cm in diameter; walls 
63.5 cm in height). To provide colour contrast for video recording the floor of the maze 
was covered in brown adhesive shelf liner.  
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 On PSD5 and PSD6 each animal was acclimated separately to the maze for 10 
minutes. Testing began on PSD 7 and consisted of placing the animal into the maze with 
a pair of identical objects positioned equidistant from the centre of the maze and the 
maze walls. The rat was allowed to explore for 4 minutes before being returned to its 
home cage. After a delay of 60 minutes, the animal was placed back in the maze with a 
new pair of identical objects for a further 4 minutes. After an additional delay of 180 
minutes, the animal was returned to the maze with one object from each of the two 
previous trials for 3 minutes. Time spent exploring the objects was recorded via a digital 
camcorder and stopwatch, and active exploration of an object was defined as the animal 
facing the object and having its head within at least two centimetres of the object's 
surface. TOR testing took place on PSD 7, PSD 14, PSD 21, and PSD 28. Two sets of 
objects were used during this experiment, with one set of objects (a metal beam and a 
plastic box of nails) being used on PSD 7 and PSD 21, and the other set of objects (a 
flower pot and a rubber wheel) being used on PSD 14 and PSD 28.  
 
 3.2.5 Histology and Infarct Quantification 
 
 On PSD 28, rats were anaesthetized with isoflurane and euthanized by 
decapitation. Brains were removed and fixed in 10% formalin. Brain tissue was 
sectioned in 100µm segments by vibratome (Ted Pella, Redding, USA) and mounted on 
Surgipath X-tra glass slides (Leica Biosystems, Richmond, USA). Sections were 
subsequently stained with cresyl violet (0.1 % w/v). Images were prepared using a 
computer scanner (HP Scanjet 7650) at 2400 DPI resolution, and infarct quantification 
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was performed by tracing the area of tissue which displayed a lack of, or abnormal, 
cresyl violet staining or altered cytological architecture. Tracing was performed using 
ImageJ software, version 1.45s (ImageJ, National Institutes of Health, USA). Once each 
area had been traced, the volume of infarct damage was quantified by summing each 
individually calculated area and multiplying the area by the distance between each 
section (100 µm). 
 
 3.2.6 Statistical Analyses 
 
 Statistical analyses were performed using Graph Pad Prism, Version 5.00 (Graph 
Pad, La Jolla, USA). Weight differences between sham and stroke pre- and post-stroke 
were calculated using a repeated measures 2 way ANOVA with Bonferroni post-hoc 
tests comparing each group on each day.  
 In the first phase of the set-shifting task the number of trials to criterion was 
analysed using a one tailed Student‟s t-test, and the slopes of the learning curves 
(average number of correct choices by trial) were compared between all groups using a 
two-way ANOVA (sham/stroke × brightness/texture). For the second phase of the set 
shifting task the number of trials to criterion for each group were compared using a one 
tailed Student‟s t-test and the types of errors made by each of the trial groups were 
compared using separate two-way ANOVAs examining the types of errors versus the 
discrimination factor (brightness versus texture) for both the sham and stroke groups. In 
addition, the slopes of the learning curves (mean correct choices by block) were 
compared between groups using a two-way ANOVA.  
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 The amount of time spent exploring each object in the temporal order 
recognition task was analysed using a two-way repeated measures ANOVA with post-
hoc comparisons using t-tests with Bonferroni correction where appropriate. 
In all analyses, results were considered statistically significant at p ≤ 0.05. 
 
3.1  RESULTS 
 
 3.3.1 Histology and Infarct Size 
 
 Bilateral ET-1 injections into the prefrontal cortex (Figures 3.2A and B) 
produced an infarct within the tissue, with the largest area of damage localized within 
the prelimbic and infralimbic cortices (approximately +3.0 anterior to bregma) (Figure 
3.2C). The average volume of the infarct was found to be 16.63 ± 2.71mm
3
 (mean ± 
SEM).  Data from two rats were not included in any analyses because one animal died 
during surgery and the other had an ischemic lesion that was significantly larger than the 
average; affecting regions well outside both the prelimbic and infralimbic cortices. Body 
weights between the two groups were compared on days PSD 0 through PSD 7 though a 
repeated measures two-way ANOVA, revealing no significant difference between the 
groups (Figure 3.3).  
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 3.3.2 Behavioural testing 
    
  3.3.2.1 Set-Shifting Task 
  
 During the first phase of testing the number of trials needed to reach criterion (8 
correct trials in a row) was recorded, and it was determined that there was no significant 
difference in the number of trials required by either the sham or stroke groups to 
correctly learn the association (t(30) = 0.271;  p > 0.05) (Figure 3.4A). As well, the slopes 
of the learning curves (mean correct choices by trial) from the first phase of the test 
were analysed through a two way ANOVA that compared both features (brightness and 
texture) as well as treatment groups (sham and stroke). There were no significant main 
effects for either the feature (brightness versus texture) (F1, 26 = 3.01; p > 0.05) or the 
surgical treatment (F1, 26 = 1.34; p > 0.05) and no significant interaction was found  
(F1, 26 = 0.07; p > 0.05), indicating that initial rates of learning the task did not differ 
between any of the groups. 
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Figures 3.2A-C. Overview of the surgical procedure and the resulting ischemic insult. (A) The approximate location of the two 
injection sites, denoted by the X. Picture adapted from the Rat Brain Atlas, 6th edition (Paxinos and Watson 2007). (B) A 
representative example of the ischemic insult found within the prefrontal cortex, stained with cresyl violet. (C) A line graph 
representing the relative area of damage at different stereotaxic levels (n = 17) 
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Figure 3.3 Animal weights pre- and post-surgery. A two-way repeated measures 
ANOVA found no significant differences between the sham (n = 18) and the stroke (n = 
17) groups (F1,33 = 0.395 p > 0.05), nor an interactive effect found between the day 
weighed and the surgical group (F7,33 = 1.59 p > 0.05). 
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Figure 3.4A and B. An overview of trials to criterion to learn during the SST. (A) The number of trials needed to reach criterion 
during the first phase of the test, which is the initial association between a maze feature and receipt of a food reward. (B) The number 
of trials needed to reach criterion during the second phase of the test, which involves set-shifting from a previously relevant stimulous 
to a previously irrelevant stimulus. Though there was no difference between the number of trials needed for animals to set-shift to a 
brightness stimlus, there was a significant difference (p <  0.05) between sham (n = 15) and stroke (n = 15) animals in the number of 
trails required to set-shift to a texture discrimination. 
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 During the second phase of testing, stroke animals that had initially learned 
texture and then shifted to brightness learned the new association as quickly as sham-
treated rats (t(13) = 0.02; p > 0.05) (Figure 3.4B). However, animals lesioned using ET-1 
that had originally learned the brightness feature were not able to learn the texture 
feature as quickly as their sham counterparts (t(14) = 1.82; p < 0.05) (Figure 3.4B). The 
average learning curves of each of the groups of animals were also calculated. The 
results from the first 80 trials were amalgamated into 10 blocks of trials, with each block 
of trials representing the percent of correct choices the animal made over 8 trials (as 
depicted in Figures 3.5A and B). Once this was completed, the slope of the average 
learning curve for each group was calculated and compared between all groups using a 
two way ANOVA that revealed a significant main interaction effect between surgery 
group and maze feature (F(3,28)= 8.46; p < 0.01).  Subsequent post-hoc analyses revealed 
that  there was no significant difference in the groups that shifted to the brightness 
feature (sham 3.51 ± 0.847, stroke 5.13 ± 0.704; t(13) = 1.48; p > 0.05)(Figure 3.5A). 
However, there was a significant difference in the slope of the learning curves between 
sham and stroke animals that shifted from brightness to the texture feature (sham 4.50 ± 
0.67, stroke 0.82 ± 1.18; t (14) = 2.61; p < 0.01)(Figure. 3.5B).  
 To determine the nature of the association formed between cue and reward, data 
obtained during the second phase of the task were further analysed for both the number 
and type of error made by each animal. Incorrect choices made during this portion of the 
task were recorded as either perseveration or unreinforced errors, with perseveration
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Figures 3.5A and B. Learning curves for the first 80 trials during phase 2 of the SST. Each block number represents an 
amalgamation of 8 trials into the percent of trials correct during that block. (A) Learning curves for the animals switching from texture 
to brightness. There was no significant difference in the learning curves of these animals (n = 7 for both sham and stroke groups). (B) 
Learning curves for the animals switching from brightness to texture. The average slope of the learning curve for the stroke animals 
was significantly less than the slope of the learning curve for the sham animals (n = 8 for both sham and stroke groups).  
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errors considered to be incorrect arm choices which would have been correct during the 
previous phase, and unreinforced errors considered to be incorrect arm choices that 
would have also been incorrect choices in the previous phase of the test. Within the 
sham group, there was a significant main effect between the number of perseveration 
errors versus unreinforced errors (F(1,26) = 7.49; p < 0.05). Post-hoc analysis of these 
data revealed that sham-treated rats in the group switching to brightness commited 
significantly more perseveration errors than unreinforced errors (Figure 3.6A). There 
was no significant difference between the two types of errors within the group switching 
to texture although there was a tendency for more perseveration errors (Figure 3.6A). In 
contrast, in the rats treated with ET-1 there was a significant interactive effect when 
comparing the number of errors of each type in the brightness versus texture groups 
(F(1,26) = 4.92; p < 0.05). Post-hoc analyses revealed that rats subjected to ischemic 
stroke committed significantly more perseveration errors whether they shifted to 
brightness (t(13) = 5.91; p < 0.001) or to texture (t(14) = 6.44; p < 0.001). As well, the total 
number of perseveration errors made between the texture-brightness and brightness- 
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Figures 3.6A and B. Overview of the types of errors made by each test group 
during the second phase of the SST test. (A) Types of errors in the sham group 
switching to the brightness feature or to the texture feature. (B) Types of errors in the 
stroke group switching to the brightness feature or to the texture feature. n = 7 for each 
brightness group (sham and stroke) and n = 8 for each texture group (sham and stroke) 
*p < 0.05. 
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texture groups was significantly different, with rats in the brightness-texture group 
committing more errors of this type (t(13) = 3.63; p < 0.01) (Figure 3.6B). 
 
  3.2.2.2 Temporal Object Recognition Task 
 
 Data obtained over 4 weeks post-surgery in the TOR task are summarized in 
Tables 3.1-3.3. There were no significant differences in the amount of time the animals 
spent examining the first or second object in either the sham or stroke groups on any of 
the test days (PSD 7 F(1, 33) = 2.85; PSD14 F(1, 33) = 1.32; PSD21 F(1, 33) = 0.31; PSD28 
F(1, 33) =  4.21; p > 0.05 for all testing days)(Table 3.1) indicating that overall both 
groups of animals were unable to distinguish between objects presented first or objects 
presented second, although there was a tendency in both groups to prefer the object 
presented first (Table 3.1). 
 Prior to testing, preliminary evaluation of the objects used indicated that normal 
rats had no innate preference for one object over the other (data not shown). In order to 
determine if ischemic stroke altered object preference, the data were separated into total 
time spent with a specific object, summarized in Tables 3.2A and 3.2B. Neither group of 
animals displayed a significant object preference on either PSD 7 or PSD 21 (PSD7 
F(1,33) = 1.51; PSD21 F(1,33) = 3.73; p > 0.05 for both testing days)(see Table 3.2A). 
However, there was a significant main effect between object preference on PSD 14, due 
to rats in the stroke group (but not sham) spending more time with the flower pot than 
the wheel (PSD 14 F(1,33) = 10.3; p < 0.01)(see Table 3.2B). On PSD 28, there was a  
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Table 3.1 Mean (+/- SEM) time (seconds) spent examining the objects presented in 
the temporal order test over three minutes. Neither test group spent significantly 
more time with the first object presented over the second object presented for any of the 
days tested. Sham n = 18, stroke n = 17.   
 Sham Stroke 
Testing  Day First Object Second Object First Object Second Object 
PSD 7 19.7s ± 2.45s 16.6s ± 1.66s 22.1s ± 2.00s 18.0s ± 2.51s 
PSD 14 15.2s ± 1.57s 12.5s ± 1.55s 17.7s ± 3.40s 14.2s ±3.33s 
PSD 21 20.3s ± 2.22s 19.0s ± 2.26s 25.9s ±3.14s 21.3s ±2.27s 
PSD 28 12.4s ± 1.66s 9.17s ± 1.30s 17.2s ±3.55s 10.9s ±2.38s 
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Table 3.2A.  Mean (+/- SEM) time (seconds) spent examining specific objects in the 
maze (a metal beam versus a plastic box of nails) on PSD 7 and PSD 21. There was no 
significant difference in the amount of time each group (sham and stroke) spent 
examining one object versus the other on either of the days that they were tested. Sham 
n = 18, stroke n = 17.  
 
 Sham Stroke 
Testing Day Metal Beam Plastic Box Metal Beam Plastic Box 
PSD 7 21.5s ± 2.27s 17.9s ± 1.71s 19.5s ± 2.66s 17.6s ± 2.18s 
PSD 21 23.0s ± 2.45s 18.1s ± 1.76s 25.9s ± 3.14s 21.3s ± 2.27s 
 
Table 3.2B Mean (+/- SEM) time (seconds) spent examining specific objects in the 
maze (an empty overturned flower pot versus a rubber wheel) on PSD 14 and PSD 28. 
On both test days rats in the stroke group spent significantly more time exploring the 
flower pot than the wheel; an effect also seen in the sham group on PSD 28.  *p<0.05.  
Sham n = 18, stroke n = 17. 
 
 Sham Stroke 
Testing Day Flower Pot Wheel Flower Pot Wheel 
PSD 14 15.6 ± 1.52 11.9 ± 1.52 22.0 ± 4.11  9.98 ± 1.36 * 
PSD 28 13.7 ± 1.59 7.85 ± 1.05* 21.4 ± 2.98 6.77 ± 1.15 * 
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significant interactive effect between the sham and stroke groups and the amount of time 
spent with each object (PSD 28 F(1,33) = 5.49; p < 0.05). To compare time spent between 
flower pot and wheel, post-hoc paired t-tests were used comparing both differences in 
exploration between the sham group object preference and stroke group object 
preference. There was a significant difference between exploration times in both groups 
(Sham t(18) = 3.781; p < 0.01); (Stroke t(17) = 4.331; p < 0.001). When comparing flower 
pot and wheel exploration times between treatment groups via unpaired t-tests, there 
was a significant difference in the amount of time spent exploring  the flower pot (t(33) = 
2.261; p < 0.05). However, there was no difference in the amount of time spent 
exploring the wheel (t(33) = 0.6910; p > 0.05). 
 The same data were also analysed to determine the discrimination ratio between 
object types (flower pot versus rubber wheel, metal box versus nail box). This value was 
calculated by averaging the amount of time spent with each object by each animal, and 
dividing the subtraction of one from the other by the total amount of time spent 
exploring both objects. Each set of values was then analysed through a one-sample t-test 
with a theoretical mean of 0. Each value on PSD 14 and PSD 28 was significantly 
different from the theoretical mean, indicating that animals spent more time exploring 
one object (the flower pot) versus the other (rubber wheel) during the task(PSD 14 Sham 
[t(16) = 2.520; p <  0 .05]; PSD 14 Stroke [t(16) = 4.236; p <  0.001]; PSD 28 Sham [t(16) = 
4.279; p < 0.001]; PSD 28 Stroke [t(16) = 5.747; p < 0.001]). (see Table 3.3). 
 
 
 
104 
 
Table 3.3 Ratio scores comparing the amount of time spent with each object in the 
temporal object recognition maze. Sham n = 18, stroke n = 17. 
 
Testing Day Sham Stroke 
PSD 7 0.065 0.017 
PSD 14 0.202* 0.280* 
PSD 21 0.115 0.098 
PSD 28 0.305* 0.469* 
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3.4. DISCUSSION 
 
 This study investigated the histological and behavioural effects of bilateral ET-1 
injections to the medial PFC. The protocol resulted in consistent and well-localized 
ischemic lesions that appeared to have no effect on associative learning, relative to 
surgical sham controls, but did have a differential effect on the set-shifting ability of ET-
1 treated rats. Lesioned animals switching from a texture feature to a brightness feature 
performed equally to their sham counterparts, but stroke animals switching from a 
brightness feature to a texture feature were neither able to shift strategies as quickly nor 
learn as quickly as sham animals.  ET-1 injections in the medial PFC did not have a 
significant effect on an assessment of temporal order memory. 
 
 Histologically, the ET-1 injection protocol employed herein resulted in lesion 
volumes similar to a 2014 report by Cordova et al (2014) who used four ET-1 injections 
(as opposed to two) into the medial prefrontal cortex but a smaller volume of ET-1 per 
injection (0.8 µl versus 1.0 µl) although the concentration of ET-1 was not reported.  
Those authors did report that ET-1 induced lesions in the medial PFC significantly 
altered performance in one of the measures examined in a test of attentional set-shifting 
originally described by Birrell and Brown (2000). In that version of the test, animals are 
tested in a variety of cognitive tasks by having to burrow through digging media in 
flower pots that are assigned a particular smell. This method of testing includes an 
attentional set-shifting task, as well as a simple discrimination task, a compound 
discrimination task, an intra-dimensional shift task, and a reversal learning task. In their 
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experiment, stroke animals performed comparably to control animals, except when 
required to switch from an odour stimulus to a texture stimulus. In the current study we 
found a similar context-dependent effect on set-shifting.  Rats with medial PFC 
localized lesions displayed no difference in how quickly the animals initially learned 
either the brightness or the texture features. When required to shift the relevant context 
feature, stroke animals switching from brightness to texture were significantly impaired 
whereas those switching from texture to brightness were not (Figures 3.3 and 3.4). This 
contrasts data reported by Stefani et al. (2003) who did not describe any differences in 
brightness/texture versus texture/brightness learning in a comparable task. However, 
these authors were not specifically studying ischemic stroke, but rather were selectively 
inhibiting excitatory neurotransmission in the medial PFC through the use of injections 
of glutamate receptor antagonists. The ischemic lesions produced in the current study 
would damage multiple transmitter systems as well as axons of passage and, 
consequently, might have differential effects on behaviour. 
 
 One possible reason for the discrepancy between brightness and texture set-
shifting observed may be the nature of the stimulus itself. During the first portion of the 
task, the animals had no predisposition to either brightness or texture. But after having 
learned that one feature is associated with reward whereas the other is not, rats would be 
inclined to make their choice as quickly as possible in order to be rewarded. When an 
animal enters the middle of the maze, they see the brightness of each arm and can 
immediately make a choice based on that feature. This is different to how animals would 
distinguish texture, for in order to do that they must first enter the arm to feel the texture 
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before they are able to distinguish a right or wrong choice. Therefore, there is a 
difference as to the timing of these two stimuli. Consequently, if an animal is prone to 
making impulsive decisions, animals may be better able to follow brightness cues as 
they are more quickly available in contrast to texture cues. Interestingly, it has been 
observed that damage to the prefrontal cortex has been previously associated with 
increased impulsivity in both rats (Mobini et al. 2002; Rudebeck et al. 2006) and 
humans (Bechara 2000; Berlin et al. 2004). This interpretation may not be able to 
explain the reasons why Cordova et al. (2014) found no dimension-specific differences 
within their experiment, despite having a similar surgical protocol and lesion size. 
However, this may be due to discreet differences in the methodologies in our 
experiments; our experimental protocols require only a two-step process (initial learning 
and an extradimensional shift), wherein their intradimensional (ID)/ extradimensional 
(ED) experimental design required simple and compound discriminations as well as a 
reversal learning task, which required the animals to undergo multiple learning 
processes. To determine if impulsivity is in fact a contributing factor to the results 
obtained, future experiments could be refined to test either the impulsivity of rats 
following an ischemic lesion to the medial PFC, or to modify aspects of this task to use 
other sensory systems, including odor or auditory stimuli. Another potential explanation 
for the discrepancy between stroke animals learning differently between the brightness 
and texture features is the nature of the training regimen. It has previously been noted 
that deprivation of water affects how animals are able to learn optimal shift 
discrimination tasks, specifically in the context of brightness versus texture cue 
utilization (Cohen and Hachey 1977). Although the deprivation schedule within this task 
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was food-based rather than water-based, different types of deprivation may alter an 
animal‟s ability to switch to relevant reward cues in their environment. 
 One of the potential limitations of this study is that the test employed could be 
considered a test of simple set-shifting rather than attentional set-shifting, similar in 
nature to plus-maze experiments requiring a change from an egocentric response to a 
visual cue-based strategy (Floresco, Ghods-Sharifi, et al. 2006). In a typical ID/ED 
shifting task, such as the one developed by Birrell and Brown, the number of trials 
typically required to perform the ED shift is more than the ID (2000). However, it has 
been reported under different experimental conditions using this task that the number of 
trials required to switch between intra and extradimensional shifts can remain the same 
(Lapiz and Morilak 2006). For the texture/brightness ED shift in the SST, both groups 
of animals performed equally, not worse, during the initial learning task. This indicates 
that an attentional set may not have been formed. However, in the brightness/texture 
discrimination portion of the task, lesioned animals had considerable difficulty strategy-
shifting compared to the sham animals, who performed equally well between the first 
and second phase of the test.  The difficulty for stroke-lesioned rats to perform the 
brightness/texture shift is supported by the data in Figure 3.5. These data reveal that rats 
in all groups committed more perseverance errors than unreinforced errors, which can 
be interpreted as evidence of forming a „set‟ during the first phase. However, in the rats 
that received ET-1 the number of perseverance errors within the brightness/texture 
stroke group was found to be significantly higher than the texture/brightness stroke 
group (Figure 3.5B). Although the issue of whether the results support an attentional 
shift or a strategy shift is hard to resolve in the test employed, as stroke animals do 
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appear to have some difficulties switching between a visual and a texture based reward 
cues in this paradigm. This suggests that the SST is an ideal task to test an animal‟s 
ability to set-shift between different reward cues following ischemic lesions.  
 The effects of a localized ischemic lesion to the medial PFC on temporal order 
memory remain unresolved. During the task, both groups of animals spent equal 
amounts of time with both objects (see Table 3.2A and B), as opposed to the expected 
effect of a preference based on how recently the object was presented, as described by 
others (Mitchell and Laiacona 1998; Barker et al. 2007). One reason for this lack of 
effect may have been the size of the test arena (148.6 cm in diameter), as this may 
reduce the total time spent exploring the objects. Otherwise, the conditions employed 
were comparable to those used by other authors (Mitchell and Laiacona 1998; Barker et 
al. 2007). Another reason why the animals may not be able to distinguish the first 
presented object from the second is due to the amount of delay time between initial 
presentation of the objects and the test phase, which in this study was three hours. Other 
studies examining object recognition have found exploration time differences between 
novel and familiar objects at 15 minutes, but not at 4 hours (Hotte et al. 2005). However, 
under similar conditions other studies suggest that temporal object recognition may be a 
relatively robust phenomenon, with differences in exploration time being reported 24 
hours after initial presentation of the objects (Mitchell and Laiacona 1998). One 
particularly intriguing finding, however, was that despite prior pilot testing (that 
determined a lack of preference for the objects used; results not shown), during the test 
sessions there was a notable but not significant tendency for sham-treated rats to prefer 
the flower pot to the rubber wheel (see Tables 3.2A and B); a tendency that became 
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statistically-significant following ischemic stroke on PSD 14. Such a difference was not 
noted with the other objects used (metal beam and box) and an obvious explanation for 
the observation remains elusive. 
 Our results add to a growing body of literature that supports a complex role for 
the prefrontal cortex in executive function in rats. Different areas of the prefrontal cortex 
can control different functions and different areas of the brain connecting to an intact 
prefrontal cortex can also affect executive functions. The dorsomedial thalamus, a brain 
region with efferent connections to the prefrontal cortex, has been demonstrated to be 
involved with attentional processing and shifting attention to new rules (Hunt and 
Aggleton 1998). In a recent study, however, injections of ET-1 to the dorsomedial 
thalamus appeared not to affect attentional set-shifting, although the authors speculate 
that this could have been the result of insufficient ischemic damage to this region 
(Cordova et al. 2014). Interestingly, another factor which has an effect on attentional 
set-shifting function and possibly the function of the medial PFC, is the age of the 
animal. One study described the ability of young (4-5 month) vs old (27-28 month) 
Long-Evans rats in an attentional set-shifting task, with the younger rats outperforming 
the older rats, achieving criterion in fewer trials than older rats (Barense et al. 2002). As 
well, the aged rats showed no deficits in either reversal learning or spatial memory, 
suggesting that the deficit in function could be localized to the medial PFC. Although 
their study described no detectable histological differences between young and old 
animals, it was hypothesized that this difference could have been due to decreases in 
glutamate receptors within the PFC. Compounding this issue is the fact that the brain is 
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less resilient to ischemic insult as it ages, which could prove detrimental to recovery 
efforts for older individuals suffering from ischemic damage (Davis et al. 1995).  
 In summary our data indicate that ET-1 injections within the brain can be 
localized to specific subregions of the prefrontal cortex, resulting in targeted and 
reproducible ischemic lesions to the medial PFC. Such lesions appear to affect specific 
aspects of cognitive behaviour in rats but do not generalize to global deficits in 
executive function. Further experimentation on other aspects of cognitive behaviour, 
including impulsivity, effort-based decision making, and aspects of social competencies 
in rats, is needed to unravel the apparently complex role of the PFC in appetitively-
motivated decision making, and to guide future research into cognitive rehabilitative 
strategies following stroke.  
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CHAPTER 4 
EFFECTS OF PREFRONTAL CORTICAL LESIONS ON INHIBITORY 
CONTROL AND ULTRASONIC VOCALIZATIONS IN THE RAT 
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SUMMARY 
 Stroke is one of the most prominent causes of neurological disability in the 
world, and the number of cases occurring worldwide is expected to increase of the 
coming decades. As such, new mechanisms for combating this disease will be 
increasingly necessary. One of the issues with the treatment of stroke is that there are 
few methods by which we can help alleviate the cognitive deficits caused by this 
disease. As well, there are very few pre-clinical models of stroke with a specific focus 
on higher-order cognitive functions. The goal of the experiments performed in this 
chapter of the thesis was to examine the effects of ischemic lesions to the medial and 
orbital prefrontal cortices on inhibitory control, an important aspect of executive 
function, and ultrasonic vocalizations, which give an indication as to the affective state 
of the animal. Adult male Sprague-Dawley rats were tested in a delay discounting maze 
to examine their inhibitory behaviour, as well as to record and analyse ultrasonic 
vocalizations made during the test. It was found that animals with lesions to the orbital 
prefrontal cortex (PFC) displayed deficits in inhibitory control compared to their sham 
and medial PFC lesioned counterparts at multiple time points. In contrast, the medial 
PFC lesioned animals displayed differences in vocalization duration and frequency as 
compared to orbital PFC and sham controls. The results presented in this chapter 
warrant further research into the effects of localized prefrontal ischemic lesions and 
offer possibilities for improved pre-clinical modelling of post-stroke cognitive 
outcomes. 
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4.1 INTRODUCTION 
  
 Stroke is one of the most common causes of death and disability worldwide. In 
the United States alone, it is estimated that on an annual basis approximately 800,000 
individuals will suffer a stroke, and the number of individuals having been afflicted by 
this disease is also set to rise as the population ages (Mozaffarian et al. 2014). This will 
result in large increases in direct and indirect health care costs, which are expected to 
rise from $71.6 billion dollars in 2012 to $184.1 billion dollars in 2030 (Ovbiagele et al. 
2013). As such, new treatment strategies need to be developed to help ease this 
economic and social burden.  
 One of the more insidious results of an acute stroke is the detrimental effects on 
cognitive function. A number of studies have been performed examining the prevalence 
of cognitive dysfunction post-stroke. A study from Madureira et al. (2001) estimated 
that 55% of stroke survivors had deficits in at least one cognitive domain while 
undergoing the Mini Mental State Exam (MMSE). Other studies have shown similar 
findings, with Pohjasvaara et al. (2002) estimating that over 40% of stroke survivors 
exhibit executive function deficits, and Rasquin et al (2004) demonstrating that over half 
of stroke survivors show at least mild cognitive impairment (MCI) one year post-stroke. 
Not only does cognitive dysfunction post-stroke affect the patient's mental faculties, but 
these declines in cognition can also affect the patient's ability to successfully complete 
other rehabilitation programs, which in turn affects their overall ability to function in 
everyday life (Galski et al. 1993).  
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 One of the higher-order cognitive functions that can be negatively affected 
through stroke or other brain lesions is inhibitory control, which is crucial to proper 
decision making as well as emotional control (Starkstein and Robinson 1997). Patients 
with deficits in proper inhibitory control often demonstrate difficulties in a wide variety 
of behaviours and tasks, including deficits in Go/No-Go executive function testing and 
behavioural disinhibition, and can demonstrate severe emotional incontinence (Aybek et 
al. 2005; Tang et al. 2009). At this time, there are few treatment options available for 
those patients who suffer loss of behavioural control.  
 Previous animal studies examining the effects of modelled prefrontal cortex 
(PFC) damage on inhibitory control report various findings as to the brain regions 
required for this behaviour. For example, recent evidence suggests that both the medial 
and orbital prefrontal cortices are required for impulsive choice control as measured in a 
delay discounting task (Yates et al. 2014). However, other findings suggest that 
inhibitory control can be traced to specific areas of the PFC, depending on how the 
behavioural tasks testing impulsivity are administered (Rudebeck et al. 2006; 
Churchwell et al. 2009; Mar et al. 2011). As such, we chose to explore the effects of 
ischemic prefrontal lesions in the medial PFC and orbital PFC on impulsivity, which 
may result in new methodologies for modelling the effects of stroke on complex 
cognitive dysfunction. The results of these experiments could facilitate further studies 
on cognitive or pharmacological rehabilitation post-stroke. 
 Another aspect of cognitive function and rat behaviour that was examined was 
the effects of ischemic lesions on ultrasonic vocalization behaviour. Generally, adult rats 
emit ultrasonic vocalizations under specific sets of conditions, and the general frequency 
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and duration of these vocalizations depends on the context and situation of the 
experiment. For example, rats can emit long and relatively low-frequency calls (22 kHz) 
in response to aversive stimuli, such as the presence of a predator or experimentally 
elicited pain (Blanchard et al. 1991; Calvino et al. 1996). Conversely, rats also emit 
relatively short, higher frequency calls (50 kHz) in response to relatively positive 
stimuli, such as during experimental-induced tickling, amphetamine injection and 
reward expectation (Burgdorf et al. 2001; Mällo et al. 2007; Brenes and Schwarting 
2014). These 50 kHz calls are thought to indicate a positive appetitive affective state. 
 The behavioural task performed in our series of experiments testing inhibitory 
control provided an excellent opportunity to study elicited 50 kHz calls in anticipation 
of a food reward. The potential effects of ischemic lesions in areas of the PFC on 
vocalization behaviour have not been extensively studied, and this research may be able 
to give new insight into the affective state of rats with PFC lesions. As such, we 
performed ultrasonic recordings during the experimental procedures in an attempt to 
determine the effects of specific lesions in the PFC on ultrasonic vocalization behaviour. 
 The central purpose of this study was to investigate whether focal ischemic 
lesions within specific areas of the prefrontal cortex, specifically the medial and orbital 
prefrontal cortices (mPFC and oPFC, respectively), would affect inhibitory control 
behaviour as measured through a specific delay discounting paradigm. The hypothesis 
was that animals with lesions in the prefrontal cortex would choose the immediately 
available, lower reward option more frequently than control animals. 
 As a secondary experiment involving the delay discounting paradigm, the effects 
of prefrontal cortical lesions on ultrasonic vocalizations while performing the 
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behavioural experiment was also assessed, with the hypothesis that prefrontal ischemic 
lesions would affect aspects of duration, frequency, and number of calls made by 
lesioned animals, indicating changes in affective state. 
 
4.2  METHODS 
 
 4.2.1 Experimental Animals 
 
 All procedures were conducted in accordance with the guidelines of the 
Canadian Council for Animal Care and were approved in advance by the University of 
Prince Edward Island Animal Care Committee, protocol number 12-035. Adult male 
Sprague-Dawley rats (n = 37, 250-275g on arrival) were purchased from Charles River 
Laboratories (Montreal, Canada) and singly housed on a reverse 12 h light/dark cycle 
(lights on at 18:00 and off at 06:00) with food (Purina rat chow) and water available ad 
libitum until training and testing. Upon arrival, animals were acclimated to the facility 
for 5 - 7 days and were handled by the experimenter for 5 minutes each day for three 
days during the acclimation period. Subsequent to daily handling, all animals were given 
10 banana-flavoured sucrose pellets (Bio-Serv, Frenchtown, USA) in their home cage in 
order to acclimate the animals to the reward. All behavioural training and testing 
occurred during the dark phase of the light cycle. During the training and testing phases, 
animals were maintained at approximately 90% of their initial free feeding weight.  
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 4.2.2  Surgical Procedures 
 
 The surgical protocols for producing an ET-1 stroke lesion were as reported 
previously (see Chapter 3, Materials and Methods),
 
with the exception of injection 
coordinates and volumes. The rats were anaesthetised by being placed into an induction 
box prefilled with 3.5% isoflurane (PPC, Richmond Hill, Canada) in oxygen for 8 
minutes, and anaesthesia was maintained throughout the surgery with a 2-3% isoflurane 
mixture. Animals were mounted on a stereotaxic frame (Kopf Instruments, Tujunga, 
USA), and their heads were shaved. Once shaved, topical Xylocaine (AstraZeneca, 
Mississauga, Canada) was applied to the shaved area and left for 5 minutes before a 
subsequent 2 cm midline incision was made down the top of the cranium. This incision 
was held open by 4 clamps. Two small burr holes were then drilled into the cranium 
above the coordinates for drug injection. A 26 gauge 10 µl syringe (Hamilton, Reno, 
USA) was lowered into each of the injection sites according to coordinates listed in 
Tables 4.1 and 4.2 for mPFC and oPFC, respectively, and was left for 1 minute prior to 
ET-1 injection (see Figure 4.2A and B for injection diagrams). After one minute, 1 µl of 
ET-1 (400 pmol) dissolved in artificial cerebral spinal fluid  (aCSF) was injected into 
the cortex at a rate of 0.5 µl/minute. Once injected, the needle was left undisturbed for 4 
minutes to allow for drug dispersal at the injection site, and then the needle was slowly 
retracted from the brain. After both ET-1 injections, the incision site was sutured and 
Xylocaine was reapplied. At the conclusion of the surgery each animal was given a 2.0 
mg/kg subcutaneous injection of butorphanol (Wyeth, Guelph, Ontario) for post- 
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Table 4.1 Surgical Injection Coordinates Targeting the mPFC. Injection coordinates 
for endothelin-1 in the mPFC. A/P = anterior/posterior, M/L = medial/lateral, D/V = 
dorsal/ventral, with distances in mm relative to bregma. n = 10. 
 
 A/P (mm) M/L (mm) D/V (mm) Volume (µl) 
Injection 1 +3.0 -0.7 -4.5 1  
Injection 2 +3.0 +0.7 -4.5 1 
 
Table 4.2 Surgical Injection Coordinates Targeting the oPFC. Injection coordinates 
for endothelin-1 in the oPFC. A/P = anterior/posterior, M/L = medial/lateral, D/V = 
dorsal/ventral, with distances in mm relative to bregma. n = 11.  
 
 A/P (mm) M/L (mm) D/V (mm) Volume (µl) 
Injection 1 +4.0 -2.0 -5.0 1  
Injection 2 +4.0 +2.0 -5.0 1 
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Figures 4.1A and B. Cartoon figures adapted from Paxinos and Watson (2007). 
Each marked "X" represents a separate injection point. (A) represents the injection 
points for the mPFC ET-1 injections (n = 10), and (B) represents the oPFC ET-1 
injections (n = 11). 
  
B 
A 
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operative analgesia. Sham treated animals received the same surgical treatment as stroke 
animals but received an equal volume injection of aCSF. 
 
  4.2.3 Behavioural Testing 
 
  4.2.3.1   Delay Discounting 
 
 The experimental procedures and maze apparatus were adapted from 
experiments published by Rudebeck et al. (2006). The maze consisted of a re-adapted 
and modified Pathfinder Maze System radial-arm maze (Figure 4.2) (Lafayette 
Instruments, Lafayette, USA). Briefly, the radial arm apparatus was modified to the 
shape of a T-maze (one stem arm, two choice arms), with each of the metal arms being 
71 cm in length, 10.5 cm in width, and with Plexiglas
®
 walls 20 cm in height. Black 
Bristol board covered the exterior portions of the choice arm walls. Each choice arm had 
a small food cup crafted within the floor of the arm. 
 Training of the animals consisted of four days of maze acclimation, wherein the 
animal would be placed at the stem of the T-maze with all maze gates open.  Dustless 
banana sucrose pellets (45 mg; Bio-Serv, Frenchtown, USA) were placed within the 
arms and food cups, with 10 pellets placed in the left arm, and 1 pellet in the right arm. 
The animals were left to explore the entire maze until all pellets were consumed or until 
10 minutes had passed. Over the course of four days, the number of pellets strewn 
within the arms was reduced until there were only pellets within the  
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Figure 4.2 An overhead representation of the delay discounting maze. The red lines 
represent the gates, which open and close during the training and testing phases of the 
task. For a full description of the delay discounting methodology, refer to section 
4.2.3.1. 
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food cups. The following four days consisted of placing the animal in the stem of the T-
maze, and allowing the animal to enter the middle of the arena and choose one arm. 
Once the animal chose an arm (defined as having placed all four limbs on the base of the 
arm), the gate behind the animal was closed, and the gate immediately in front of the 
animal was opened. From there, the animal could then consume the sucrose pellet(s) at 
the end of the arm within the food cup. During each of these four days the animal was 
given 5 trials each day, with an approximate inter-trial interval (ITI) of 3 minutes. 
 The subsequent 12 days of training consisted of two "forced" trials, followed by 
five "choice" trials. The two forced trials consisted of placing the animal in the stem of 
the maze, and keeping the entry gate for one arm open, thereby forcing the animal to 
choose this arm. For each testing day, the first trial had the low reward arm (LRA) 
opened and the second trial had the high reward arm (HRA) opened. Once the animal 
entered one of these arms, the arm‟s first gate was closed and the arm‟s second gate was 
opened. Once these forced trials were complete, the animal then had 5 subsequent 
choice trials wherein the first gate of the HRA and the LRA were both left open and the 
animal could choose either arm into which to enter.  
 The 12 days of training were subdivided into three groups (days 1-4, days 5-8, 
and days 9-12). During training days 1-4, once the animal chose an arm, the arm‟s first 
gate would close, and the second gate would open, allowing immediate access to the 
sucrose pellet(s). During days 5-8 of testing, when the animal chose the HRA, there 
would be a 5 second delay between the first gate closing and the second gate opening, 
and during days 9-12 of testing, when the animal chose the HRA, there would be a 10 
second delay between the first gate closing and the second gate opening. During this 
124 
 
time there would be no delay between the first gate closing and the second gate opening 
in the LRA. 
 The four days of pre-surgical testing were similar to the 12 prior days of training, 
with the exception of the amount of delay time in the HRA, which was 15 seconds. 
Again, there was no delay between the first gate closing and the second gate opening in 
the LRA. The number of HRA and LRA choices made for the choice trials were 
recorded for each animal for each day. 
 Post-surgical testing for choice behaviour was performed similarly to pre-
surgical testing, and began on PSD7 and continued until PSD24. For the first 6 days of 
post-surgery testing (PSD7-12), there was a 15 second delay between the first gate 
closing and the second gate opening in the HRA. For the subsequent 6 days of testing 
(PSD13-18), there was a 30 second delay between the first gate closing and the second 
gate opening in the HRA, and for the final 6 days of testing (PSD19-24) there was a 60 
second delay between the first gate closing and the second gate opening in the HRA. 
 
  4.2.3.2 Ultrasonic Vocalizations 
 
 During the testing phases of the delay discounting maze (pre-surgery and post-
surgery 15 second delay trials), ultrasonic vocalization recordings (USVs) were obtained 
when the animal chose the delayed high-reward arm, and analyzed recordings were 
limited to the 15 second interval the animal would spend between the first and second 
gates in anticipation of the food reward. The recordings were taken using an Avisoft 
CM16/CMPA condenser ultrasound microphone (Avisoft, Berlin, Germany) and the 
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recordings were further processed and analyzed using Avisoft-SASLab Pro software 
version 5.1 (Avisoft, Berlin, Germany). For the purposes of categorization, USVs were 
characterized as either 50 kHz “appetitive” calls or 22 kHz “aversive” calls, with calls 
made with an average mean frequency on or over 30 kHz considered to be an 
“appetitive” call. This is based on previous work categorizing vocalizations into two 
separate ranges between 20 - 30 kHz as being "aversive" and 30 - 90 kHz calls as 
indicating a positive affect (Reno et al. 2013). Animals that did not emit any 
vocalizations during testing were excluded from further USV analysis, rendering the 
group sizes for USV analysis to be sham, n = 13; mPFC, n = 10; oPFC, n = 9. 
 
 4.2.4 Histology and Infarct Quantification 
 
 On PSD 28, rats were anaesthetized with isoflurane and euthanized by 
decapitation. Brains were removed and immersion fixed in 10% formalin. After 48 hour 
fixation in formalin, brain tissues were preserved and cryoprotected using Cryomatrix 
(Thermo Scientific, USA) and stored at -80°C. Brain tissues were sectioned in 50µm 
segments using a cryostat (Thermo Scientific, USA) and one section every 300 microns 
was applied to slides, dried for a minimum of 24 hours, and stained with cresyl violet 
(0.1 % w/v). Images were prepared using a computer scanner (HP Scanjet 7650) at 2400 
DPI resolution, and infarct quantification was performed by tracing the area of tissue 
which displayed a lack of, or abnormal, cresyl violet staining or altered cytological 
architecture. Tracing was performed using ImageJ software, version 1.45s (ImageJ, 
National Institutes of Health, USA). Once each area had been traced, the volume of 
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infarct damage was quantified by summing each individually calculated area and 
multiplying the area by the distance between each section (300 µm). 
 
 4.2.5 Statistical Analyses  
 
 Statistical analyses were performed using Graph Pad Prism, Version 5.00 (Graph 
Pad, La Jolla, USA). Two way repeated measures ANOVA analyses were used to 
examine the effects of surgical intervention and day of testing on the behaviour of HRA 
choice, and amalgamated choice data for each day was examined between surgical 
groups by one way ANOVA. USV data for the number of calls made pre- versus post-
surgery were analyzed by converting the number of calls made post-surgery as a 
percentage of calls made prior to surgery, and each of the values were analyzed by a 
one-sample t-test with a hypothetical mean of 100%. USV data for the frequency and 
duration of calls made in the HRA arm was analysed by Wilcoxon signed-rank test 
comparing each group‟s pre-surgery vs post-surgery values. Correlation analyses 
between the size of the ET-1 induced lesion and delay discounting maze performance 
were analyzed using a Pearson‟s coefficient.  Data was considered significant at p < 
0.05. 
4.3 RESULTS 
 
 4.3.1 Delay Discounting 
 
  4.3.1.1 Pre-surgery choice behaviour 
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 Task performance within the maze was assessed by determining the percentage 
of high reward arm (HRA) choices made during the free choice (non-forced choice) 
portion of the task. As expected, prior to surgery there were no significant differences in 
task performance between surgical groups (F2,34 =  1.14 p > 0.05) or between days (F3,34 
= 0.547 p > 0.05), nor was there any interactive effect between these two variables (F6,34 
= 0.888 p > 0.05) (Figure 4.3A). Choice behaviour was also assessed by amalgamating 
the data from each day for each surgical group (Figure 4.3B) to determine overall choice 
behaviour, and performing a one-way ANOVA between groups, wherein no difference 
between groups was found (F2,34 = 1.18 p > 0.05). Average mean HRA choice behaviour 
for each group was: Sham (80.9% ± 1.93%, n = 16), mPFC (83.0% ± 4.16%, n =10), 
oPFC (75.7% ± 4.23%, n = 11) (Mean ± SEM).   
 
   4.3.1.2 Post-surgery choice behaviour 
 
 Task performance was assessed in the same manner post-surgery as it was pre-
surgery, wherein HRA choice behaviour percentages were compared between days and 
between surgery groups (Figure 4.4A). There was no significant difference in choice 
behaviour over the course of days (F5,34 = 1.19 p > 0.05), nor an interactive effect 
between surgery group and testing day (F10,34  = 0.584 p > 0.05). However, there was a 
significant difference between surgery groups (F2,34 = 11.2 p < 0.001). Choice behaviour 
was also assessed by amalgamating the data from each day for each surgical group 
(Sham: 71.6% ± 3.00% n = 16; mPFC: 77.3%  ± 5.14% n = 10; oPFC: 51.6%  ± 3.84%  
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Figure 4.3A and B. Delay discounting choice behaviour pre-surgery. (A) Animals 
were tested for four consecutive days pre-surgery, in which animals were given two 
forced choice trials immediately followed by five free-choice trials. There were no 
significant differences in task performance over days, between surgical groups, nor was 
there an interactive effect. (B) Amalgamated average pre-surgery choice performance 
for all three surgical groups. No significant differences were detected between groups. 
Sham, n = 16; mPFC, n = 10; oPFC, n = 11. 
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Figure 4.4A and B. Delay discounting choice behaviour post-surgery with a 15 
second delay for high reward arm access. (A) Animals were tested for six consecutive 
days, wherein animals were given two forced choice trials immediately followed by five 
free-choice trials. There were significant differences in task performance between 
surgical groups, with no significant effects detected between surgical days nor was there 
an interactive effect between both variables tested. (B) Amalgamated average post-
surgery choice performance for all three surgical groups. Significant differences were 
detected between the sham and oPFC groups and the mPFC and oPFC groups. Sham, n 
= 16; mPFC, n = 10; oPFC, n = 11. 
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n = 11) (Mean ± SEM) and performing a one-way ANOVA and a post-hoc Tukey's 
Multiple Comparison Test (Figure 4.4B). This revealed significant differences between 
the sham and oPFC group (P > 0.01) and the mPFC and oPFC group (P < 0.001), but not 
between sham and mPFC groups (P > 0.05). This analysis was continued for post-
surgery behaviour in the delay discounting task for both the 30 second delay and the 60 
second delay for the HRA, which revealed some similar trends. For the second delay 
time of 30 seconds (Figure 4.5A) there was no significant difference in choice behaviour 
over the course of days (F5,34 = 0.621 p > 0.05), nor an interactive effect between choice 
behaviour  and testing day (F10,34  = 1.30 p > 0.05). However, an effect was found 
between surgical groups (F2,34 = 7.93 p < 0.001). This effect was further examined, 
wherein the overall averages from each group over each day were calculated (Sham: 
67.6%  ± 3.51% n = 16; mPFC: 74.3  ± 3.52% n = 10; oPFC: 54.0%  ± 2.74% n = 
11)(Mean ± SEM). Statistical analysis revealed significant differences between the sham 
and oPFC choice behaviour (P < 0.05), and between mPFC and oPFC (P < 0.01), but 
none between sham and mPFC (P > 0.05) (Figure 4.5B). In the 60 second delay testing 
(Figure 4.6A), a significant difference was found between surgical groups (F2,34 = 4.63 p 
<0.05), and between days (F5,34 = 2.30 p < 0.05), however no interactive effect between 
these two variables was found (F10,34 = 1.76 p > 0.05). The effect of testing day was 
further examined by looking at the data for each individual day and determining any 
differences between the groups through a one-way ANOVA with a Tukey's multiple 
comparison post-test. There were significant differences between mPFC and oPFC 
groups on days 1 and 3 (p < 0.01), and between sham and oPFC on day 1 (P < 0 .05). No  
131 
 
A 
 
 
 
 
 
 
 
B. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.5A and B. Delay discounting choice behaviour post-surgery with a 30 
second delay for high reward arm access. (A) Animals were tested for six consecutive 
days, wherein animals were given two forced choice trials immediately followed by five 
free-choice trials. There were significant differences in task performance between 
surgical groups, with no significant effects detected between surgical days or an 
interactive effect between both variables tested. (B) Amalgamated average pre-surgery 
choice performance for all three surgical groups. Significant differences were detected 
between the sham and oPFC groups and the mPFC and oPFC groups. Sham, n = 16; 
mPFC, n = 10; oPFC, n = 11. 
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Figure 4.6A and B. Delay discounting choice behaviour post-surgery with a 60 
second delay for high reward arm access. (A) Animals were tested for six consecutive 
days, wherein animals were given two forced choice trials immediately followed by five 
free-choice trials. There were significant differences in task performance between 
surgical groups, as well as significant effects detected between surgical days, although 
there was no significant interactive effect between both variables tested. (B) 
Amalgamated average pre-surgery choice performance for all three surgical groups. 
Significant differences were detected only between the mPFC and oPFC groups. Sham, 
n = 16; mPFC, n = 10; oPFC, n = 11. 
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differences between mPFC and sham were found. As well, data from each time point 
(day) for each surgical group were amalgamated and analyzed by a one-way ANOVA 
with a Tukey's multiple comparison post-test (Figure 4.6B), and a difference was found 
between mPFC lesioned animals and oPFC lesioned animals (p < 0.05), however, there 
was no difference between oPFC lesioned and sham animals (p > 0.05). 
 
 4.3.2 Ultrasonic Vocalizations 
 
 Three different aspects of ultrasonic vocalizations were examined, analysing the 
effects of the surgery on pre- versus post-surgery vocalization behaviour. These three 
variables were the number of vocalizations made, the relative frequency of these 
vocalizations, and the duration of each vocalization.  
 The number of 50 kHz calls made during the HRA choice behaviours was 
measured both pre- and post-surgery and used to calculate the percentage of 50 kHz 
calls made following surgery. There was no statistical difference between the groups, 
however, each of the groups was statistically different from a hypothetical mean of 
100% (p < 0.05). Table 4.3 summarizes the effects of surgery on the number of 
vocalizations made post-surgery as compared to their pre-surgery values. Although there 
were no differences between groups as assessed by a one-way ANOVA, each of the 
groups were individually analyzed through one sample t-tests with a hypothetical mean 
of 100%, and it was found that each surgical group of animals made significantly fewer 
calls after surgery as compared to before surgery.  
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Table 4.3. Percentage of vocalizations made post-surgery, compared to pre-
surgery. Although there was no difference in the percent of vocalizations made post-
stroke between each of the groups (one-way ANOVA: F2,27 = 0.8218 p > 0.05) there was 
a significant difference in all groups in terms of the number of vocalizations made as 
assessed by their pre-surgery values, denoted by a (*) for p < 0.05 and by a (**) for p < 
0.01. Sham, n = 13; mPFC, n = 10; oPFC, n = 9. Values are Mean ± SEM 
 
Surgical Group Percent Pre-Surgery Vocalizations 
Sham 62.2% ± 11.0% ** 
mPFC 47.4% ± 16.8% * 
oPFC 38.1% ± 14.7% ** 
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 The relative frequencies and durations of individual calls made by the animals 
were also assessed, examining for differences between their pre- and post-surgery 
values. Figures 4.7A and 4.7B show the pre- vs post-surgery values for both the duration  
and frequency of the sham animal calls, which demonstrated no differences post-
surgery. Figures 4.8A and B show the pre- and post-surgery values for these same 
variables in the mPFC lesion group. Unlike the sham group, these animals displayed 
differences in both duration (Figure 4.8A) and relative frequency (Figure 4.8B) of their 
calls, making shorter calls of a higher frequency as compared to their pre-surgical 
values. In contrast, animals in the oPFC lesion group (Figures 4.9A and B), displayed no 
differences in the relative durations or frequencies of their calls. 
 
  4.3.3 Histology and Infarct Quantification 
 
 Cresyl violet staining of the anterior portion of the brain relative to bregma 
showed lesions located primarily within the prefrontal cortex of the animals. Figures 
4.10A and B show the extent of prefrontal damage from the two lesion groups. Overall, 
the damage from the mPFC lesion produced a lesion with a volume of 18.0 ± 2.84(Mean 
± SEM). The volume of the assessed damage in the oPFC lesioned animals was 26.1 ± 
4.05 (Mean ± SEM). Line graphs in Figures 4.11A and 4.11B give an overall 
representation of where lesion damage occurred. As assessed by a two-tailed unpaired t-
test, there was no significant difference detected in lesion size between the two groups 
(t19 = 1.60, p > 0.05).  
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Figure 4.7A and B. Average duration and frequency of ultrasonic vocalizations of 
sham animals pre- and post-surgery. There was no significant difference detected 
between pre- and post-surgery values in the (A) average duration of the calls (p = .340), 
or in the (B) average frequency of the calls emitted (p = .685). Values are Mean ± SEM, 
n = 13. 
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Figure 4.8A and B. Average duration and frequency of ultrasonic vocalizations of 
mPFC lesioned animals pre- and post-surgery. (A) There was a significant difference 
in the average duration of the calls made between pre- and post-surgery animals, with 
post-surgery animals making shorter 50 kHz calls (p = .048) (B) There was a significant 
difference the average duration of the calls made between pre- and post-surgery, with 
animals emitting higher frequency calls post-surgery (p = .027). Values are Mean ± 
SEM, n = 10. 
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Figure 4.9A and B. Average duration and frequency of ultrasonic vocalizations of 
oPFC lesioned animals pre- and post-surgery. There was no significant difference 
detected between pre- and post-surgery values in the (A) average duration of the calls (p 
= .359), nor in the (B) average frequency of the calls emitted (p = .301). Values are 
Mean ± SEM, n = 9. 
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Figure 4.10A and B. Representative cresyl violet staining and sectioning of anterior 
stroke brain tissue.  Damaged tissue is represented by lower stain uptake, as well as 
altered cytoarchitecture. (A) representative sections of mPFC damaged tissue and (B) 
representative sections of oPFC damaged tissue.  
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Figures 4.11A and B. Line graphs representing the approximate areas of damage and 
size of areas damaged as a result of the ischemic lesions.(A) area damaged as a result of 
the mPFC lesion (n = 10) and (B) area damaged as a result of the oPFC lesion (n = 11).  
Values are Mean ± SEM. 
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 Further analysis comparing the relative size of the infarct within the mPFC group 
and delay discounting choice behaviour revealed no correlation between lesion size and 
HRA choice behaviour at any time point tested (15 second choice behaviour [r = .2830, 
n = 10, p > 0.05]; 30 second choice behaviour [r = -0.064, n = 10, p > 0.05]; 60 second 
choice behaviour [r = -0.047, n = 10, p > 0.05]). The same was found when comparing 
oPFC choice behaviour and lesion size, wherein no correlation was present between 
lesion size and HRA choice behaviour (15 second choice behaviour [r = -0.017, n = 11, 
p > 0.05]; 30 second choice behaviour [r = -0.125, n = 11, p > 0.05]; 60 second choice 
behaviour [r = -0.097, n = 11, p > 0.05]). 
 
 4.4 DISCUSSION 
 
 Part of the dilemma for research into post-stroke cognitive dysfunction is the 
lack of cognitive deficit models for pre-clinical trials, especially with regards to 
executive functions. Currently, there are experimental models of stroke focusing on its 
effects on depression and other cognitive ailments post-stroke, but there are few models 
that display executive dysfunctions including attentional deficits, inhibitory control, and 
proper decision making.  
 The present study tested the effects of focal ischemic lesions localized to the 
mPFC and oPFC on delay discounting behaviour and ultrasonic vocalization behaviours. 
It was found that oPFC lesions had very specific effects on delay discounting choice 
behaviour, and that mPFC lesions appeared to have no effect relative to control animals. 
This finding is similar to what was found by Rudebeck et al. (2006), wherein animals 
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with quinolinic acid lesions to the oPFC were significantly worse at the delay 
discounting task than control animals and animals with lesions to the anterior cingulate 
cortex (ACC). Other studies examining this effect found that oPFC lesioned animals 
displayed similar impulsive behaviours in an operant conditioning paradigm (Mobini et 
al. 2002). In contrast to these findings, other research has found that the role of the 
oPFC in delay discounting may be slightly more nuanced. A further paper examining 
oPFC lesions in delay discounting found no differences in post-lesion inhibitory 
behaviour in a non-spatial version of the task (Mariano et al. 2009), and other previous 
work by Winstanley et al. (2004) suggested the oPFC is not required for inhibitory 
control, and that basal lateral amygdala lesions contribute to increased impulsive choice 
behaviour rather than oPFC lesions. These differences could be explained by differences 
in the behavioural testing paradigm employed, because oPFC lesions may be affecting 
specific aspects of inhibitory control. Another explanation could be that the lesions 
produced near the oPFC could have affected circuits between this region and the 
hippocampus, which have also been directly implicated in proper inhibitory control 
(Chudasama et al. 2012).  
 In the current study, lesions to the mPFC appeared to have no effect on 
inhibitory control behaviour. Like oPFC lesions, the effects of mPFC on impulsivity 
appear nuanced. There have been some studies that have found a link between the 
mPFC and inhibitory control under certain circumstances (Winstanley 2005; Loos et al. 
2010), and others finding no such link (Eagle and Robbins 2003; Eagle et al. 2007). 
These differences may depend on the circumstances of the experimental manipulation of 
the test animal, as well as the behavioural testing procedure employed. As well, a paper 
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by Feja et al (2014) demonstrated that inhibitory behaviour as measured by a five-choice 
serial reaction task was altered by inactivation of the vmPFC, but inhibitory control as 
measured through delay discounting was not affected. Therefore, our model may not 
have demonstrated measureable deficits in inhibitory control in this delay discounting 
maze, however, future experiments using this model of ischemic stroke could test 
inhibitory control in different behavioural tasks. 
 One issue with the behavioural testing that was not addressed by our delay 
discounting paradigm was handedness. Although rats do not display as much of a right-
handed bias as humans, it has been noted that rodents' circling behaviour and forepaw 
use, measured through an operant conditioning chamber, are right side biased (Glick and 
Ross 1981). Future studies with this paradigm would be able to control for this by 
testing the animal's innate preference for sides both before and after surgery, as brain 
lesions have been shown to affect handedness in response to lesions, depending on pre-
lesion behavioural training  (Peterson and Devine 1963).  
 The overall size of the oPFC lesions was comparable to the mPFC lesions in 
terms of overall volume (17.98 mm
3
 in mPFC animals versus 26.05 mm
3
 in the oPFC 
animals), although there was a tendency for the orbital lesions to be slightly larger in 
size. This may be due, in part, to the bilateral location of the imposed lesions. For the 
mPFC animals, the sites of injection for the vasoconstrictor ET-1 are approximately 1.4 
mm apart (M/L -0.7 and M/L +0.7 from the midline). The drug's effects on the 
surrounding tissue appear to extend from the site of injection and overlap with the other 
bilateral injection. For the oPFC lesioned animals, there is very little to no overlap in the 
bilateral lesions, with the lesions spaced 2mm away from the midline; 4 mm apart. 
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Another interesting finding in the oPFC group was that the greatest extent of lesion size 
was not found at the site of injection (4.0 mm anterior to bregma), but rather closer to 
the anterior portion of the brain. This was not the case for the mPFC group in our study 
and in our previous study (Deziel et al. 2015;  see Chapter 3), wherein the maximal size 
of the lesion was at the site of injection, 3.0 mm anterior to bregma. This could be 
explained by incorrect injection coordinates, however sham animals with aCSF injected 
into the oPFC showed needle tracts entering into approximately the appropriate areas of 
the oPFC (Figures 4.12A - C). An alternate explanation could be that the degree of 
bevelling of the Hamilton Removable Needle, combined with the direction of the needle 
hole facing the anterior pole of the brain. During surgery, the location of the needle hole 
faces the anterior end of the brain, which could have the effect of pushing the injection 
liquid forward. Provided that there is less interstitial tissue to displace, compared to the 
medial PFC, the displacement of the injection liquid could potentially move further 
forward compared to the medial PFC injections. Future experiments could determine 
whether the bevelling of the needles had an effect by either using flat needles, or by 
having the hole of the needle facing the posterior of the brain and observing the ET-1 
lesion's size and location.  
 Other future studies examining these two different stroke lesion models may 
wish to examine the lesions' effects on post-stroke depression. The prefrontal cortex is 
an area of the brain that has been directly implicated with depression and depressive 
symptoms (Koenigs and Grafman 2009) , and there have been numerous links made 
between the co-morbidities of depression and executive dysfunction (Snyder 2013; 
Letkiewicz et al. 2014). Although there are models of post-stroke depression with some  
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Figure 4.12 A-C Needle injection points in three selected sham animals. Injections 
in these animals occurred between approximately +4.2 - +4.5 A/P of bregma.  
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measureable cognitive dysfunction in certain domains, none of these models test the 
effects of the stroke on executive function (Kim et al. 2015; Wu et al. 2015). 
Understanding the underpinnings of concurrent executive dysfunction and post-stroke 
depression could be aided by using focal ischemic models of stroke which display both 
symptoms. 
 The discrepancies between behaviour and changes in USV production were 
counterintuitive, as it would be expected that changes in the animals' behaviour would 
be reflected by changes in their vocalizations (i.e. decreased choice of the high reward 
arm may result in changes to 50 kHz calls, as those indicate a positive affective state). 
However, it was the mPFC lesions, not the oPFC lesions, that resulted in changes to 
vocalization frequencies and durations. 
 These differences may be explained by examining which cognitive processes are 
involved with the control of affective states, rather than those responsible for inhibitory 
control as measured through a delay discounting paradigm. For example, it has been 
shown that mPFC lesions affect both physiological stress responses as well as 
behavioural stress responses, both of which indicate that lesions specific to this area of 
the brain may be anxiolytic (Sullivan and Gratton 1999; Shah and Treit 2003). If the 
animals in the mPFC group have a differential response to stress compared to their sham 
and oPFC counterparts, the differences in vocalizations could be a result of these 
changes. Further research should be performed to further sub-categorize these 50 kHz 
calls, which has been done previously in other paradigms, including studies of the 
effects of social interaction, pharmacological therapies, and food cue changes in rat 
vocalizations (Wright et al. 2010; Buck et al. 2014).  
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 Although the differences in USV production in these animals are interesting, 
only adult male Sprague-Dawley animals were tested in these experiments. Previous 
experiments have noted some strain differences in rat ultrasonic behaviour, with 
differences in vocalizations in certain rat strains observed as early as post-natal day 6 
(Sales 1979). However, research into different USV behaviours in adult rat strains is 
sparse, and it is unknown whether different strains would respond in similar or 
dissimilar ways. As well, there have been noted differences between male and female rat 
vocalization exchanges, however these experiments are often performed to test for 
vocalizations made between male and female animals during courting or copulation 
(McGinnis and Vakulenko 2003), and it is unknown whether female animals would 
vocalize differently in our experiments in response to food rewards as appetitive stimuli.    
  In conclusion, the experiments described in this chapter demonstrate that 
ischemic lesions localized to the prefrontal cortex have a multitude of effects on certain 
cognitive functions. Future studies regarding these models of post-stroke cognitive 
changes could open new avenues to research into pre-clinical stroke assessment, and 
should attempt to better characterize the changes to inhibitory control and appetitive 
vocalization patterns of these animals. 
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CHAPTER 5 
GENERAL DISCUSSION AND FUTURE DIRECTIONS 
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5.1 SUMMARY 
 
 As discussed previously in this thesis, stroke is one of the most common causes 
of death and disability worldwide (Kim and Johnston 2011; Lozano et al. 2012). People 
can live a relatively long time post-stroke, and a significant portion of these individuals 
are left with debilitating injuries that affect motor, sensory, and cognitive function. 
Related to these disabilities, we currently have fairly robust models of motor 
dysfunction post-stroke that accurately portray the behavioural and pathophysiological 
effects of the disease, as well as animal models of ischemia displaying some limited 
aspects of cognitive dysfunction. Unfortunately, there is a distinct lack of post-stroke 
models to study higher-order levels of cognitive dysfunction that makes it difficult to 
identify and test the effects of different pharmacological and behavioural therapies as 
potential treatment strategies to conserve or rehabilitate cognitive functionality lost due 
to an ischemic stroke. Because of the large worldwide prevalence of this disease, the 
increasing number of surviving stroke patients in the developed and developing world 
displaying cognitive dysfunction, and the relative lack of animal models of higher-order 
cognitive dysfunction, the experiments described in this thesis were performed in an 
attempt to model cognitive dysfunction in this disease in rodents.  
 The work contained within this thesis gives an overview of the histological 
effects of focal ischemic lesions within the prefrontal cortex, an area intricately linked to 
higher-order cognitive function, as well as the results of behavioural tests designed to 
test certain higher-order cognitive functions and other behaviours in the rat. Initial 
development of the model began as discussed in chapter 2, wherein two separate 
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experiments were performed, the first of which was to test particular injection protocols 
in order to target damage to the mPFC of the rat. The second set of experiments was 
performed to discern what sorts of behavioural effects these lesions might have on the 
animal. The first experiments examined a four-injection versus a two-injection 
endothelin-1 protocol, and determined that a two injection protocol within the mPFC 
results in a more focused lesion as well as less animal mortality. The protocol was then 
tested in a larger experiment with sham animals undergoing the surgery with a vehicle 
(aCSF) injection, and test animals injected with one set of bilateral ET-1 injections to 
the mPFC. These animals were tested in an elevated plus maze as well as a task 
examining temporal object memory. In these experiments, it was found that lesions 
affecting the mPFC produced anxiogenic behaviours in the animals as assessed through 
time spent in certain arms of the EPM as well as the performance of particular 
behaviours while in the maze itself. The temporal object recognition task was ineffective 
at assessing temporal order memory changes in the animals, and it was hypothesized 
that this observation could have been due to methodological discrepancies between the 
test used in this experiment and others that have been performed in the literature 
(Hannesson et al. 2004; Hotte et al. 2005).   
 The next series of experiments, discussed in chapter 3, with the ET-1 two 
injection model were further developed to test for specific deficits in executive function 
in the domain of attention, with a specific focus on set-shifting. As well, experiments 
were performed to modify the temporal object recognition task in order to elucidate 
potential changes to temporal order memory. In the experiments performed in this 
chapter, it was noted that animals with damage to the mPFC had some specific 
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difficulties in switching attention from colour features in the set-shifting maze to texture 
features, as well as making considerably more perseverative errors while in the set-
shifting task. Unfortunately, once again the temporal object recognition (TOR) task 
failed to be effective at measuring temporal order memory in these animals despite the 
methodological changes made from the previous experiments. 
 Further cognitive testing of the two injection model continued for the next series 
of experiments (chapter 4), examining the effects of two separate lesion sites (the oPFC 
and the mPFC) on decision making and inhibitory control as assessed through a delay 
discounting task, as well as examining the effects of lesions on the production of 
ultrasonic vocalizations while running the maze. It was found that oPFC lesions, rather 
than mPFC lesions affected the behaviour by having the animals choose the smaller, but 
immediately available, reward over the higher delayed reward. Interestingly, mPFC 
lesions, but not oPFC lesions, affected certain aspects of appetitive 50 kHz 
vocalizations, indicating that the changes in behaviour did not necessarily correlate to 
changes in appetitive vocalizations and vice versa. 
 Many of these experiments provided results that were not originally 
hypothesized to occur, leading to further questions regarding the models themselves as 
well as ideas for future experiments. These will now be discussed.  
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5.2 THE ENDOTHELIN-1 ISCHEMIC MODEL AND EXECUTIVE 
DYSFUNCTION: CONSIDERATIONS  
 
 In general, there are two large categories by which we can characterize rodent 
models of ischemia: global models and focal models. Global models function by 
occluding the vertebral or carotid arteries, mimicking a cardiac arrest. Focal models, on 
the other hand, function by occluding smaller vessels directly in the brain, and are 
thought to be more representative of strokes found in human patients as they replicate 
the conditions of the disease more closely than global ischemic models (Tajiri et al. 
2013). 
 The post-stroke cognitive dysfunction models developed during the course of 
this thesis used the compound endothelin-1 to mimic the effects of focal ischemic stroke 
in human patients. ET-1 has been used for three decades in many different animal 
models of stroke, although the first use of ET-1 that had the direct intention of 
specifically affecting cognitive function was through the application of the compound to 
the anterior cerebral artery of the rat, performed by Ward et al. (1998). In this paper, it 
was noted that these ischemic lesions affected the ability of rats to accurately perform 
the serial reaction task as well as choice reaction tests, indicating deficits in the initiation 
of movement which left motor function intact. Recently, other groups have attempted to 
replicate the effects of ET-1 ACAo lesions, having some success in affecting aspects of 
executive function including decision-making, spatial working memory, and some 
exploratory activity (Endepols et al. 2015). Other uses of ET-1 for inducing cognitive 
dysfunction have been described in rats, wherein ET-1 was injected directly next to the 
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MCA, although the types of cognitive dysfunctions tested for concentrated mainly on 
spatial memory and working memory (Jiwa et al. 2010). Because of these experiments 
and the previous use of ET-1 in our lab to induce focal ischemic lesions directly in to the 
motor strip (Livingston-Thomas et al. 2014), it was hypothesized that injecting this 
compound directly into areas of the prefrontal cortex could be an effective method of 
mimicking ischemic stroke affecting higher-order cognitive functions. 
 Through the experiments done during the course of this thesis, it was 
demonstrated that, overall, there were a number of positive benefits to using this 
ischemic stroke model. First, the use of ET-1 to induce the lesions demonstrated that it 
could be targeted to specific brain areas with a minor amount of damage to other areas 
outside of the region of interest. Secondly, the surgical procedure was relatively easy to 
accomplish and resulted in few animal mortalities. Although, from an animal welfare 
standpoint this is important, it is most crucial to the work in this thesis because of the 
small number of animals in each cohort for each study: reducing the number of animals 
in the experimental group could increase the variability found in the behavioural tests. 
Finally, and of most relevance to this thesis, is that the lesions do result in some 
measurable forms of post stroke cognitive dysfunction as previously described in 
Chapters two through four. These forms of cognitive dysfunction include deficits in set-
shifting, changes in exploratory behaviour, increases in anxiogenic behaviours, and 
altered decision-making. Despite some of the negative aspects of the model, including a 
small amount of damage outside of the targeted lesions of the medial or orbital 
prefrontal cortex as well as the appearance of aggressive behaviours directed towards 
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the experimenters, the model appears to be suitable for the study of some executive 
function deficits post-stroke. 
 Although the model did display some of the hypothesized deficits in cognitive 
function, there are some limitations to using this method in an attempt to model stroke. 
For one, Localized lesions in human patients, specifically within the PFC, are relatively 
rare. Although many patients have deficits in executive function, it is more than likely 
not due to a lesion localized to the PFC. As well, in many patients that have suffered a 
stroke they may have coinciding deficits in both cognitive and motor functions. In the 
ET-1 stroke models assessed in this thesis, the animals were not tested for motor 
dysfunctions. Therefore, it is unknown whether motor dysfunction could have had an 
effect on some of the cognitive tests employed.   
 If the ET-1 model was to be continued for further use of modelling executive 
dysfunction post-stroke, there are other areas of the cortex that could be targeted to elicit 
changes in higher order cognition. For example, it has been noted that damage to white 
matter, as measured through MRI, is correlated to reduced executive function as well as 
episodic memory (Smith et al. 2011), which could provide another avenue for the study 
of executive dysfunction in rats. It has also been noted that damage to thalamic 
structures also leads to some measurable deficits in executive function (Carrera and 
Bogousslavsky 2006). Finally, it should be noted again that a large percentage of strokes 
that occur in human patients have occlusions of the middle cerebral artery. Therefore, it 
may be reasonable to revisit the ET-1 MCAo model and to examine it thoroughly for 
any signs of executive dysfunction which could be measured through tests of attention, 
decision making, or inhibitory control. 
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5.3 ULTRASONIC VOCALIZATIONS AND THE PREFRONTAL CORTEX: 
CONSIDERATIONS  
 
 An interesting side aspect of the fourth chapter of this thesis examined the 
effects of mPFC and oPFC lesions on ultrasonic vocalizations (USVs), and found some 
unexpected results. Originally, what was predicted for this experiment was post-surgery 
that animals with ET-1 induced lesions would produce fewer 50 kHz USVs as well as 
produce more 22 kHz USVs. This was hypothesized as damage to the PFC can affect 
emotionality and may cause animals to become more aggressive or anxious, thereby 
reducing the number of appetitive 50 kHz calls and thus increasing aversive 22 kHz 
calls.  
 Although there was some evidence supporting the first prediction in that mPFC 
and oPFC surgical procedures did reduce the number of 50 kHz calls, which has been 
seen before with lesions to the mPFC (Frysztak and Neafsey 1991), it appeared that 
sham animals also reduced their 50 kHz vocalizations. This would indicate that the 
reduction of calls was due to the surgical procedure itself, rather than the extent and 
nature of the ET-1 lesions themselves. As well, animals overall made very few 22 kHz 
calls overall, with most never making one individual aversive call throughout the entire 
series of experiments, and there was no evidence of any of the groups increasing the 
number of aversive calls post-surgery. Unexpectedly, the mPFC lesioned animals 
appeared to be modulating their calls, which was demonstrated by the animals changing 
the relative frequency and duration of their calls to emit higher pitched and shorter 
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vocalizations. Although there is evidence that rodents have sub-categorizations of 50 
kHz calls (Brudzynski 2013), it is unclear from the data obtained during the experiments 
conducted in this thesis if the animals are changing to specific subtypes of calls. 
 The lack of 22 kHz calls emitted by the animals was surprising. However it has 
been noted that 22 kHz calls are often elicited by overtly negative stimuli, such as 
predators or chronic pain (Blanchard et al. 1991; Calvino et al. 1996), rather than a lack 
of positive stimuli. If future experiments were planned to examine the effects of 
ischemic lesions specifically on some aspect regarding 22 kHz calls, negative stimuli 
designed to elicit these calls should be used. 
 
5.4 FUTURE DIRECTIONS 
  
 Arising from the results of the experiments presented within this thesis, there are 
a number of methodological modifications and future experiments that could be made to 
better refine and further the discoveries made in this work. 
  
 5.4.1 METHODOLOGICAL CONSIDERATIONS 
 
 One of the first changes that could be made regarding this work could be to 
implement a plan for housing the animals in groups rather than housing the animals 
permanently in separate cages, as was done throughout the thesis. There has been 
evidence that periods of isolation housing can have negative effects on certain 
behaviours, including affecting reversal learning in adolescent rats (Han et al. 2011), 
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causing memory deficits and changes in object recognition behaviour (Bianchi et al. 
2006), and affecting auditory gating as measured through pre-pulse inhibition (Stevens 
et al. 1997). As well, it has been noted that pre-stroke social isolation in human patients 
affects functional recovery post-stroke, indicating a potential link between social 
interaction and the negative effects of ischemia (Boden-Albala et al. 2005).  
 Despite the potential positive effects of group housing, by the nature of the 
surgery itself and the types of lesions induced in the animals it may not be completely 
feasible for forced social interaction immediately following the surgical procedure. 
Animals recovering from stroke would need an undetermined period of recovery time 
prior to reintegration, and the effects of mPFC or oPFC ischemic lesions could alter the 
social interactions between the animals, potentially rendering the animals more 
aggressive (Kolb and Nonneman 1974), causing harm to the animals housed together. If 
the animals were to be housed in groups, a pilot study would need to address these 
issues first before continuing with a more in-depth study.    
 Prior to experiments, power analyses to determine the number of animals needed 
for each of the experiments were not conducted. Although there were statistical 
differences in behaviour found within some of the experiments, using a larger subset of 
animals may have revealed further differences that could have been justified depending 
on the estimated effect of the lesion of behaviour. Relating to this, the effect size of the 
lesions upon cognitive behaviour, although statistically significant, was relatively small. 
Future experiments examining intervention strategies to alleviate these cognitive deficits 
may need to use larger groups of animals to be able to discern whether treatments have 
any significant effects. 
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 The lesions presented in this thesis are induced into both sides of the cortex 
(bilateral), as opposed to ischemic strokes in human patients which typically present 
unilaterally (Grotta et al. 2015). The reasoning behind performing the surgeries 
bilaterally was to increase the likelihood of observing post-stroke deficits in function by 
injuring both regions of interest in each hemisphere. However, recent evidence has 
demonstrated that unilateral lesions in the prefrontal cortices of rodents can induce 
measureable deficits in some cognitive domains (de Souza Silva et al. 2016; Vahid-
Ansari et al. 2016). Therefore, if further experiments examining the effects of prefrontal 
lesions on higher order cognitive function are continued, it is suggested that they are to 
be initially performed unilaterally. If no effects are seen with a unilateral infarct, then a 
bilateral infarct should be performed. Another methodological consideration would be 
the use of older animals versus younger adult animals as was done in this thesis. It has 
been noted that older animals may be more representative of the disease found in human 
patients (Casals et al. 2011), and it has been recommended that pre-clinical stroke trials 
take advantage of older animals (Fisher et al. 2009). It is unknown what the effects of 
ET-1 would be in aged rats, however, therefore further pilot studies would need to 
determine the overall lesion size and survivorship of older rats undergoing this 
procedure.   
 The use of butorphanol, although commonly used as a post-operative analgesic 
in rodent models (Zhu et al. 2004; Ikeda et al. 2015), may have caused unintended 
consequences within our model. Butorphanol has been known to affect behaviour, 
including increased food intake as well as increased locomotor activity (Levine and 
Morley 1983; Liles and Flecknell 1992), and opioids are known to affect body 
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temperature (Adler et al. 1988), which has been shown to affect both lesion size and 
functional deficits post-stroke (Green et al. 1992; Clark et al. 2008). However, of the 
many commonly-used post-operative opioids, butorphanol appears to have the smallest 
analgesic effect and the shortest analgesic time, thereby limiting this potential confound 
as best as possible (Gades et al. 2000).  
 Finally, another aspect that should be included with future research with this 
model would be to include some basic tests of motor function post-stroke. Although 
most of the executive function tasks employed within this thesis would not have been 
affected by slight motor dysfunction, tests of object recognition requiring object 
exploration could be affected by altering the amount of time spent exploring objects as a 
whole. If future cognitive tasks requiring proper motor function were employed, 
assessing motor capabilities would be recommended. 
 
5.4.2 Proposed Future Experiments 
  
 One of the first sets of experiments performed in Chapter 3 concerned the effects 
of mPFC lesions on set-shifting, finding that under certain parameters this behaviour 
appears to show deficits in lesioned animals versus sham animals. What was interesting 
is that it was noted that animals shifting to particular cues of the maze, specifically from 
colour to texture, appeared to have more difficulty learning to associate this feature with 
the receipt of a food reward. In contrast, lesioned animals shifting from texture to colour 
cues performed as well as control animals. What is different from other experiments that 
have investigated the effects of mPFC manipulations on set-shifting behaviour is that 
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this difference in colour / texture set-shifting has not been observed (Birrell and Brown 
2000; Stefani et al. 2003). At this time, it is unclear whether this difference is due to 
material and methodological differences between our study and others performed, or 
because the nature of these ischemic lesions in the mPFC is intrinsically different than 
those induced through other methods. Although this method of testing set-shifting is 
well established (Stefani et al. 2003), there are other methods of testing set-shifting in 
rodents. For example, a modification of this maze demonstrated by Floresco et al. 
(2006) using a strategy set-shifting paradigm appeared to be sensitive to manipulations 
within the mPFC of rats. Employing this methodology could be one further method to 
reassess the attentional set-shifting abilities of these animals to further understand the 
true nature of the deficits induced by these lesions. 
 One aspect of post-stroke cognitive dysfunction that has been extensively 
examined in the literature has been post-stroke depression, which can affect significant 
portions of the population (Paolucci 2008). Interestingly, post-stroke depression has 
been correlated to increased levels of executive dysfunction, indicating that there may 
be some connection between these two phenomena (Snyder 2013). At present, most 
methods to induce this in rodents rely on both the induction of ischemia as well as 
another factor, such as subjecting the animal to chronic mild stress (Wang et al. 2009), 
however, with targeted lesions to regions associated with post-stroke depression it may 
be possible to cause PSD without the need for further experimental manipulations. For 
example, depression has been associated with experimental manipulations affecting the 
nucleus accumbens and the olfactory bulbs (Di Chiara et al. 1999; Song and Leonard 
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2005), therefore targeted lesions to these or other regions may be able to elicit the PSD 
phenotype without further intervention.  
 Finally, follow up studies could examine the effects of mPFC lesions on the 
specific types of USVs produced pre- and post-lesion. Although adult USVs are 
generally classified as either 22 kHz (aversive) or 50 kHz (appetitive) calls (Schwarting 
and Wöhr 2012), the latter of these two calls can be further sub-categorized in a 
multitude of different calls (Wright et al. 2010). Further knowledge of the types of 
appetitive calls emitted by lesioned animals may give future insights as to the exact 
nature of the large number of 50 kHz calls produced by rodents. 
 
5.5 CONCLUSION 
 
 Despite decades of research into pharmacological and behavioural therapies for 
ischemia as well as animal models of the disease, we are still unable to provide much in 
the way of targeted therapies for post-stroke cognitive dysfunction. Of course, this is in 
part due to the massive complexity and fragility of the human central nervous system, 
but some of this failure is due to a lack of effective modelling of the post-stroke 
cognitive dysfunction that is common amongst surviving stroke patients.  I believe the 
information derived from the experiments presented in this thesis provides valuable 
information for other researchers attempting to model post-ischemic cognitive 
dysfunction as well future directions for experiments designed to aid in the treatment of 
this disease. 
  
162 
 
6.0 REFERENCES 
 
Adler MW, Geller EB, Rosow CE, Cochin J. 1988. The Opioid System and Temperature 
Regulation. Annu. Rev. Pharmacol. Toxicol. 28:429–449. 
Alexander LD, Black SE, Gao F, Szilagyi G, Danells CJ, McIlroy WE. 2010. 
Correlating lesion size and location to deficits after ischemic stroke: the influence of 
accounting for altered peri-necrotic tissue and incidental silent infarcts. Behav. Brain 
Funct. 6:6. 
Almli CR, Levy TJ, Han BH, Shah AR, Gidday JM, Holtzman DM. 2000. BDNF 
protects against spatial memory deficits following neonatal hypoxia-ischemia. Exp. 
Neurol. 166:99–114. 
Anderson BJ, Rapp DN, Baek DH, McCloskey DP, Coburn-Litvak PS, Robinson JK. 
2000. Exercise influences spatial learning in the radial arm maze. Physiol. Behav. 
70:425–429. 
Anderson CS, Jamrozik KD, Broadhurst RJ, Stewart-Wynne EG. 1994. Predicting 
survival for 1 year among different subtypes of stroke. Results from the Perth 
Community Stroke Study. Stroke. 25:1935–44. 
Ansari S, Azari H, Caldwell KJ, Regenhardt RW, Hedna VS, Waters MF, Hoh BL, 
Mecca AP. 2013. Endothelin-1 induced middle cerebral artery occlusion model for 
ischemic stroke with laser Doppler flowmetry guidance in rat. J. Vis. Exp. 
Asplund CL, Todd JJ, Snyder AP, Marois R. 2010. A central role for the lateral 
prefrontal cortex in goal-directed and stimulus-driven attention. Nat. Neurosci. 13:507–
12. 
Aström M, Adolfsson R, Asplund K. 1993. Major depression in stroke patients. A 3-
year longitudinal study. Stroke. 24:976–82. 
Astrup J, Siesjö BK, Symon L. 1981. Thresholds in cerebral ischemia - the ischemic 
penumbra. Stroke. 12:723–5. 
Auchus AP, Brashear HR, Salloway S, Korczyn AD, De Deyn PP, Gassmann-Mayer C. 
2007. Galantamine treatment of vascular dementia: a randomized trial. Neurology 
69:448–58. 
Aybek S, Carota A, Ghika-Schmid F, Berney A, Melle G Van, Guex P, Bogousslavsky 
J. 2005. Emotional behavior in acute stroke: the Lausanne emotion in stroke study. 
Cogn. Behav. Neurol. 18:37–44. 
Balleine BW, Delgado MR, Hikosaka O. 2007. The role of the dorsal striatum in reward 
and decision-making. J. Neurosci. 27:8161–5. 
Bandera E, Botteri M, Minelli C, Sutton A, Abrams KR, Latronico N. 2006. Cerebral 
163 
 
blood flow threshold of ischemic penumbra and infarct core in acute ischemic stroke: a 
systematic review. Stroke. 37:1334–9. 
Barba R, Martínez-Espinosa S, Rodríguez-García E, Pondal M, Vivancos J, Del Ser T. 
2000. Poststroke dementia : clinical features and risk factors. Stroke. 31:1494–501. 
Barense MD, Fox MT, Baxter MG. 2002. Aged rats are impaired on an attentional set-
shifting task sensitive to medial frontal cortex damage in young rats. Learn. Mem. 
9:191–201. 
Barker-Collo SL. 2007. Depression and anxiety 3 months post stroke: prevalence and 
correlates. Arch. Clin. Neuropsychol. 22:519–31. 
Barker GRI, Bird F, Alexander V, Warburton EC. 2007. Recognition memory for 
objects, place, and temporal order: a disconnection analysis of the role of the medial 
prefrontal cortex and perirhinal cortex. J. Neurosci. 27:2948–57. 
Barker GRI, Warburton EC. 2011. When is the hippocampus involved in recognition 
memory? J. Neurosci. 31:10721–31. 
Barrett KM, Brott TG, Brown RD, Carter RE, Geske JR, Graff-Radford NR, McNeil 
RB, Meschia JF. 2011. Enhancing recovery after acute ischemic stroke with donepezil 
as an adjuvant therapy to standard medical care: results of a phase IIA clinical trial. J. 
Stroke Cerebrovasc. Dis. 20:177–82. 
Basile DP, Anderson MD, Sutton TA. 2011. Comprehensive Physiology. Terjung R, 
editor. Hoboken, NJ, USA: John Wiley & Sons, Inc. 
Bechara A. 2000. Characterization of the decision-making deficit of patients with 
ventromedial prefrontal cortex lesions. Brain 123:2189–2202. 
Bechara A, Damasio AR, Damasio H, Anderson SW. 1994. Insensitivity to future 
consequences following damage to human prefrontal cortex. Cognition 50:7–15. 
Becker JT, Olton DS. 1980. Object discrimination by rats: The role of frontal and 
hippocampal systems in retention and reversal. Physiol. Behav. 24:33–38. 
Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL, Bartkowski H. 1986. Rat 
middle cerebral artery occlusion: evaluation of the model and development of a 
neurologic examination. Stroke 17:472–6. 
Belayev L, Alonso OF, Busto R, Zhao W, Ginsberg MD, Hsu CY. 1996. Middle 
Cerebral Artery Occlusion in the Rat by Intraluminal Suture: Neurological and 
Pathological Evaluation of an Improved Model. Stroke 27:1616–1623. 
Berlin HA, Rolls ET, Kischka U. 2004. Impulsivity, time perception, emotion and 
reinforcement sensitivity in patients with orbitofrontal cortex lesions. Brain 127:1108–
26. 
Bhogal SK, Teasell R, Foley N, Speechley M. 2004. Lesion location and poststroke 
164 
 
depression: systematic review of the methodological limitations in the literature. Stroke. 
35:794–802. 
Bhogal SK, Teasell R, Speechley M. 2003. Intensity of aphasia therapy, impact on 
recovery. Stroke 34:987–93. 
Bianchi M, Fone KFC, Azmi N, Heidbreder CA, Hagan JJ, Marsden CA. 2006. 
Isolation rearing induces recognition memory deficits accompanied by cytoskeletal 
alterations in rat hippocampus. Eur. J. Neurosci. 24:2894–902. 
Birrell JM, Brown VJ. 2000. Medial Frontal Cortex Mediates Perceptual Attentional Set 
Shifting in the Rat. J. Neurosci. 20:4320–4324. 
Bissiere S, McAllister KH, Olpe H-R, Cryan JF. 2006. The rostral anterior cingulate 
cortex modulates depression but not anxiety-related behaviour in the rat. Behav. Brain 
Res. 175:195–9. 
Black S, Román GC, Geldmacher DS, Salloway S, Hecker J, Burns A, Perdomo C, 
Kumar D, Pratt R. 2003. Efficacy and tolerability of donepezil in vascular dementia: 
positive results of a 24-week, multicenter, international, randomized, placebo-controlled 
clinical trial. Stroke. 34:2323–30. 
Blanchard RJ, Blanchard DC, Agullana R, Weiss SM. 1991. Twenty-two kHz alarm 
cries to presentation of a predator, by laboratory rats living in visible burrow systems. 
Physiol. Behav. 50:967–972. 
Blanco E, Castilla-Ortega E, Miranda R, Begega A, Aguirre JA, Arias JL, Santín LJ. 
2009. Effects of medial prefrontal cortex lesions on anxiety-like behaviour in restrained 
and non-restrained rats. Behav. Brain Res. 201:338–42. 
Boden-Albala B, Litwak E, Elkind MS V, Rundek T, Sacco RL. 2005. Social isolation 
and outcomes post stroke. Neurology 64:1888–92. 
Bogousslavsky J, Van Melle G, Regli F. 1988. The Lausanne Stroke Registry: analysis 
of 1,000 consecutive patients with first stroke. Stroke 19:1083–1092. 
Bonita, Beaglehole. 1988. Recovery of motor function after stroke. Stroke. 19:1497–
500. 
Bouët V, Freret T, Toutain J, Divoux D, Boulouard M, Schumann-Bard P. 2007. 
Sensorimotor and cognitive deficits after transient middle cerebral artery occlusion in 
the mouse. Exp. Neurol. 203:555–67. 
Bourke WT. 1954. The effects of frontal lobe damage upon habit reversal in the white 
rat. J. Comp. Physiol. Psychol. 47:277–82. 
Brenes JC, Schwarting RKW. 2014. Attribution and expression of incentive salience are 
differentially signaled by ultrasonic vocalizations in rats. PLoS One 9:e102414. 
Brevers D, Bechara A, Cleeremans A, Noël X. 2013. Iowa Gambling Task (IGT): 
165 
 
twenty years after - gambling disorder and IGT. Front. Psychol. 4:665. 
Brodaty H, Withall A, Altendorf A, Sachdev PS. 2007. Rates of depression at 3 and 15 
months poststroke and their relationship with cognitive decline: the Sydney Stroke 
Study. Am. J. Geriatr. Psychiatry 15:477–86. 
Broomfield NM, Laidlaw K, Hickabottom E, Murray MF, Pendrey R, Whittick JE, 
Gillespie DC. 2011. Post-stroke depression: the case for augmented, individually 
tailored cognitive behavioural therapy. Clin. Psychol. Psychother. 18:202–17. 
Broughton BRS, Reutens DC, Sobey CG. 2009. Apoptotic mechanisms after cerebral 
ischemia. Stroke. 40:e331-9. 
Brown AM, Ransom BR. 2007. Astrocyte glycogen and brain energy metabolism. Glia 
55:1263–71. 
Brudzynski SM. 2013. Ethotransmission: communication of emotional states through 
ultrasonic vocalization in rats. Curr. Opin. Neurobiol. 23:310–317. 
de Bruin JPC, Van Oyen HGM, Van De Poll N. 1983. Behavioural changes following 
lesions of the orbital prefrontal cortex in male rats. Behav. Brain Res. 10:209–232. 
de Bruin JPC, Sanchez-Santed F, Heinsbroek RPW, Donker A, Postmes P. 1994. A 
behavioural analysis of rats with damage to the medial prefrontal cortex using the morris 
water maze: evidence for behavioural flexibility, but not for impaired spatial navigation. 
Brain Res. 652:323–333. 
Buck CL, Vendruscolo LF, Koob GF, George O. 2014. Dopamine D1 and μ-opioid 
receptor antagonism blocks anticipatory 50 kHz ultrasonic vocalizations induced by 
palatable food cues in Wistar rats. Psychopharmacology (Berl). 231:929–37. 
Burgdorf J, Knutson B, Panksepp J, Ikemoto S. 2001. Nucleus accumbens amphetamine 
microinjections unconditionally elicit 50-kHz ultrasonic vocalizations in rats. Behav. 
Neurosci. 115:940–4. 
Butler TL, Kassed CA, Sanberg PR, Willing AE, Pennypacker KR. 2002. 
Neurodegeneration in the rat hippocampus and striatum after middle cerebral artery 
occlusion. Brain Res. 929:252–260. 
Butters MA, Kaszniak AW, Glisky EL, Eslinger PJ, Schacter DL. 1994. Recency 
discrimination deficits in frontal lobe patients. Neuropsychology 8:343–353. 
Calvino B, Besson JM, Boehrer A, Depaulis A. 1996. Ultrasonic vocalization (22-28 
kHz) in a model of chronic pain, the arthritic rat: effects of analgesic drugs. Neuroreport 
7:581–4. 
Carmichael ST. 2005. Rodent models of focal stroke: size, mechanism, and purpose. 
NeuroRx 2:396–409. 
Carrera E, Bogousslavsky J. 2006. The thalamus and behavior: Effects of anatomically 
166 
 
distinct strokes. Neurology 66:1817–1823. 
Carter CJ, Pycock CJ. 1980. Behavioural and biochemical effects of dopamine and 
noradrenaline depletion within the medial prefrontal cortex of the rat. Brain Res. 
192:163–176. 
Casals JB, Pieri NCG, Feitosa MLT, Ercolin ACM, Roballo KCS, Barreto RSN, 
Bressan FF, Martins DS, Miglino MA, Ambrósio CE. 2011. The use of animal models 
for stroke research: a review. Comp. Med. 61:305–13. 
Chemerinski E, Robinson RG, Kosier JT. 2001. Improved Recovery in Activities of 
Daily Living Associated With Remission of Poststroke Depression. Stroke 32:113–117. 
Cheng YD, Al-Khoury L, Zivin JA. 2004. Neuroprotection for ischemic stroke: two 
decades of success and failure. NeuroRx 1:36–45. 
Di Chiara G, Loddo P, Tanda G. 1999. Reciprocal changes in prefrontal and limbic 
dopamine responsiveness to aversive and rewarding stimuli after chronic mild stress: 
implications for the psychobiology of depression. Biol. Psychiatry 46:1624–33. 
Chiba AA, Kesner RP, Gibson CJ. 1997. Memory for temporal order of new and 
familiar spatial location sequences: role of the medial prefrontal cortex. Learn. Mem. 
4:311–317. 
Choi-Kwon S, Han SW, Kwon SU, Kang D-W, Choi JM, Kim JS. 2006. Fluoxetine 
treatment in poststroke depression, emotional incontinence, and anger proneness: a 
double-blind, placebo-controlled study. Stroke. 37:156–61. 
Chudasama Y, Doobay VM, Liu Y. 2012. Hippocampal-prefrontal cortical circuit 
mediates inhibitory response control in the rat. J. Neurosci. 32:10915–24. 
Chung CSY, Pollock A, Campbell T, Durward BR, Hagen S. 2013. Cognitive 
rehabilitation for executive dysfunction in adults with stroke or other adult non-
progressive acquired brain damage. Cochrane database Syst. Rev. 4:CD008391. 
Churchwell JC, Morris AM, Heurtelou NM, Kesner RP. 2009. Interactions between the 
prefrontal cortex and amygdala during delay discounting and reversal. Behav. Neurosci. 
123:1185–96. 
Ciaramelli E, Muccioli M, Làdavas E, di Pellegrino G. 2007. Selective deficit in 
personal moral judgment following damage to ventromedial prefrontal cortex. Soc. 
Cogn. Affect. Neurosci. 2:84–92. 
Cicerone KD, Dahlberg C, Malec JF, Langenbahn DM, Felicetti T, Kneipp S, Ellmo W, 
Kalmar K, Giacino JT, Harley JP, et al. 2005. Evidence-based cognitive rehabilitation: 
updated review of the literature from 1998 through 2002. Arch. Phys. Med. Rehabil. 
86:1681–92. 
Clark DL, Penner M, Orellana-Jordan IM, Colbourne F. 2008. Comparison of 12, 24 
and 48 h of systemic hypothermia on outcome after permanent focal ischemia in rat. 
167 
 
Exp. Neurol. 212:386–392. 
Clausen T, Van Hardeveld C, Everts ME. 1991. Significance of cation transport in 
control of energy metabolism and thermogenesis. Physiol. Rev. 71:733–74. 
Clemens JA, Stephenson DT, Smalstig EB, Dixon EP, Little SP. 1997. Global Ischemia 
Activates Nuclear Factor- B in Forebrain Neurons of Rats. Stroke 28:1073–1081. 
Cognat E, Lagarde J, Decaix C, Hainque E, Azizi L, Gaura-Schmidt V, Mesnage V, 
Levy R. 2010. “Habit” gambling behaviour caused by ischemic lesions affecting the 
cognitive territories of the basal ganglia. J. Neurol. 257:1628–32. 
Cohen JS, Hachey G. 1977. Utilization and dominance of spatially separated cues as a 
function of water deprivation. Anim. Learn. Behav. 5:103–109. 
Colley RC, Garriguet D, Janssen I, Craig CL, Clarke J, Tremblay MS. 2011. Physical 
activity of Canadian adults: accelerometer results from the 2007 to 2009 Canadian 
Health Measures Survey. Heal. reports 22:7–14. 
Cordova CA, Jackson D, Langdon KD, Hewlett KA, Corbett D. 2014. Impaired 
executive function following ischemic stroke in the rat medial prefrontal cortex. Behav. 
Brain Res. 258:106–11. 
Cramer SC. 2008. Repairing the human brain after stroke: I. Mechanisms of 
spontaneous recovery. Ann. Neurol. 63:272–87. 
Cullen B, O‟Neill B, Evans JJ, Coen RF, Lawlor BA. 2007. A review of screening tests 
for cognitive impairment. J. Neurol. Neurosurg. Psychiatry 78:790–9. 
Cumming TB, Churilov L, Linden T, Bernhardt J. 2013. Montreal Cognitive 
Assessment and Mini-Mental State Examination are both valid cognitive tools in stroke. 
Acta Neurol. Scand. 128:122–9. 
Cummings JL. 1984. Dementia: Definition, classification, and differential diagnosis. 
Psychiatr. Ann. 14:85–89. 
Dahlqvist P, Rönnbäck A, Bergström S-A, Söderström I, Olsson T. 2004. 
Environmental enrichment reverses learning impairment in the Morris water maze after 
focal cerebral ischemia in rats. Eur. J. Neurosci. 19:2288–98. 
Davis HP, Tribuna J, Pulsinelli WA, Volpe BT. 1986. Reference and working memory 
of rats following hippocampal damage induced by transient forebrain ischemia. Physiol. 
Behav. 37:387–392. 
Davis M, Mendelow AD, Perry RH, Chambers IR, James OF. 1995. Experimental 
stroke and neuroprotection in the aging rat brain. Stroke. 26:1072–8. 
Desmond DW, Moroney JT, Sano M, Stern Y. 1996. Recovery of cognitive function 
after stroke. Stroke 27:1798–1803. 
Déziel RA, Ryan CL, Tasker RA. 2015. Ischemic lesions localized to the medial 
168 
 
prefrontal cortex produce selective deficits in measures of executive function in rats. 
Behav. Brain Res. 293:54–61. 
Diamond A. 2013. Executive functions. Annu. Rev. Psychol. 64:135–68. 
Diederich K, Schmidt A, Strecker J-K, Schäbitz W-R, Schilling M, Minnerup J. 2014. 
Cortical photothrombotic infarcts impair the recall of previously acquired memories but 
spare the formation of new ones. Stroke. 45:614–8. 
Dijkhuizen RM, Knollema S, van der Worp HB, Ter Horst GJ, De Wildt DJ, van der 
Sprenkel JWB, Tulleken KAF, Nicolay K, van Bruggen N, van Lookeren Campagne M. 
1998. Dynamics of Cerebral Tissue Injury and Perfusion After Temporary Hypoxia-
Ischemia in the Rat : Evidence for Region-Specific Sensitivity and Delayed Damage 
Editorial Comment: Evidence for Region-Specific Sensitivity and Delayed Damage. 
Stroke 29:695–704. 
Doornhein K, De Haan EHF. 1998. Cognitive Training for Memory Deficits in Stroke 
Patients. Neuropsychol. Rehabil. 8:393–400. 
Duncan PW, Goldstein LB, Horner RD, Landsman PB, Samsa GP, Matchar DB. 1994. 
Similar motor recovery of upper and lower extremities after stroke. Stroke. 25:1181–8. 
Durukan A, Tatlisumak T. 2007. Acute ischemic stroke: Overview of major 
experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia. 
Pharmacol. Biochem. Behav. 87:179–197. 
Eagle D., Robbins T. 2003. Lesions of the medial prefrontal cortex or nucleus 
accumbens core do not impair inhibitory control in rats performing a stop-signal 
reaction time task. Behav. Brain Res. 146:131–144. 
Eagle DM, Baunez C, Hutcheson DM, Lehmann O, Shah AP, Robbins TW. 2007. Stop-
Signal Reaction-Time Task Performance: Role of Prefrontal Cortex and Subthalamic 
Nucleus. Cereb. Cortex 18:178–188. 
van Eeden M, Kootker JA, Evers SMAA, van Heugten CM, Geurts ACH, van Mastrigt 
GAPG. 2015. An economic evaluation of an augmented cognitive behavioural 
intervention vs. computerized cognitive training for post-stroke depressive symptoms. 
BMC Neurol. 15:266. 
Eklöf B, Siesjö BK. 1972. The effect of bilateral carotid artery ligation upon acid-base 
parameters and substrate levels in the rat brain. Acta Physiol. Scand. 86:528–38. 
Endepols H, Mertgens H, Backes H, Himmelreich U, Neumaier B, Graf R, Mies G. 
2015. Longitudinal assessment of infarct progression, brain metabolism and behavior 
following anterior cerebral artery occlusion in rats. J. Neurosci. Methods 253:279–91. 
Ennaceur A, Delacour J. 1988. A new one-trial test for neurobiological studies of 
memory in rats. 1: Behavioral data. Behav. Brain Res. 31:47–59. 
Espejo EF. 1997. Selective dopamine depletion within the medial prefrontal cortex 
169 
 
induces anxiogenic-like effects in rats placed on the elevated plus maze. Brain Res. 
762:281–4. 
Faraji J, Lehmann H, Metz GA, Sutherland RJ. 2009. Stress and corticosterone enhance 
cognitive recovery from hippocampal stroke in rats. Neurosci. Lett. 462:248–52. 
Farkas E, Luiten PGM, Bari F. 2007. Permanent, bilateral common carotid artery 
occlusion in the rat: a model for chronic cerebral hypoperfusion-related 
neurodegenerative diseases. Brain Res. Rev. 54:162–80. 
Feigin VL, Forouzanfar MH, Krishnamurthi R, Mensah GA, Connor M, Bennett DA, 
Moran AE, Sacco RL, Anderson L, Truelsen T, et al. 2014. Global and regional burden 
of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. 
Lancet 383:245–54. 
Feigin VL, Lawes CM, Bennett DA, Barker-Collo SL, Parag V. 2009. Worldwide stroke 
incidence and early case fatality reported in 56 population-based studies: a systematic 
review. Lancet Neurol. 8:355–369. 
Feja M, Koch M. 2014. Ventral medial prefrontal cortex inactivation impairs impulse 
control but does not affect delay-discounting in rats. Behav. Brain Res. 264:230–9. 
Fellows LK, Farah MJ. 2003. Ventromedial frontal cortex mediates affective shifting in 
humans: evidence from a reversal learning paradigm. Brain 126:1830–7. 
Fellows LK, Farah MJ. 2005. Different underlying impairments in decision-making 
following ventromedial and dorsolateral frontal lobe damage in humans. Cereb. Cortex 
15:58–63. 
Fisher M, Feuerstein G, Howells DW, Hurn PD, Kent TA, Savitz SI, Lo EH, Group  for 
the S. 2009. Update of the Stroke Therapy Academic Industry Roundtable Preclinical 
Recommendations. Stroke 40:2244–2250. 
Floresco SB, Ghods-Sharifi S, Vexelman C, Magyar O. 2006. Dissociable roles for the 
nucleus accumbens core and shell in regulating set shifting. J. Neurosci. 26:2449–57. 
Floresco SB, Magyar O, Ghods-Sharifi S, Vexelman C, Tse MTL. 2006. Multiple 
Dopamine Receptor Subtypes in the Medial Prefrontal Cortex of the Rat Regulate Set-
Shifting. Neuropsychopharmacology 31:297–309. 
Frysztak RJ, Neafsey EJ. 1991. The effect of medial frontal cortex lesions on 
respiration, “freezing,” and ultrasonic vocalizations during conditioned emotional 
responses in rats. Cereb. cortex 1:418–25. 
Fuster JM. 2005. The Prefrontal Cortex. 4th ed. London: Elsevier. 
Fuxe K, Bjelke B, Andbjer B, Grahn H, Rimondini R, Agnati LF. 1997. Endothelin-1 
induced lesions of the frontoparietal cortex of the rat. A possible model of focal cortical 
ischemia. Neuroreport 8:2623–9. 
170 
 
Gades NM, Danneman PJ, Wixson SK, Tolley EA. 2000. The magnitude and duration 
of the analgesic effect of morphine, butorphanol, and buprenorphine in rats and mice. 
Contemp. Top. Lab. Anim. Sci. 39:8–13. 
Galski T, Bruno RL, Zorowitz R, Walker J. 1993. Predicting length of stay, functional 
outcome, and aftercare in the rehabilitation of stroke patients. The dominant role of 
higher-order cognition. Stroke 24:1794–1800. 
Giancola PR. 1995. EVidence for dorsolateral and orbital prefrontal cortical 
involvement in the expression of aggressive behavior. Aggress. Behav. 21:431–450. 
Glick SD, Ross DA. 1981. Right-sided population bias and lateralization of activity in 
normal rats. Brain Res. 205:222–5. 
Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, Dai S, Ford ES, 
Fox CS, Franco S, et al. 2014. Heart disease and stroke statistics--2014 update: a report 
from the American Heart Association. Circulation 129:e28–e292. 
Gonzalez-Torrecillas JL, Mendlewicz J, Lobo A. 1995. Effects of early treatment of 
poststroke depression on neuropsychological rehabilitation. Int. Psychogeriatr. 7:547–
60. 
Gonzalez FF, Abel R, Almli CR, Mu D, Wendland M, Ferriero DM. 2009. 
Erythropoietin sustains cognitive function and brain volume after neonatal stroke. Dev. 
Neurosci. 31:403–11. 
Granger C V, Hamilton BB, Gresham GE. 1988. The stroke rehabilitation outcome 
study--Part I: General description. Arch. Phys. Med. Rehabil. 69:506–9. 
Granon S, Vidal C, Thinus-Blanc C, Changeux JP, Poucet B. 1994. Working memory, 
response selection, and effortful processing in rats with medial prefrontal lesions. 
Behav. Neurosci. 108:883–91. 
Green EJ, Dietrich WD, van Dijk F, Busto R, Markgraf CG, McCabe PM, Ginsberg 
MD, Schneiderman N. 1992. Protective effects of brain hypothermia on behavior and 
histopathology following global cerebral ischemia in rats. Brain Res. 580:197–204. 
Grotta JC, Albers GW, Broderick JP, Kasner SE, Lo EH, Mendelow D, Sacco RL, 
Wong LK. 2015. Stroke: Pathophysiology, Diagnosis, and Management. 6th ed. 
Grünblatt E, Bartl J, Iuhos D-I, Knezovic A, Trkulja V, Riederer P, Walitza S, Salkovic-
Petrisic M. 2015. Characterization of cognitive deficits in spontaneously hypertensive 
rats, accompanied by brain insulin receptor dysfunction. J. Mol. psychiatry 3:6. 
Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, Larrue V, Bluhmki 
E, Davis S, Donnan G, et al. 1998. Randomised double-blind placebo-controlled trial of 
thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). 
Second European-Australasian Acute Stroke Study Investigators. Lancet (London, 
England) 352:1245–51. 
171 
 
Hamm RJ, Temple MD, Pike BR, O‟Dell DM, Buck DL, Lyeth BG. 1996. Working 
memory deficits following traumatic brain injury in the rat. J. Neurotrauma 13:317–23. 
Han X, Wang W, Xue X, Shao F, Li N. 2011. Brief social isolation in early adolescence 
affects reversal learning and forebrain BDNF expression in adult rats. Brain Res. Bull. 
86:173–178. 
Hankey GJ, Jamrozik K, Broadhurst RJ, Forbes S, Anderson CS. 2002. Long-Term 
Disability After First-Ever Stroke and Related Prognostic Factors in the Perth 
Community Stroke Study, 1989-1990. Stroke 33:1034–1040. 
Hannesson DK, Howland JG, Phillips AG. 2004. Interaction between Perirhinal and 
Medial Prefrontal Cortex Is Required for Temporal Order But Not Recognition Memory 
for Objects in Rats. J. Neurosci. 24:4596–4604. 
Harlow JM. 1868. Recovery from the passage of an iron bar through the head. Publ. 
Massachusetts Med. Soc. 3:1–21. 
Harlow JM. 1999. Passage of an iron rod through the head. 1848. J. Neuropsychiatry 
Clin. Neurosci. 11:281–3. 
Hartman RE, Lee JM, Zipfel GJ, Wozniak DF. 2005. Characterizing learning deficits 
and hippocampal neuron loss following transient global cerebral ischemia in rats. Brain 
Res. 1043:48–56. 
Harvey RJ. 2003. The prevalence and causes of dementia in people under the age of 65 
years. J. Neurol. Neurosurg. Psychiatry 74:1206–1209. 
Hinzman JM, DiNapoli VA, Mahoney EJ, Gerhardt GA, Hartings JA. 2015. Spreading 
depolarizations mediate excitotoxicity in the development of acute cortical lesions. Exp. 
Neurol. 267:243–53. 
Hochstenbach JB, den Otter R, Mulder TW. 2003. Cognitive recovery after stroke: a 2-
year follow-up 11No commercial party having a direct financial interest in the results of 
the research supporting this article has or will confer a benefit upon the author(s) or 
upon any organization with which the aut. Arch. Phys. Med. Rehabil. 84:1499–1504. 
Hochstenbach JJ, Mulder TT, van Limbeek JJ, Donders RR, Schoonderwaldt HH. 1998. 
Cognitive Decline Following Stroke: A Comprehensive Study of Cognitive Decline 
Following Stroke. J. Clin. Exp. Neuropsychol. 20:503–517. 
Hoffmann M, Cases LB, Hoffmann B, Chen R. 2010. The impact of stroke on emotional 
intelligence. BMC Neurol. 10:103. 
Hoffmann T, Bennett S, Koh C-L, McKenna K. 2010. A systematic review of cognitive 
interventions to improve functional ability in people who have cognitive impairment 
following stroke. Top. Stroke Rehabil. 17:99–107. 
Hollander M, Koudstaal PJ, Bots ML, Grobbee DE, Hofman A, Breteler MMB. 2003. 
Incidence, risk, and case fatality of first ever stroke in the elderly population. The 
172 
 
Rotterdam Study. J. Neurol. Neurosurg. Psychiatry 74:317–21. 
Hong JM, Shin DH, Lim TS, Lee JS, Huh K. 2012. Galantamine administration in 
chronic post-stroke aphasia. J. Neurol. Neurosurg. Psychiatry 83:675–80. 
Hope TMH, Seghier ML, Leff AP, Price CJ. 2013. Predicting outcome and recovery 
after stroke with lesions extracted from MRI images. NeuroImage. Clin. 2:424–33. 
Horie N, Maag A-L, Hamilton SA, Shichinohe H, Bliss TM, Steinberg GK. 2008. 
Mouse model of focal cerebral ischemia using endothelin-1. J. Neurosci. Methods 
173:286–90. 
Hossmann K. 1998. Experimental models for the investigation of brain ischemia. 
Cardiovasc. Res. 39:106–120. 
Hotte M, Naudon L, Jay TM. 2005. Modulation of recognition and temporal order 
memory retrieval by dopamine D1 receptor in rats. Neurobiol. Learn. Mem. 84:85–92. 
House A, Dennis M, Mogridge L, Warlow C, Hawton K, Jones L. 1991. Mood disorders 
in the year after first stroke. Br. J. Psychiatry 158:83–92. 
Hu X, Lu Y, Zhang Y, Li Y, Jiang L. 2013. Remote ischemic preconditioning improves 
spatial learning and memory ability after focal cerebral ischemia-reperfusion in rats. 
Perfusion 28:546–51. 
Hughes PM, Anthony DC, Ruddin M, Botham MS, Rankine EL, Sablone M, Baumann 
D, Mir AK, Perry VH. 2003. Focal lesions in the rat central nervous system induced by 
endothelin-1. J. Neuropathol. Exp. Neurol. 62:1276–86. 
Hunt PR, Aggleton JP. 1998. Neurotoxic Lesions of the Dorsomedial Thalamus Impair 
the Acquisition But Not the Performance of Delayed Matching to Place by Rats: a 
Deficit in Shifting Response Rules. J. Neurosci. 18:10045–10052. 
Ikeda J, Kojima N, Saeki K, Ishihara M, Takayama M. 2015. Perindopril increases the 
swallowing reflex by inhibiting substance P degradation and tyrosine hydroxylase 
activation in a rat model of dysphagia. Eur. J. Pharmacol. 746:126–131. 
Inaba S, Iwai M, Furuno M, Tomono Y, Kanno H, Senba I, Okayama H, Mogi M, 
Higaki J, Horiuchi M. 2009. Continuous activation of renin-angiotensin system impairs 
cognitive function in renin/angiotensinogen transgenic mice. Hypertension 53:356–62. 
Inglis WL, Semba K. 1997. Discriminable excitotoxic effects of ibotenic acid, AMPA, 
NMDA and quinolinic acid in the rat laterodorsal tegmental nucleus. Brain Res. 755:17–
27. 
Iwasaki Y, Ito S, Suzuki M, Nagahori T, Yamamoto T, Konno H. 1989. Forebrain 
ischemia induced by temporary bilateral common carotid occlusion in normotensive 
rats. J. Neurol. Sci. 90:155–165. 
Jaeschke H, Lemasters JJ. 2003. Apoptosis versus oncotic necrosis in hepatic 
173 
 
ischemia/reperfusion injury. Gastroenterology 125:1246–1257. 
Jahanshahi M, Rowe J, Saleem T, Brown RG, Limousin-Dowsey P, Rothwell JC, 
Thomas DGT, Quinn NP. 2002. Striatal contribution to cognition: working memory and 
executive function in Parkinson‟s disease before and after unilateral posteroventral 
pallidotomy. J. Cogn. Neurosci. 14:298–310. 
Jehkonen M, Laihosalo M, Kettunen JE. 2006. Impact of neglect on functional outcome 
after stroke: a review of methodological issues and recent research findings. Restor. 
Neurol. Neurosci. 24:209–15. 
Jenkins LW, Povlishock JT, Lewelt W, Miller JD, Becker DP. 1981. The role of 
postischemic recirculation in the development of ischemic neuronal injury following 
complete cerebral ischemia. Acta Neuropathol. 55:205–20. 
Jiang C, Agulian S, Haddad GG. 1992. Cl- and Na+ homeostasis during anoxia in rat 
hypoglossal neurons: intracellular and extracellular in vitro studies. J. Physiol. 448:697–
708. 
Jiwa NS, Garrard P, Hainsworth AH. 2010. Experimental models of vascular dementia 
and vascular cognitive impairment: a systematic review. J. Neurochem. 115:814–28. 
Jones TA, Schallert T. 1992. Overgrowth and pruning of dendrites in adult rats 
recovering from neocortical damage. Brain Res. 581:156–60. 
Kaste M, Murayama S, Ford GA, Dippel DWJ, Walters MR, Tatlisumak T. 2013. 
Safety, tolerability and pharmacokinetics of MCI-186 in patients with acute ischemic 
stroke: new formulation and dosing regimen. Cerebrovasc. Dis. 36:196–204. 
Katzan IL, Hammer MD, Hixson ED, Furlan AJ, Abou-Chebl A, Nadzam DM. 2004. 
Utilization of intravenous tissue plasminogen activator for acute ischemic stroke. Arch. 
Neurol. 61:346–50. 
Kaufmann AM, Firlik AD, Fukui MB, Wechsler LR, Jungries CA, Yonas H. 1999. 
Ischemic Core and Penumbra in Human Stroke. Stroke 30:93–99. 
Kauhanen M-L, Korpelainen JT, Hiltunen P, Brusin E, Mononen H, Maatta R, 
Nieminen P, Sotaniemi KA, Myllyla V V. 1999. Poststroke Depression Correlates With 
Cognitive Impairment and Neurological Deficits. Stroke 30:1875–1880. 
Kelly-Hayes M, Beiser A, Kase CS, Scaramucci A, D‟Agostino RB, Wolf PA. 2003. 
The influence of gender and age on disability following ischemic stroke: the 
Framingham study. J. Stroke Cerebrovasc. Dis. 12:119–26. 
Kesner RP, Hopkins RO, Fineman B. 1994. Item and order dissociation in humans with 
prefrontal cortex damage. Neuropsychologia 32:881–891. 
Kesner RP, Measom MO, Forsman SL, Holbrook TH. 1984. Serial-position curves in 
rats: Order memory for episodic spatial events. Anim. Learn. Behav. 12:378–382. 
174 
 
Khatri P, Conaway MR, Johnston KC. 2012. Ninety-day outcome rates of a prospective 
cohort of consecutive patients with mild ischemic stroke. Stroke. 43:560–2. 
Kidwell CS, Liebeskind DS, Starkman S, Saver JL. 2001. Trends in acute ischemic 
stroke trials through the 20th century. Stroke. 32:1349–59. 
Kilander L, Nyman H, Boberg M, Hansson L, Lithell H. 1998. Hypertension Is Related 
to Cognitive Impairment : A 20-Year Follow-up of 999 Men. Hypertension 31:780–786. 
Kim AS, Johnston SC. 2011. Global Variation in the Relative Burden of Stroke and 
Ischemic Heart Disease. Circulation 124:314–323. 
Kim HJ, Craik FIM, Luo L, Ween JE. 2009. Impairments in prospective and 
retrospective memory following stroke. Neurocase 15:145–56. 
Kim JS, Choi-Kwon S. 1996. Discriminative Sensory Dysfunction After Unilateral 
Stroke. Stroke 27:677–682. 
Kim YR, Kim HN, Pak ME, Ahn SM, Hong KH, Shin HK, Choi BT. 2015. Studies on 
the animal model of post-stroke depression and application of antipsychotic 
aripiprazole. Behav. Brain Res. 287:294–303. 
King RB. 1996. Quality of Life After Stroke. Stroke 27:1467–1472. 
Kirino T. 1982. Delayed neuronal death in the gerbil hippocampus following ischemia. 
Brain Res. 239:57–69. 
Kleim JA, Boychuk JA, Adkins DL. 2007. Rat models of upper extremity impairment in 
stroke. ILAR J. 48:374–84. 
Koenigs M, Grafman J. 2009. The functional neuroanatomy of depression: distinct roles 
for ventromedial and dorsolateral prefrontal cortex. Behav. Brain Res. 201:239–43. 
Kolb B, Gibb R. 1993. Possible anatomical basis of recovery of function after neonatal 
frontal lesions in rats. Behav. Neurosci. 107:799–811. 
Kolb B, Nonneman AJ. 1974. Frontolimbic lesions and social behavior in the rat. 
Physiol. Behav. 13:637–643. 
Konishi S, Nakajima K, Uchida I, Kameyama M, Nakahara K, Sekihara K, Miyashita Y. 
1998. Transient activation of inferior prefrontal cortex during cognitive set shifting. Nat. 
Neurosci. 1:80–4. 
Krueger H, Koot J, Hall RE, O‟Callaghan C, Bayley M, Corbett D. 2015. Prevalence of 
Individuals Experiencing the Effects of Stroke in Canada: Trends and Projections. 
Stroke. 46:2226–31. 
Kumar A, Aakriti, Gupta V. 2016. A review on animal models of stroke: An update. 
Brain Res. Bull. 122:35–44. 
Kuroiwa T, Xi G, Hua Y, Nagaraja TN, Fenstermacher JD, Keep RF. 2009. 
175 
 
Development of a rat model of photothrombotic ischemia and infarction within the 
caudoputamen. Stroke. 40:248–53. 
Kwakkel G, Wagenaar RC, Twisk JW, Lankhorst GJ, Koetsier JC. 1999. Intensity of leg 
and arm training after primary middle-cerebral-artery stroke: a randomised trial. Lancet 
354:191–196. 
Labat-gest V, Tomasi S. 2013. Photothrombotic ischemia: a minimally invasive and 
reproducible photochemical cortical lesion model for mouse stroke studies. J. Vis. Exp. 
Lacroix L, Broersen L., Weiner I, Feldon J. 1998. The effects of excitotoxic lesion of 
the medial prefrontal cortex on latent inhibition, prepulse inhibition, food hoarding, 
elevated plus maze, active avoidance and locomotor activity in the rat. Neuroscience 
84:431–442. 
Langhorne P, Coupar F, Pollock A. 2009. Motor recovery after stroke: a systematic 
review. Lancet Neurol. 8:741–54. 
Lapchak PA. 2010. A critical assessment of edaravone acute ischemic stroke efficacy 
trials: is edaravone an effective neuroprotective therapy? Expert Opin. Pharmacother. 
11:1753–63. 
Lapiz MDS, Morilak DA. 2006. Noradrenergic modulation of cognitive function in rat 
medial prefrontal cortex as measured by attentional set shifting capability. Neuroscience 
137:1039–49. 
Lawrence ES, Coshall C, Dundas R, Stewart J, Rudd AG, Howard R, Wolfe CDA. 
2001. Estimates of the Prevalence of Acute Stroke Impairments and Disability in a 
Multiethnic Population. Stroke 32:1279–1284. 
Lee JK, Park MS, Kim YS, Moon KS, Joo SP, Kim TS, Kim JH, Kim SH. 2007. 
Photochemically induced cerebral ischemia in a mouse model. Surg. Neurol. 67:620–5; 
discussion 625. 
Lee JM, Grabb MC, Zipfel GJ, Choi DW. 2000. Brain tissue responses to ischemia. J. 
Clin. Invest. 106:723–31. 
Leśniak M, Bak T, Czepiel W, Seniów J, Członkowska A. 2008. Frequency and 
prognostic value of cognitive disorders in stroke patients. Dement. Geriatr. Cogn. 
Disord. 26:356–63. 
Letkiewicz AM, Miller GA, Crocker LD, Warren SL, Infantolino ZP, Mimnaugh KJ, 
Heller W. 2014. Executive Function Deficits in Daily Life Prospectively Predict 
Increases in Depressive Symptoms. Cognit. Ther. Res. 38:612–620. 
Levine AS, Morley JE. 1983. Butorphanol tartrate induces feeding in rats. Life Sci. 
32:781–785. 
Li W-L, Cai H-H, Wang B, Chen L, Zhou Q-G, Luo C-X, Liu N, Ding X-S, Zhu D-Y. 
2009. Chronic fluoxetine treatment improves ischemia-induced spatial cognitive deficits 
176 
 
through increasing hippocampal neurogenesis after stroke. J. Neurosci. Res. 87:112–22. 
Liles JH, Flecknell PA. 1992. The effects of buprenorphine, nalbuphine and butorphanol 
alone or following halothane anaesthesia on food and water consumption and locomotor 
movement in rats. Lab. Anim. 26:180–9. 
Liu J, Solway K, Messing RO, Sharp FR. 1998. Increased Neurogenesis in the Dentate 
Gyrus After Transient Global Ischemia in Gerbils. J. Neurosci. 18:7768–7778. 
Liu Z, Zhang RL, Li Y, Cui Y, Chopp M. 2009. Remodeling of the Corticospinal 
Innervation and Spontaneous Behavioral Recovery After Ischemic Stroke in Adult 
Mice. Stroke 40. 
Livingston-Thomas JM, Hume AW, Doucette TA, Tasker RA. 2013. A novel approach 
to induction and rehabilitation of deficits in forelimb function in a rat model of ischemic 
stroke. Acta Pharmacol. Sin. 34:104–12. 
Livingston-Thomas JM, McGuire EP, Doucette TA, Tasker RA. 2014. Voluntary forced 
use of the impaired limb following stroke facilitates functional recovery in the rat. 
Behav. Brain Res. 261:210–9. 
Loetscher T, Lincoln NB. 2013. Cognitive rehabilitation for attention deficits following 
stroke. Cochrane database Syst. Rev. 5:CD002842. 
Longa EZ, Weinstein PR, Carlson S, Cummins R. 1989. Reversible middle cerebral 
artery occlusion without craniectomy in rats. Stroke. 20:84–91. 
Loos M, Pattij T, Janssen MCW, Counotte DS, Schoffelmeer ANM, Smit AB, Spijker 
S, van Gaalen MM. 2010. Dopamine receptor D1/D5 gene expression in the medial 
prefrontal cortex predicts impulsive choice in rats. Cereb. Cortex 20:1064–70. 
Lowrance SA, Fink KD, Crane A, Matyas J, Dey ND, Matchynski JJ, Thibo T, Reinke 
T, Kippe J, Hoffman C, et al. 2015. Bone-marrow-derived mesenchymal stem cells 
attenuate cognitive deficits in an endothelin-1 rat model of stroke. Restor. Neurol. 
Neurosci. 33:579–88. 
Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, 
Aggarwal R, Ahn SY, et al. 2012. Global and regional mortality from 235 causes of 
death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden 
of Disease Study 2010. Lancet (London, England) 380:2095–128. 
Lubeck DP, Danese MD, Duryea J, Halperin M, Tayama D, Yu E, Lalla D, Grotta JC. 
2016. Quality adjusted life year gains associated with administration of recombinant 
tissue-type plasminogen activator for treatment of acute ischemic stroke: 1998-2011. Int. 
J. Stroke 11:198–205. 
Luo W, Morrison H, de Groh M, Waters C, DesMeules M, Jones-McLean E, Ugnat A-
M, Desjardins S, Lim M, Mao Y. 2007. The burden of adult obesity in Canada. Chronic 
Dis. Can. 27:135–44. 
177 
 
Luscher TF, Barton M. 2000. Endothelins and Endothelin Receptor Antagonists : 
Therapeutic Considerations for a Novel Class of Cardiovascular Drugs. Circulation 
102:2434–2440. 
Macrae IM. 2011. Preclinical stroke research--advantages and disadvantages of the most 
common rodent models of focal ischaemia. Br. J. Pharmacol. 164:1062–78. 
Madureira S, Guerreiro M, Ferro JM. 2001. Dementia and cognitive impairment three 
months after stroke. Eur. J. Neurol. 8:621–7. 
Mällo T, Matrov D, Herm L, Kõiv K, Eller M, Rinken A, Harro J. 2007. Tickling-
induced 50-kHz ultrasonic vocalization is individually stable and predicts behaviour in 
tests of anxiety and depression in rats. Behav. Brain Res. 184:57–71. 
Manes F, Sahakian B, Clark L, Rogers R, Antoun N, Aitken M, Robbins T. 2002. 
Decision-making processes following damage to the prefrontal cortex. Brain 125:624–
639. 
Mar AC, Walker ALJ, Theobald DE, Eagle DM, Robbins TW. 2011. Dissociable effects 
of lesions to orbitofrontal cortex subregions on impulsive choice in the rat. J. Neurosci. 
31:6398–404. 
Mariano TY, Bannerman DM, McHugh SB, Preston TJ, Rudebeck PH, Rudebeck SR, 
Rawlins JNP, Walton ME, Rushworth MFS, Baxter MG, et al. 2009. Impulsive choice 
in hippocampal but not orbitofrontal cortex-lesioned rats on a nonspatial decision-
making maze task. Eur. J. Neurosci. 30:472–84. 
Marsden PA, Danthuluri NR, Brenner BM, Ballermann BJ, Brock TA. 1989. Endothelin 
action on vascular smooth muscle involves inositol trisphosphate and calcium 
mobilization. Biochem. Biophys. Res. Commun. 158:86–93. 
Mátéffyová A, Otáhal J, Tsenov G, Mareš P, Kubová H. 2006. Intrahippocampal 
injection of endothelin-1 in immature rats results in neuronal death, development of 
epilepsy and behavioral abnormalities later in life. Eur. J. Neurosci. 24:351–360. 
Mayo NE, Neville D, Kirkland S, Ostbye T, Mustard CA, Reeder B, Joffres M, Brauer 
G, Levy AR. 1996. Hospitalization and Case-Fatality Rates for Stroke in Canada From 
1982 Through 1991: The Canadian Collaborative Study Group of Stroke 
Hospitalizations1. Stroke 27:1215–1220. 
Mayzel-Oreg O, Omae T, Kazemi M, Li F, Fisher M, Cohen Y, Sotak CH. 2004. 
Microsphere-induced embolic stroke: an MRI study. Magn. Reson. Med. 51:1232–8. 
McDowd JM, Filion DL, Pohl PS, Richards LG, Stiers W. 2003. Attentional Abilities 
and Functional Outcomes Following Stroke. Journals Gerontol. Ser. B Psychol. Sci. 
Soc. Sci. 58:P45–P53. 
McGinnis MY, Vakulenko M. 2003. Characterization of 50-kHz ultrasonic vocalizations 
in male and female rats. Physiol. Behav. 80:81–88. 
178 
 
McIntyre A, Viana R, Janzen S, Mehta S, Pereira S, Teasell R. 2012. Systematic review 
and meta-analysis of constraint-induced movement therapy in the hemiparetic upper 
extremity more than six months post stroke. Top. Stroke Rehabil. 19:499–513. 
Miller EK, Cohen JD. 2001. An integrative theory of prefrontal cortex function. Annu. 
Rev. Neurosci. 24:167–202. 
Miller EK, Wallis JD. 2009. Executive Function and Higher-Order Cognition: 
Definition and Neural Substrates. Elsevier. 
Milner B. 1963. Effects of Different Brain Lesions on Card Sorting. Arch. Neurol. 9:90. 
Minnerup J, Sutherland BA, Buchan AM, Kleinschnitz C. 2012. Neuroprotection for 
stroke: current status and future perspectives. Int. J. Mol. Sci. 13:11753–72. 
Mitchell J, Laiacona J. 1998. The medial frontal cortex and temporal memory: tests 
using spontaneous exploratory behaviour in the rat. Behav. Brain Res. 97:107–113. 
Mittmann N, Seung SJ, Hill MD, Phillips SJ, Hachinski V, Coté R, Buck BH, Mackey 
A, Gladstone DJ, Howse DC, et al. 2012. Impact of Disability Status on Ischemic Stroke 
Costs in Canada in the First Year. Can. J. Neurol. Sci.:793–800. 
Miyai I, Suzuki T, Kang J, Kubota K, Volpe BT. 1999. Middle Cerebral Artery Stroke 
That Includes the Premotor Cortex Reduces Mobility Outcome. Stroke 30. 
Mobini S, Body S, Ho M-Y, Bradshaw CM, Szabadi E, Deakin JFW, Anderson IM. 
2002. Effects of lesions of the orbitofrontal cortex on sensitivity to delayed and 
probabilistic reinforcement. Psychopharmacology (Berl). 160:290–8. 
Mok VCT. 2004. Cognitive impairment and functional outcome after stroke associated 
with small vessel disease. J. Neurol. Neurosurg. Psychiatry 75:560–566. 
Moore TL, Killiany RJ, Rosene DL, Prusty S, Hollander W, Moss MB. 2002. 
Impairment of executive function induced by hypertension in the rhesus monkey 
(Macaca mulatta). Behav. Neurosci. 116:387–96. 
Moore TL, Schettler SP, Killiany RJ, Rosene DL, Moss MB. 2009. Effects on executive 
function following damage to the prefrontal cortex in the rhesus monkey (Macaca 
mulatta). Behav. Neurosci. 123:231–41. 
Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, de Ferranti S, 
Després J-P, Fullerton HJ, Howard VJ, et al. 2014. Heart Disease and Stroke Statistics-
2015 Update: A Report From the American Heart Association. Circulation 131:e29-322. 
Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, 
Cummings JL, Chertkow H. 2005. The Montreal Cognitive Assessment, MoCA: a brief 
screening tool for mild cognitive impairment. J. Am. Geriatr. Soc. 53:695–9. 
Neher JJ, Emmrich J V, Fricker M, Mander PK, Théry C, Brown GC. 2013. 
Phagocytosis executes delayed neuronal death after focal brain ischemia. Proc. Natl. 
179 
 
Acad. Sci. U. S. A. 110:E4098-107. 
Ng M, Freeman MK, Fleming TD, Robinson M, Dwyer-Lindgren L, Thomson B, 
Wollum A, Sanman E, Wulf S, Lopez AD, et al. 2014. Smoking prevalence and 
cigarette consumption in 187 countries, 1980-2012. JAMA 311:183–92. 
Ni J, Ohta H, Matsumoto K, Watanabe H. 1994. Progressive cognitive impairment 
following chronic cerebral hypoperfusion induced by permanent occlusion of bilateral 
carotid arteries in rats. Brain Res. 653:231–236. 
Nicholson C, Bruggencate GT, Steinberg R, Stöckle H. 1977. Calcium modulation in 
brain extracellular microenvironment demonstrated with ion-selective micropipette. 
Proc. Natl. Acad. Sci. U. S. A. 74:1287–90. 
Nys GMS, van Zandvoort MJE, de Kort PLM, Jansen BPW, Kappelle LJ, de Haan EHF. 
2005. Restrictions of the Mini-Mental State Examination in acute stroke. Arch. Clin. 
Neuropsychol. 20:623–9. 
Nys GMS, van Zandvoort MJE, van der Worp HB, de Haan EHF, de Kort PLM, Jansen 
BPW, Kappelle LJ. 2006. Early cognitive impairment predicts long-term depressive 
symptoms and quality of life after stroke. J. Neurol. Sci. 247:149–56. 
Nys GMS, van Zandvoort MJE, van der Worp HB, de Haan EHF, de Kort PLM, 
Kappelle LJ. 2005. Early depressive symptoms after stroke: neuropsychological 
correlates and lesion characteristics. J. Neurol. Sci. 228:27–33. 
O‟Donnell MJ, Xavier D, Liu L, Zhang H, Chin SL, Rao-Melacini P, Rangarajan S, 
Islam S, Pais P, McQueen MJ, et al. 2010. Risk factors for ischaemic and intracerebral 
haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. 
Lancet (London, England) 376:112–23. 
Okamoto K, Aoki K. 1963. Development of a strain of spontaneously hypertensive rats. 
Jpn. Circ. J. 27:282–93. 
Olton DS, Samuelson RJ. 1976. Remembrance of places passed: Spatial memory in rats. 
J. Exp. Psychol. Anim. Behav. Process. 2:97–116. 
Ongür D, Ferry AT, Price JL. 2003. Architectonic subdivision of the human orbital and 
medial prefrontal cortex. J. Comp. Neurol. 460:425–49. 
Ovbiagele B, Goldstein LB, Higashida RT, Howard VJ, Johnston SC, Khavjou OA, 
Lackland DT, Lichtman JH, Mohl S, Sacco RL, et al. 2013. Forecasting the future of 
stroke in the United States: a policy statement from the American Heart Association and 
American Stroke Association. Stroke. 44:2361–75. 
Paine TA, Asinof SK, Diehl GW, Frackman A, Leffler J. 2013. Medial prefrontal cortex 
lesions impair decision-making on a rodent gambling task: reversal by D1 receptor 
antagonist administration. Behav. Brain Res. 243:247–54. 
Palmer R, Enderby P, Cooper C, Latimer N, Julious S, Paterson G, Dimairo M, Dixon S, 
180 
 
Mortley J, Hilton R, et al. 2012. Computer therapy compared with usual care for people 
with long-standing aphasia poststroke: a pilot randomized controlled trial. Stroke. 
43:1904–11. 
Paolucci S. 2008. Epidemiology and treatment of post-stroke depression. 
Neuropsychiatr. Dis. Treat. 4:145–54. 
Paradiso S, Anderson BM, Boles Ponto LL, Tranel D, Robinson RG. 2011. Altered 
neural activity and emotions following right middle cerebral artery stroke. J. Stroke 
Cerebrovasc. Dis. 20:94–104. 
Parikh RM, Lipsey JR, Robinson RG, Price TR. 1987. Two-year longitudinal study of 
post-stroke mood disorders: dynamic changes in correlates of depression at one and two 
years. Stroke. 18:579–84. 
Patel M, Coshall C, Rudd AG, Wolfe CDA. 2003. Natural history of cognitive 
impairment after stroke and factors associated with its recovery. Clin. Rehabil. 17:158–
66. 
Paxinos G, Watson C. 2007. The Rat Brain in Stereotaxic Coordinates, 6th Edition. 6th 
ed. 
Pedersen PM, Jørgensen HS, Nakayama H, Raaschou HO, Olsen TS. 1995. Aphasia in 
acute stroke: incidence, determinants, and recovery. Ann. Neurol. 38:659–66. 
Peng N, Clark JT, Prasain J, Kim H, White CR, Wyss JM. 2005. Antihypertensive and 
cognitive effects of grape polyphenols in estrogen-depleted, female, spontaneously 
hypertensive rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 289:R771-5. 
Peng Y, Xu S, Chen G, Wang L, Feng Y, Wang X. 2007. l-3-n-Butylphthalide improves 
cognitive impairment induced by chronic cerebral hypoperfusion in rats. J. Pharmacol. 
Exp. Ther. 321:902–10. 
Peterson GM, Devine J V. 1963. Transfers in handedness in the rat resulting from small 
cortical lesions after limited forced practice. J. Comp. Physiol. Psychol. 56:752–756. 
Petrides M, Pandya DN. 1999. Dorsolateral prefrontal cortex: comparative 
cytoarchitectonic analysis in the human and the macaque brain and corticocortical 
connection patterns. Eur. J. Neurosci. 11:1011–1036. 
Plowman E, Hentz B, Ellis C. 2012. Post-stroke aphasia prognosis: a review of patient-
related and stroke-related factors. J. Eval. Clin. Pract. 18:689–94. 
Pohjasvaara T, Leskela M, Vataja R, Kalska H, Ylikoski R, Hietanen M, Leppavuori A, 
Kaste M, Erkinjuntti T. 2002. Post-stroke depression, executive dysfunction and 
functional outcome. Eur. J. Neurol. 9:269–275. 
Popp A, Jaenisch N, Witte OW, Frahm C. 2009. Identification of ischemic regions in a 
rat model of stroke. PLoS One 4:e4764. 
181 
 
Preuss TM. 1995. Do rats have prefrontal cortex? The rose-woolsey-akert program 
reconsidered. J. Cogn. Neurosci. 7:1–24. 
Prokopenko SV, Mozheyko EY, Petrova MM, Koryagina TD, Kaskaeva DS, Chernykh 
TV, Shvetzova IN, Bezdenezhnih AF. 2013. Correction of post-stroke cognitive 
impairments using computer programs. J. Neurol. Sci. 325:148–153. 
Rasquin SMC, Lodder J, Ponds RWHM, Winkens I, Jolles J, Verhey FRJ. 2004. 
Cognitive functioning after stroke: a one-year follow-up study. Dement. Geriatr. Cogn. 
Disord. 18:138–44. 
Reno JM, Marker B, Cormack LK, Schallert T, Duvauchelle CL. 2013. Automating 
ultrasonic vocalization analyses: the WAAVES program. J. Neurosci. Methods 
219:155–61. 
Risterucci C, Terramorsi D, Nieoullon A, Amalric M. 2003. Excitotoxic lesions of the 
prelimbic-infralimbic areas of the rodent prefrontal cortex disrupt motor preparatory 
processes. Eur. J. Neurosci. 17:1498–1508. 
Robinson RG. 1997. Neuropsychiatric consequences of stroke. Annu. Rev. Med. 
48:217–29. 
Robinson RG, Kubos KL, Starr LB, Rao K, Price TR. 1984. Mood disorders in stroke 
patients. Importance of location of lesion. Brain 107 ( Pt 1:81–93. 
Robinson RG, Shoemaker WJ, Schlumpf M, Valk T, Bloom FE. 1975. Effect of 
experimental cerebral infarction in rat brain on catecholamines and behaviour. Nature 
255:332–4. 
Rogers DC, Campbell CA, Stretton JL, Mackay KB. 1997. Correlation between motor 
impairment and infarct volume after permanent and transient middle cerebral artery 
occlusion in the rat. Stroke. 28:2060–5; discussion 2066. 
Romanova GA, Shakova FM, Gudasheva TA, Ostrovskaya RU. 2002. Impairment of 
learning and memory after photothrombosis of the prefrontal cortex in rat brain: effects 
of Noopept. Bull. Exp. Biol. Med. 134:528–30. 
Rosenblum WI, El-Sabban F. 1977. Platelet aggregation in the cerebral 
microcirculation: effect of aspirin and other agents. Circ. Res. 40:320–8. 
Rossi AF, Bichot NP, Desimone R, Ungerleider LG. 2007. Top down attentional deficits 
in macaques with lesions of lateral prefrontal cortex. J. Neurosci. 27:11306–14. 
Rothman SM, Olney JW. 1986. Glutamate and the pathophysiology of hypoxic--
ischemic brain damage. Ann. Neurol. 19:105–11. 
Rubino GJ, Young W. 1988. Ischemic cortical lesions after permanent occlusion of 
individual middle cerebral artery branches in rats. Stroke. 19:870–7. 
Rudebeck PH, Walton ME, Smyth AN, Bannerman DM, Rushworth MFS. 2006. 
182 
 
Separate neural pathways process different decision costs. Nat. Neurosci. 9:1161–8. 
Sales GD. 1979. Strain Differences in the Ultrasonic Behavior of Rats (Rattus 
norvegicus) on JSTOR. Am. Zool. 19:513–527. 
Salzman CD, Fusi S. 2010. Emotion, cognition, and mental state representation in 
amygdala and prefrontal cortex. Annu. Rev. Neurosci. 33:173–202. 
Sarti C, Rastenyte D, Cepaitis Z, Tuomilehto J. 2000. International Trends in Mortality 
From Stroke, 1968 to 1994. Stroke 31:1588–1601. 
Scheffer M, Monteiro JK, de Almeida RMM. 2011. Frontal stroke: Problem solving, 
decision making, impulsiveness, and depressive symptoms in men and women. Psychol. 
Neurosci. 4:267–278. 
Schmid-Elsaesser R, Zausinger S, Hungerhuber E, Baethmann A, Reulen HJ. 1998. A 
critical reevaluation of the intraluminal thread model of focal cerebral ischemia: 
evidence of inadvertent premature reperfusion and subarachnoid hemorrhage in rats by 
laser-Doppler flowmetry. Stroke. 29:2162–70. 
Schmidt A, Diederich K, Strecker J-K, Geng B, Hoppen M, Duning T, Schäbitz W-R, 
Minnerup J. 2015. Progressive cognitive deficits in a mouse model of recurrent 
photothrombotic stroke. Stroke. 46:1127–31. 
Schmidt A, Hoppen M, Strecker J-K, Diederich K, Schäbitz W-R, Schilling M, 
Minnerup J. 2012. Photochemically induced ischemic stroke in rats. Exp. Transl. Stroke 
Med. 4:13. 
Schmidt A, Wellmann J, Schilling M, Strecker J-K, Sommer C, Schäbitz W-R, 
Diederich K, Minnerup J. 2014. Meta-analysis of the efficacy of different training 
strategies in animal models of ischemic stroke. Stroke. 45:239–47. 
Schmitter-Edgecombe M, Seelye AM. 2012. Recovery of content and temporal order 
memory for performed activities following moderate to severe traumatic brain injury. J. 
Clin. Exp. Neuropsychol. 34:256–68. 
Schoo LA, van Zandvoort MJE, Reijmer YD, Biessels GJ, Kappelle LJ, Postma A. 
2014. Absolute and relative temporal order memory for performed activities following 
stroke. J. Clin. Exp. Neuropsychol. 36:648–58. 
Schwamm LH, Ali SF, Reeves MJ, Smith EE, Saver JL, Messe S, Bhatt DL, Grau-
Sepulveda M V, Peterson ED, Fonarow GC. 2013. Temporal Trends in Patient 
Characteristics and Treatment With Intravenous Thrombolysis Among Acute Ischemic 
Stroke Patients at Get With the Guidelines-Stroke Hospitals. Circ. Cardiovasc. Qual. 
Outcomes 6:543–549. 
Schwarting RKW, Wöhr M. 2012. On the relationships between ultrasonic calling and 
anxiety-related behavior in rats. Brazilian J. Med. Biol. Res.   Rev. Bras. Pesqui. 
médicas e biológicas   Soc. Bras. Biof sica ... [et al.] 45:337–48. 
183 
 
Semendeferi K, Lu A, Schenker N, Damasio H. 2002. Humans and great apes share a 
large frontal cortex. Nat. Neurosci. 5:272–6. 
Shah AA, Treit D. 2003. Excitotoxic lesions of the medial prefrontal cortex attenuate 
fear responses in the elevated-plus maze, social interaction and shock probe burying 
tests. Brain Res. 969:183–194. 
Sharkey J, Butcher SP. 1995. Characterisation of an experimental model of stroke 
produced by intracerebral microinjection of endothelin-1 adjacent to the rat middle 
cerebral artery. J. Neurosci. Methods 60:125–131. 
Sharkey J, Butcher SP, Kelly JS. 1994. Endothelin-1 induced middle cerebral artery 
occlusion: pathological consequences and neuroprotective effects of MK801. J. Auton. 
Nerv. Syst. 49 Suppl:S177-85. 
Sharma G, Vijayaraghavan S. 2003. Modulation of Presynaptic Store Calcium Induces 
Release of Glutamate and Postsynaptic Firing. Neuron 38:929–939. 
Shimamura AP, Janowsky JS, Squire LR. 1990. Memory for the temporal order of 
events in patients with frontal lobe lesions and amnesic patients. Neuropsychologia 
28:803–13. 
Shimp CP. 1976. Short-term memory in the pigeon: relative recency. J. Exp. Anal. 
Behav. 25:55–61. 
Siddiqui SV, Chatterjee U, Kumar D, Siddiqui A, Goyal N. 2008. Neuropsychology of 
prefrontal cortex. Indian J. Psychiatry 50:202–8. 
Skoog I, Nilsson L, Palmertz B, Andreasson LA, Svanborg A. 1993. A population-based 
study of dementia in 85-year-olds. N. Engl. J. Med. 328:153–8. 
Smith EE, Salat DH, Jeng J, McCreary CR, Fischl B, Schmahmann JD, Dickerson BC, 
Viswanathan A, Albert MS, Blacker D, et al. 2011. Correlations between MRI white 
matter lesion location and executive function and episodic memory. Neurology 
76:1492–9. 
Snyder HR. 2013. Major depressive disorder is associated with broad impairments on 
neuropsychological measures of executive function: a meta-analysis and review. 
Psychol. Bull. 139:81–132. 
Song C, Leonard BE. 2005. The olfactory bulbectomised rat as a model of depression. 
Neurosci. Biobehav. Rev. 29:627–647. 
Soria G, Tudela R, Márquez-Martín A, Camón L, Batalle D, Muñoz-Moreno E, Eixarch 
E, Puig J, Pedraza S, Vila E, et al. 2013. The ins and outs of the BCCAo model for 
chronic hypoperfusion: a multimodal and longitudinal MRI approach. PLoS One 
8:e74631. 
de Souza Silva MA, Huston JP, Wang A-L, Petri D, Chao OY-H. 2016. Evidence for a 
Specific Integrative Mechanism for Episodic Memory Mediated by AMPA/kainate 
184 
 
Receptors in a Circuit Involving Medial Prefrontal Cortex and Hippocampal CA3 
Region. Cereb. Cortex 26:3000–9. 
St Jacques P, Rubin DC, LaBar KS, Cabeza R. 2008. The short and long of it: neural 
correlates of temporal-order memory for autobiographical events. J. Cogn. Neurosci. 
20:1327–41. 
Starkstein SE, Robinson RG. 1997. Mechanism of disinhibition after brain lesions. J. 
Nerv. Ment. Dis. 185:108–14. 
Statistics Canada. 2014. Annual Demographic Estimates: Canada, Provinces and 
Territories. 
Stefani MR, Groth K, Moghaddam B. 2003. Glutamate receptors in the rat medial 
prefrontal cortex regulate set-shifting ability. Behav. Neurosci. 117:728–737. 
Steultjens EMJ, Dekker J, Bouter LM, van de Nes JCM, Cup EHC, van den Ende CHM. 
2003. Occupational Therapy for Stroke Patients. Stroke 34. 
Stevens KE, Johnson RG, Rose GM. 1997. Rats Reared in Social Isolation Show 
Schizophrenia-Like Changes in Auditory Gating. Pharmacol. Biochem. Behav. 
58:1031–1036. 
Strong K, Mathers C, Bonita R. 2007. Preventing stroke: saving lives around the world. 
Lancet Neurol. 6:182–7. 
Sturm W, Willmes K. 1991. Efficacy of a reaction training on various attentional and 
cognitive functions in stroke patients. Neuropsychol. Rehabil. 1:259–280. 
Stuss DT, Alexander MP. 2000. Executive functions and the frontal lobes: a conceptual 
view. Psychol. Res. 63:289–98. 
Stuss DT, Levine B, Alexander MP, Hong J, Palumbo C, Hamer L, Murphy KJ, 
Izukawa D. 2000. Wisconsin Card Sorting Test performance in patients with focal 
frontal and posterior brain damage: effects of lesion location and test structure on 
separable cognitive processes. Neuropsychologia 38:388–402. 
Sullivan JE, Hedman LD. 2008. Sensory dysfunction following stroke: incidence, 
significance, examination, and intervention. Top. Stroke Rehabil. 15:200–17. 
Sullivan RM, Gratton A. 1999. Lateralized effects of medial prefrontal cortex lesions on 
neuroendocrine and autonomic stress responses in rats. J. Neurosci. 19:2834–40. 
Sumner MJ, Cannon TR, Mundin JW, White DG, Watts IS. 1992. Endothelin ETA and 
ETB receptors mediate vascular smooth muscle contraction. Br. J. Pharmacol. 107:858–
860. 
Sun H-S, Doucette TA, Liu Y, Fang Y, Teves L, Aarts M, Ryan CL, Bernard PB, Lau 
A, Forder JP, et al. 2008. Effectiveness of PSD95 Inhibitors in Permanent and Transient 
Focal Ischemia in the Rat. Stroke 39. 
185 
 
Sun JH, Tan L, Yu J. 2014. Post-stroke cognitive impairment: epidemiology, 
mechanisms and management. Ann. Transl. Med. 2:80. 
Swerdlow NR, Koob GF. 1987. Lesions of the dorsomedial nucleus of the thalamus, 
medial prefrontal cortex and pedunculopontine nucleus: effects on locomotor activity 
mediated by nucleus accumbens-ventral pallidal circuitry. Brain Res. 412:233–243. 
Tajiri N, Dailey T, Metcalf C, Mosley YI, Lau T, Staples M, van Loveren H, Kim SU, 
Yamashima T, Yasuhara T, et al. 2013. In vivo animal stroke models: a rationale for 
rodent and non-human primate models. Transl. Stroke Res. 4:308–21. 
Takeuchi N, Izumi S-I. 2013. Rehabilitation with poststroke motor recovery: a review 
with a focus on neural plasticity. Stroke Res. Treat. 2013:128641. 
Talwar T, Srivastava MVP. 2014. Role of vascular endothelial growth factor and other 
growth factors in post-stroke recovery. Ann. Indian Acad. Neurol. 17:1–6. 
Tang WK, Chen Y, Lam WWM, Mok V, Wong A, Ungvari GS, Xiang YT, Wong KS. 
2009. Emotional incontinence and executive function in ischemic stroke: a case-
controlled study. J. Int. Neuropsychol. Soc. 15:62–8. 
Tatemichi TK, Desmond DW, Paik M, Figueroa M, Gropen TI, Stern Y, Sano M, 
Remien R, Williams JB, Mohr JP. 1993. Clinical determinants of dementia related to 
stroke. Ann. Neurol. 33:568–75. 
Tatemichi TK, Desmond DW, Stern Y, Paik M, Sano M, Bagiella E. 1994. Cognitive 
impairment after stroke: frequency, patterns, and relationship to functional abilities. J. 
Neurol. Neurosurg. Psychiatry 57:202–207. 
Tatu L, Moulin T, Vuillier F, Bogousslavsky J. 2012. Arterial territories of the human 
brain. Front. Neurol. Neurosci. 30:99–110. 
Thiyagarajan M, Sharma SS. 2004. Neuroprotective effect of curcumin in middle 
cerebral artery occlusion induced focal cerebral ischemia in rats. Life Sci. 74:969–985. 
Thomas AJ, Perry R, Kalaria RN, Oakley A, McMeekin W, O‟Brien JT. 2003. 
Neuropathological evidence for ischemia in the white matter of the dorsolateral 
prefrontal cortex in late-life depression. Int. J. Geriatr. Psychiatry 18:7–13. 
Traylor M, Farrall M, Holliday EG, Sudlow C, Hopewell JC, Cheng Y-C, Fornage M, 
Ikram MA, Malik R, Bevan S, et al. 2012. Genetic risk factors for ischaemic stroke and 
its subtypes (the METASTROKE collaboration): a meta-analysis of genome-wide 
association studies. Lancet. Neurol. 11:951–62. 
Traystman RJ. 2003. Animal Models of Focal and Global Cerebral Ischemia. ILAR J. 
44:85–95. 
Tyson SF, Hanley M, Chillala J, Selley AB, Tallis RC. 2008. Sensory loss in hospital-
admitted people with stroke: characteristics, associated factors, and relationship with 
function. Neurorehabil. Neural Repair 22:166–72. 
186 
 
Uesugi M, Kasuya Y, Hama H, Yamamoto M, Hayashi K, Masaki T, Goto K. 1996. 
Endogenous endothelin-1 initiates astrocytic growth after spinal cord injury. Brain Res. 
728:255–9. 
Uylings HBM, Groenewegen HJ, Kolb B. 2003. Do rats have a prefrontal cortex? 
Behav. Brain Res. 146:3–17. 
Vahid-Ansari F, Lagace DC, Albert PR. 2016. Persistent post-stroke depression in mice 
following unilateral medial prefrontal cortical stroke. Transl. Psychiatry 6:e863. 
Vataja R, Pohjasvaara T, Mantyla R, Ylikoski R, Leppavuori A, Leskela M, Kalska H, 
Hietanen M, Aronen HJ, Salonen O, et al. 2003. MRI correlates of executive 
dysfunction in patients with ischaemic stroke. Eur. J. Neurol. 10:625–631. 
Vogt G, Laage R, Shuaib A, Schneider A. 2012. Initial lesion volume is an independent 
predictor of clinical stroke outcome at day 90: an analysis of the Virtual International 
Stroke Trials Archive (VISTA) database. Stroke. 43:1266–72. 
Volpe BT, Pulsinelli WA, Tribuna J, Davis HP. 1984. Behavioral performance of rats 
following transient forebrain ischemia. Stroke. 15:558–62. 
Voorhies AC, Jones TA. 2002. The behavioral and dendritic growth effects of focal 
sensorimotor cortical damage depend on the method of lesion induction. Behav. Brain 
Res. 133:237–46. 
Wade DT, Parker V, Langton Hewer R. 1986. Memory disturbance after stroke: 
frequency and associated losses. Int. Rehabil. Med. 8:60–4. 
Wade DT, Wood VA, Hewer RL. 1988. Recovery of cognitive function soon after 
stroke: a study of visual neglect, attention span and verbal recall. J. Neurol. Neurosurg. 
Psychiatry 51:10–13. 
Walton ME, Bannerman DM, Alterescu K, Rushworth MFS. 2003. Functional 
Specialization within Medial Frontal Cortex of the Anterior Cingulate for Evaluating 
Effort-Related Decisions. J. Neurosci. 23:6475–6479. 
Walton ME, Bannerman DM, Rushworth MFS. 2002. The Role of Rat Medial Frontal 
Cortex in Effort-Based Decision Making. J. Neurosci. 22:10996–11003. 
Wang S, Zhang Z, Guo Y, Teng G, Chen B. 2009. Decreased expression of serotonin 
1A receptor in the dentate gyrus in association with chronic mild stress: A rat model of 
post-stroke depression. Psychiatry Res. 170:245–251. 
Wang Y, Galvan V, Gorostiza O, Ataie M, Jin K, Greenberg DA. 2006. Vascular 
endothelial growth factor improves recovery of sensorimotor and cognitive deficits after 
focal cerebral ischemia in the rat. Brain Res. 1115:186–93. 
Warburton EC, Brown MW. 2015. Neural circuitry for rat recognition memory. Behav. 
Brain Res. 285:131–139. 
187 
 
Ward AB. 2012. A literature review of the pathophysiology and onset of post-stroke 
spasticity. Eur. J. Neurol. 19:21–7. 
Ward NM, Sharkey J, Marston HM, Brown VJ. 1998. Simple and choice reaction-time 
performance following occlusion of the anterior cerebral arteries in the rat. Exp. brain 
Res. 123:269–81. 
Watson BD, Dietrich WD, Busto R, Wachtel MS, Ginsberg MD. 1985. Induction of 
reproducible brain infarction by photochemically initiated thrombosis. Ann. Neurol. 
17:497–504. 
Weimar C, Ziegler A, König IR, Diener H-C. 2002. Predicting functional outcome and 
survival after acute ischemic stroke. J. Neurol. 249:888–95. 
Westerberg H, Jacobaeus H, Hirvikoski T, Clevberger P, Ostensson M-L, Bartfai A, 
Klingberg T. 2007. Computerized working memory training after stroke--a pilot study. 
Brain Inj. 21:21–9. 
Williams A. 1994. What bothers caregivers of stroke victims? J. Neurosci. Nurs. 
26:155–61. 
Windle V, Szymanska A, Granter-Button S, White C, Buist R, Peeling J, Corbett D. 
2006. An analysis of four different methods of producing focal cerebral ischemia with 
endothelin-1 in the rat. Exp. Neurol. 201:324–334. 
Winstanley CA. 2004. Contrasting Roles of Basolateral Amygdala and Orbitofrontal 
Cortex in Impulsive Choice. J. Neurosci. 24:4718–4722. 
Winstanley CA. 2005. Double Dissociation between Serotonergic and Dopaminergic 
Modulation of Medial Prefrontal and Orbitofrontal Cortex during a Test of Impulsive 
Choice. Cereb. Cortex 16:106–114. 
Winstein C. 1999. Motor learning after unilateral brain damage. Neuropsychologia 
37:975–987. 
Wolf SL, Winstein CJ, Miller JP, Taub E, Uswatte G, Morris D, Giuliani C, Light KE, 
Nichols-Larsen D. 2006. Effect of constraint-induced movement therapy on upper 
extremity function 3 to 9 months after stroke: the EXCITE randomized clinical trial. 
JAMA 296:2095–104. 
Wood NI, Sopesen B V., Roberts JC, Pambakian P, Rothaul AL, Hunter AJ, Hamilton 
TC. 1996. Motor dysfunction in a photothrombotic focal ischaemia model. Behav. Brain 
Res. 78:113–120. 
Wright JM, Gourdon JC, Clarke PBS. 2010. Identification of multiple call categories 
within the rich repertoire of adult rat 50-kHz ultrasonic vocalizations: effects of 
amphetamine and social context. Psychopharmacology (Berl). 211:1–13. 
Wu C, Zhang J, Chen Y. 2015. Study on the behavioral changes of a post-stroke 
depression rat model. Exp. Ther. Med. 10:159–163. 
188 
 
Xing C, Arai K, Lo EH, Hommel M. 2012. Pathophysiologic cascades in ischemic 
stroke. Int. J. Stroke 7:378–85. 
Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, 
Goto K, Masaki T. 1988. A novel potent vasoconstrictor peptide produced by vascular 
endothelial cells. Nature 332:411–5. 
Yates JR, Perry JL, Meyer AC, Gipson CD, Charnigo R, Bardo MT. 2014. Role of 
medial prefrontal and orbitofrontal monoamine transporters and receptors in 
performance in an adjusting delay discounting procedure. Brain Res. 1574:26–36. 
Yi ZM, Liu F, Zhai SD. 2010. Fluoxetine for the prophylaxis of poststroke depression in 
patients with stroke: a meta-analysis. Int. J. Clin. Pract. 64:1310–7. 
Yonemori F, Yamaguchi T, Yamada H, Tamura A. 1998. Evaluation of a motor deficit 
after chronic focal cerebral ischemia in rats. J. Cereb. Blood Flow Metab. 18:1099–106. 
Yu JC, Pickard JD, Davenport AP. 1995. Endothelin ETA receptor expression in human 
cerebrovascular smooth muscle cells. Br. J. Pharmacol. 116:2441–6. 
Yuan J. 2009. Neuroprotective strategies targeting apoptotic and necrotic cell death for 
stroke. Apoptosis 14:469–77. 
Zangerle A, Kiechl S, Spiegel M, Furtner M, Knoflach M, Werner P, Mair A, Wille G, 
Schmidauer C, Gautsch K, et al. 2007. Recanalization after thrombolysis in stroke 
patients: predictors and prognostic implications. Neurology 68:39–44. 
Zhang L, Chen J, Li Y, Zhang ZG, Chopp M. 2000. Quantitative measurement of motor 
and somatosensory impairments after mild (30 min) and severe (2 h) transient middle 
cerebral artery occlusion in rats. J. Neurol. Sci. 174:141–146. 
Zhang L, Zhang RL, Wang Y, Zhang C, Zhang ZG, Meng H, Chopp M. 2005. 
Functional recovery in aged and young rats after embolic stroke: treatment with a 
phosphodiesterase type 5 inhibitor. Stroke. 36:847–52. 
Zheng Z, Yenari MA. 2004. Post-ischemic inflammation: molecular mechanisms and 
therapeutic implications. Neurol. Res. 26:884–92. 
Zhou DHD, Wang JYJ, Li J, Deng J, Gao C, Chen M. 2005. Frequency and risk factors 
of vascular cognitive impairment three months after ischemic stroke in china: the 
Chongqing stroke study. Neuroepidemiology 24:87–95. 
Zhu H-D, Martin R, Meloni B, Oltvolgyi C, Moore S, Majda B, Knuckey N. 2004. 
Magnesium sulfate fails to reduce infarct volume following transient focal cerebral 
ischemia in rats. Neurosci. Res. 49:347–353. 
Zinn S, Bosworth HB, Hoenig HM, Swartzwelder HS. 2007a. Executive function 
deficits in acute stroke. Arch. Phys. Med. Rehabil. 88:173–180. 
Zinn S, Bosworth HB, Hoenig HM, Swartzwelder HS. 2007b. Executive Function 
189 
 
Deficits in Acute Stroke. Arch. Phys. Med. Rehabil. 88:173–180. 
Zumbansen A, Thiel A. 2014. Recent advances in the treatment of post-stroke aphasia. 
Neural Regen. Res. 9:703–6. 
 
  
190 
 
APPENDIX A:  aCSF COMPOSITION 
 
Compound g/mol Conc (mM) 
NaCl 58.44 124 
KCl 74.55 4 
NaH2PO4 137.99 1.24 
MgSO4 246.48 1.3 
CaCl2 147.01 2 
NaHCO3 84.01 26 
Glucose 180.2 10 
 
pH of aCSF was adjusted to 7.4 using hydrochloric acid. 
 
